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Abstract 
  
 Mycobacterium tuberculosis remains a major human health problem killing millions of 
people around the world. Therefore, the need for an in depth understanding of its 
pathogenicity is very important to enable rational development of new control 
strategies.  Not all M. tuberculosis infected individuals progress to active disease at the time 
of primary infection as some carry an asymptomatic persistent infection that may reactivate 
later in life to cause disease. Despite a great deal of M. tuberculosis research, the ability of 
M. tuberculosis to cause long-term persistent infection in immune-competent hosts is poorly 
understood. When M. tuberculosis is inside the body it faces many environmental stress 
conditions including hypoxia, starvation and oxidative stress that damage proteins, DNA and 
other molecules. Gene expression studies have identified many bacterial genes that are 
differentially regulated when M. tuberculosis is subjected to such environmental stresses. 
This thesis focusses on three of these genes, the ssrA gene, which encodes the tmRNA 
molecule involved in ribosome recycling and degradation of denatured proteins, and two 
genes encoding a-crystallin molecular chaperones (acr1 and acr2).  
 
This study was designed to achieve two aims: (1) to examine the role of tmRNA in 
translational control and protein homeostasis in stressed mycobacteria; and (2) to understand 
the roles of Acr1 and Acr2 in the stress response of M. tuberculosis and to reveal the degree 
of redundancy between them.  
 
In this thesis it was shown that ssrA/tmRNA is essential for bacterial viability as it was  
not possible to delete the gene unless a second fully functional copy was introduced 
  iv 
elsewhere in the genome. The results suggested that the protease tagging function of tmRNA 
is essential alongside its role in ribosome recycling. A recombinant His-tagged tmRNA was 
expressed in the mycobacteria in an attempt to identify if tmRNA is directly involved in the 
translation of stress proteins. Expression of the His-tagged tmRNA was detrimental to the 
cell and appeared to preclude successful tagging of tmRNA substrate polypeptides. Thus 
there was insufficient evidence to support the hypothesis. 
 
 Ultrastructural localisation of Acr1 and Acr2 by immuno-electron microscopy and Western 
blotting of subcellular fractions of mycobacteria showed that Acr1 and Acr2 were localised 
in different parts of the cell. Assay of the phenotypes of single and double deletion mutants 
of Acr1 and Acr2 in different in vitro conditions failed to show any evidence that the two 
chaperones are functionally redundant. Indeed, experiments on intracellular infection of 
macrophages showed no phenotypic consequences resulted from loss of Acr1 but deletion 
of Acr2 resulted in an altered cytotoxic effect on the host cell.  
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1.1 Introduction 
Tuberculosis (TB) is an ancient disease and has been documented since early human history 
(Vimlesh and Kabra, 2006); however the causative agent, Mycobacterium tuberculosis (M. 
tb) was not discovered until 1882 by Robert Koch (Ducati et al., 2006).  M. tuberculosis is 
a very successful, slow growing, non-obligatory intracellular pathogen, and TB is a 
worldwide issue, with a mortality rate of 42% to 50% (in some high burden countries)   
(WHO, 2015). Although about one-third of the world’s population is estimated to be infected 
with M. tuberculosis but, in some infected individuals this pathogen can enter an apparent 
dormant (viable, non-replicative) state leading to latent infection. About 10% of latently 
infected individual may progress to active disease (WHO, 2015).  The risk of reactivation of 
latently infected patients has been estimated to be 2% annually; however, co-infection with 
HIV increases this rate to 5-10% (Dolin et al., 1994). The sustained prevalence of M. 
tuberculosis highlights the need for understanding host-pathogen interactions in order to 
discover new strategies to overcome the ever growing problem of M. tuberculosis infection. 
Understanding how the bacterium responds to various environmental stresses it encounters 
within the human body is likely to be important for the development of new methods of 
control. For M. tuberculosis to survive within a macrophage it must have appropriate and 
effective mechanisms for adaptation to such a harsh environment. This study will investigate 
the response of M. tuberculosis to various stresses, both in vivo and in vitro, and it seeks to 
investigate the role of three M. tuberculosis genes (α-crystallin 1, α-crystrallin 2 and ssrA) 
in the stress response in the context of mycobacterial survival and pathogenesis. This thesis 
is presented in two parts; the first focuses on tmRNA encoded by the ssrA gene and the 
second on α-crystallins. 
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1.2  Mycobacterial Strains causing Tuberculosis 
 
Taxonomically, mycobacteria belong to the order Actinomycetales, the family 
Mycobacteriaceae, and the genus Mycobacterium. There are around 60 species within the 
Mycobacterium genus with the majority existing as saprophytes, whilst a minority are 
pathogenic to humans, such as M. tuberculosis, M. bovis, M. africanum and M. leprae. Not 
all pathogenic mycobacteria species can cause human TB (Jarlier and Nikaido, 1994), and 
those species known to cause human tuberculosis are all closely related and are grouped 
within the M. tuberculosis complex, which is composed of M. tuberculosis, M. bovis, M. 
africanum, M. canetti and M. microti. These different species exhibit a different phenotype 
and level of virulence; M. africanum is not widespread and is limited to parts of Africa 
(Murry et al., 2005), while M. canetti is also rare and is confined to the Horn of Africa. M. 
bovis is no longer a common cause of human TB, especially in developed countries since 
the introduction of milk pasteurisation (de la Rua-Domenech, 2006); however, it is still a 
concern in some developing countries, especially among HIV patients (Cosivi et al., 1998). 
These four species, M. bovis, M. africanum, M. canetti and M. microti are relatively rare 
causative agents of TB in comparison to M. tuberculosis. 
 
The complete genome sequence of the virulent M. tuberculosis strain 37rv was published in 
1998. The genome size was reported as 4,411,529 bp with 4000 genes and it has a high G+C 
content at 65.5% (Cole et al., 1998). Genome analysis indicated that it has an efficient DNA 
repair system, as 45 genes related to DNA repair mechanisms are present. 
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1.3  Epidemiology 
 
TB is a major global public health problem and has a severe economic impact on countries 
where it is endemic. In 2014, South-East Asia and Western Pacific regions reported the 
greatest share of TB cases (58%), followed by Africa (28%), where the highest incidence 
rate of 281 cases per 100,000 individuals was observed (WHO, 2015). The largest number 
of cases by country was reported was India (23%), Indonesia (10%) and China (10%). TB 
has high morbidity rate and the World Health Organization (WHO) in their Global 
Tuberculosis Report in 2015 estimated that there are approximately 2-3 billion people 
infected worldwide, although only 5-15% of the total infected population progress to active 
symptomatic disease. The probability of developing the symptomatic disease is much higher 
about 10% per year (Narasimhan et al., 2013) among the HIV positive population. 
According to the WHO, there were 9.6 million new TB cases in 2014, 5.4 million in men, 
3.2 million in women and 1 million in children. TB has a very high mortality rate and the 
WHO reported that in 2014 there were 1.5 million deaths caused by TB, with 1.1 million 
among HIV negative individuals and 400,000 among HIV positive individuals (WHO, 
2015). The estimation of the TB incident rate is a very expensive process and requires long 
term studies; therefore, it might not reflect the actual rate as there may be underreporting or 
misdiagnosis. The WHO stated in their Global Tuberculosis Report (WHO, 2015) that 
different methods were used to estimate the TB incidence: (1) case notification data 
combined with expert opinion about case detection gaps; (2) results from national TB 
prevalence surveys; (3) notifications in high-income countries adjusted by a standard factor 
to account for under-reporting and under-diagnosis; and (4) results from inventory/capture-
recapture studies.  
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1.4  Immunopathogenesis of M. tuberculosis  
 
TB spreads via the inhalation of aerosols produced by an infected individual as a result of 
coughing. When inhaled, bacilli are phagocytosed by cells, including alveolar macrophages 
and tissue dendritic cells (DCs). Post-phagocytosis, these cells produce various pro-
inflammatory cytokines, responsible for the migration of other immune cells from the blood 
stream to the site of infection, and hence lead to the recruitment of more neutrophils and 
monocytes as well as more DC. The presence of Mycobacteria within DCs results in their 
activation and migration to local lymph nodes, where they will present processed 
Mycobacterium antigens to T lymphocytes. This ability to survive intracellularly enables M. 
tuberculosis to avoid the potent immune response and persist (Suhail, 2010), leading to 
chronic antigen stimulation and the accumulation of T cells around macrophages (Grace and 
Ernst, 2015). Chronic cytokine stimulation results in further differentiation of macrophages 
into different forms, including epithelioid, foamy macrophages loaded with lipid droplets, 
and multinucleated giant cells (Russell et al., 2009).  
 
Infected DCs produce cytokines, such as IL-12 and IL-18, which are important for the 
induction of natural killer (NK) T cells. Activation of NK cells results in the production of 
IFN-ɤ, which activates macrophages to produce TNF-α. TNF-α plays a critical role in the 
immune response to M. tuberculosis infection, as it causes further macrophage activation, 
and the production of various cytokines and chemokines, as well as apoptosis (Fallahi-
Sichani et al., 2012). The recruitment of more immune cells leads to increased cytokine 
production and further cell migration and recruitment, leading to the formation of an immune 
cell aggregation, known as a granuloma. 
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To control mycobacterial infection, the formation and maintenance of granulomas is vital. 
A granuloma provides a microenvironment in which different immune cells are present and 
can communicate via different cytokines. Bacteria are trapped within a granuloma and 
prevented from spreading further throughout a host. However, M. tuberculosis is able to 
disrupt the organised structure of a granuloma, a typical feature of TB reactivation. Infected 
DCs release IL-12 and IL-23, which are cytokines that act on the receptors primarily 
expressed by T lymphocytes, such as CD4 and CD8T, leading to  their stimulation (Robert 
et al., 2008). There are various subsets of CD4+ cells, including T helper 1 (Th1) and T 
helper 2 (Th2) cells, T-regulatory cells, and Th17 cells.  Different subsets of CD4+ cells 
produce different cytokines, for example Th1 cells produce IFN-γ, mycobacteria-specific 
interferon, and TNF-a (Prezzemolo et al., 2014),  Th2 cells produce  IL-4, IL-10 and TGF-
β (Tsuyuguchi, 1995), while Th17 cells produce IL-17 and IL-22 (Janelle and Skokos, 2012).  
CD4+ lymphocytes play a very important role in the fight against TB, and any defect in their 
function can lead to disease progression and the reactivation of latent TB. HIV results in the 
loss of CD4+ T cells and hence there is a surge in TB reactivation (Chetty et al., 2015). 
Animal models that are deficient in CD4+ T cells have shown an impaired ability to fight 
and control TB, resulting in death (Caruso et al., 1999; Lin et al., 2012).  
 
The presence of CD8+ T cells within a granuloma highlights their important role in the 
control and containment of M. tuberculosis (Dhruv et al., 2006). Unlike CD4+ T cells which 
are more active during the early stage of M. tuberculosis infection,  CD8+ T cells are more 
active in the later stage of M. tuberculosis infection (Lazarevic et al., 2005).  M. tuberculosis 
infects various cells in addition to phagocytic cells, such as type II epithelial cells which 
express MHC class II but not MHC class I,  and CD8 cells have the ability to recognise these 
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sub-classes of infected cells, thereby emphasising the unique role of CD8 cells in the 
different stages of  the immune response to M. tuberculosis infection (Harriff et al., 2014). 
 
1.5  M. tuberculosis Cell Wall Interaction with the Immune System 
 
The protein Acr1 is known to be associated with the cell wall, and its interaction is covered 
in details in section 1.9.2. However, in this section a brief description of examples of cell 
wall component interactions with the immune system will be presented.  
 
The mycobacterial cell wall plays a major role in the survival and pathogenesis of M. 
tuberculosis. Unlike Gram-negative bacteria, the M. tuberculosis cell wall is largely 
composed of fatty acids, known as mycolic acids, which are linked to arabinogalactan and 
attached to a small layer of peptidoglycan. The cell wall also contains many lipoglycans, 
such as lipoarabinomannan (LAM), lipomannan (LM) and phosphatidyl-myo-inositol 
mannosides (PIM). PIM is the precursor of LAM and it forms approximately 56% of all 
phospholipids found in the mycobacterial cell wall (Nigou et al., 2001) . LAM can bind to 
Toll receptors and can insert itself into membranes, leading to the induction of many 
signalling events (Kleinnijenhuis et al., 2011). In addition, the capping of LAM with short 
mannose oligosaccharides has been found to be required for the persistence of M. 
tuberculosis and BCG within macrophages through suppression of the IL-12 response 
(Nigou et al., 2001) and it also inhibits apoptosis (Dao et al., 2004). IL-12 is a key cytokine 
in the host defences against M. tuberculosis infection, and is important for eliciting the Th1 
immune response, with some studies showing that individuals with a mutation in their IL-12 
gene or its receptors have an increased susceptibility to M. tuberculosis (Altare et al., 1998). 
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Mycolic acid is recognised by CD1-restricted T-Cells and mycolyltransferase (Ag85) is a 
powerful protective antigen against M. tuberculosis (Brennan, 2003). Phosphatidylinositols 
and  different phosphorylated forms are important regulatory molecules within eukaryotic 
cells (Vergne et al., 2004), and they have also been shown to play vital roles in signal 
transduction, cytoskeletal organisation, and regulation of discrete membrane trafficking 
events during organelle biogenesis (Corvera et al., 1999; Di Paolo and De Camilli, 2006; 
Gillooly et al., 2001; Simonsen et al., 1999).  
 
1.6  Dormancy 
 
Humans become infected by inhaling microscopic aerosol droplets containing  TB  bacilli 
(Kaufmann, 2001), and invading M. tuberculosis after entering the terminal alveoli are 
engulfed by macrophages. The environment inside these macrophages is hostile, 
consequently M. tuberculosis has to adapt to this stressful environment by: (1) re-
programming the macrophage to prevent its own destruction; (2) creating a confined 
environment where it can safely isolate itself from the host by initiating the formation of a 
granuloma which is composed of various immune cells; (3) slowing its metabolism, ceasing 
replication and entering dormancy, where is it resistant to host defences and anti-bacterial 
agents (Gengenbacher and Kaufmann, 2012); and (4) re-activation from the dormant status 
after a long latent infection and proliferation, which causes symptomatic infection. 
Approximately 10% of latently infected individuals experience reaction of their TB 
(Fattorini et al., 2013), and switching to dormancy it not only a means of survival but also a 
strategy to modulate the immune response during different stages of TB infection (Mariotti 
et al., 2013).   
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Understanding dormancy and the phenotypical resistance of dormant bacilli will help in 
eliminating dormant bacilli and in the development of drugs that have high penetration into 
the granuloma, and therefore is essential for the eradication of M. tuberculosis from humans 
(Evangelopoulos et al., 2015; Fattorini et al., 2013; Lenaerts et al., 2015; Prideaux et al., 
2015).   
 
It is very difficult to simulate the exact granuloma environment in order to properly study 
dormancy under conditions such as low pH, oxygen depletion, iron limitation, nitrosative 
stress and nutrient starvation (Timm et al., 2003; Voskuil et al., 2004) which are appropriate 
and truly representative of human latent TB infection (LTBI). However, there are many in 
vivo and in vitro models that can be used to study M. tuberculosis host interactions and to 
investigate the adaptive response of M. tuberculosis which enables it to become non-
proliferating or dormant.  
 
In vivo models are probably the best models used to study dormancy, as they provide the 
ideal environment for the multiple stresses surrounding M. tuberculosis.  Different animals 
have been used for in vivo models, including non-human primate macaque monkey, guinea 
pigs, mice, marmosets, and rabbits; however, they all have limitations. The most commonly 
used model, due to availability and cost, is the mouse model but this is not the best 
representation of M. tuberculosis infection in humans, due to the high bacterial burden in 
susceptible mice and poor clearance, and the different murine immune response compared 
to humans in terms of granuloma formation (Sugawara et al., 2004).  In contrast, rats have 
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been reported to be a better model for understanding host-TB interactions (Amit  et al., 
2011). Whilst it has been reported that non-replicating TB bacilli could be detected in lung 
lesions of infected guinea pigs (Lenaerts et al., 2007), they are not a good model for studying 
LTBI, as they are highly susceptible to a low dose inoculum of M. tuberculosis (Ordway et 
al., 2008). Rabbits are another good model system, as they have high resistance to M. 
tuberculosis resulting in LTBI (Patel et al., 2011) but due to cost and the non-availability of 
immunological reagents for rabbits, they are not often used (Amit  et al., 2011). The best 
model which can more accurately mimic human TB disease is Cynomologus macaques 
(Kaushal et al., 2012) however, this has the disadvantages of  high cost and complex bio-
containment issues. 
 
In vitro models use one or a group of stresses to simulate the conditions that M. tuberculosis 
faces inside the body, such as hypoxia, oxidative and nitrosative stresses, exposure to nitric 
oxide and carbon monoxide, starvation of essential nutrients including carbon, nitrogen and 
phosphorus, as well as iron limitation. Different methods to induce dormancy include: (1) 
non-replicative oxygen depletion (NRP) model, in which a bacterial culture is placed in 
sealed flasks and is gently stirred to allow access to oxygen in the medium until it is gradually 
depleted (Voskuil et al., 2004; Wayne and Hayes, 1996); (2) static culture oxygen depletion 
model (Kendall et al., 2004), in which a bacterial culture is left to settle and oxygen levels 
are gradually depleted;  (3) short course of complete starvation (Betts et al., 2002); (4) 
addition of nitric oxide  (Voskuil et al., 2003), human macrophages (THP1) activated with 
vitaminD3 and retinoic acid  model (Estrella et al., 2011); (5) multiple stresses model using 
low carbon and nitrogen nutrients, an acidic pH, low oxygen and high carbon dioxide levels 
(Deb et al., 2009); (6) controlled batch culture model (Brian et al., 2002); and (7) the gradual 
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depletion of oxygen and nutrients within a controlled environment (Bacon et al., 2014). The 
static culture oxygen depletion model has the limitation that it is difficult to reproduce, as a 
slight change in the settling and growth rates may upset the equilibrium between replication 
and settling that is required to maintain the oxygen gradient, and hence orderly shift to 
dormancy. In addition, it is not possible to isolate and study the sequential events that 
characterise the process of the shift down to dormancy in the heterogeneous population of 
settling bacilli (Wayne and Hayes, 1996) 
 
1.7  Reactivation and Resuscitation 
 
LTBI is caused by M. tuberculosis persisting in the dormant stage that is normally 
phenotypically, but not genetically, resistant to antibiotics (Connolly et al., 2007; Sarathy et 
al., 2013; Wayne and Hayes, 1996). This phenotypical resistance comes from the fact that 
most, if not all, of the antibiotics that are used to treat M. tuberculosis are targeted against 
actively growing or metabolically active bacilli and are not active against viable non-
replicating (dormant) cells. Reactivation of dormant actinobacteria, such as Micrococcus 
luteus, is initiated by resuscitation–promoting factor (Rpf)   (Koltunov et al., 2010; 
Mukamolova et al., 2002) and  M. tuberculosis has five homologues of resuscitation-
promoting factors, RpfA-E (Kana et al., 2008; Romano et al., 2012). The possession of a 
number of rpf genes means that some redundancy may exist, as only multiple gene knockouts 
and not single knockouts result in the impairment of resuscitation in vitro and attenuation in 
mice (Kana et al., 2008). Although there is a heterogenic population during both LTBI and 
active TB, during LTBI there are more non-replicating, metabolically inactive (dormant) 
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bacilli than metabolically active cells, and the opposite situation is found during active TB 
infection (Gengenbacher and Kaufmann, 2012). 
 
1.8  Heat Shock Proteins 
 
All living cells respond to different metabolic, environmental and pathophysiological 
stresses by up-regulating the expression of a particular group of proteins known as heat 
shock proteins (Hsps). The heat shock response (HSR) is a fundamental cytoprotective 
pathway which confers resistance to heat stress, and it has been proposed that the HSR was 
evolutionarily selected to prevent anticipated  future stress damage, rather than to facilitate 
recovery from an existing stress effect (Verghese et al., 2012). Hsps are generally diverse 
and ubiquitous, and are induced under various stress conditions; they are classified into six 
major families, known as small heat-shock proteins (sHsps), Hsp40, Hsp60, Hsp70, Hsp90 
and Hsp100 (Bakthisaran et al., 2015; Buchner, 1996; Sun and MacRae, 2005). Each major 
heat shock family is composed of members that are either constitutively produced or are 
regulatory induced, targeting different subcellular compartments.   Protein members from 
the same family show significant sequence homology and are structurally, as well as 
functionally, related, but homology and similarity is not present between different chaperone 
families (Walter and Buchner, 2002).  
Hsps are also known as chaperones and play a vital role in the transport of proteins into the 
correct cellular compartments, the assembly of multiprotein complexes, the folding and 
unfolding of proteins, the regulation of protein degradation within the proteasome pathway, 
the protection of cells against stress and apoptosis, as well as cell-cycle control and signalling 
(Schmitt et al., 2007; Takayama et al., 2003). They also stimulate antigen presenting cells 
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(APCs), such as macrophages and DCs, and play a role in antigen presentation via 
chaperoning antigenic peptides to class I and class II molecules of the major 
histocompatibility complexes (Li and Srivastava, 2004).  Most chaperones have a broad 
range of protein clients because they promiscuously bind to unfolded proteins (Tyedmers et 
al., 2010).   Hsps are numerous and providing a full account of them is out of the scope of 
this study; therefore, only those relevant to this study, which is the sHsp a-crystallin 1 and  
a-crystallin 2 will be further expanded on. 
 
1.9   Small Heat Shock Proteins  
sHsps have molecular masses ranging from 12-43kDa and are characterised by the presence 
of a highly conserved region of 80-100 amino acids within their C-terminal domain, known 
as the α-crystallin domain. The N-terminal region exhibits variability both in length and 
amino acid sequence, and is responsible for much of the variability between different sHSps 
and hence their diversity (Figure 1). The role of the α-crystallin domain is to facilitate subunit 
interactions, while the role of the N-terminal domain is in multimerisation (Ganea, 2001). α-
crystallins function primarily as molecular chaperones preventing improper protein 
association (Abgar et al., 2001) through their ability to bind to non-native proteins under 
various stress situations, leading to inhibiting their irreversible aggregation and the 
prevention of  cell damage (Lindner et al., 2000).    
 
Figure 1 Domain organisation of sHsp   
The α-crystallin domain is flanked by the N-terminal domain (NTD) in green and the C-terminal domain (CTD) 
in yellow. 
NTD CTDAlpha	crystallin
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Based on their main function, chaperones are divided into two classes; foldases and holdases. 
The Hsp 70/40 system and Hsp90 are ATP dependent and belong to foldases class, whereas 
chaperone like sHsps are holdases.   Holdases are ATP-independent and bind aggregation-
prone proteins often under stress conditions and protect them from aggregation. When the 
stress condition is lifted then the bound proteins are released for refolding with the help 
foldases  (Basha et al., 2012; Haslbeck et al., 2005) 
 
1.9.1 Mycobacteria a-crystallins 
 
Previous studies have shown that M. tuberculosis responds to the stress it faces within 
macrophages by producing many proteins (Lee and Horwitz, 1995). Among these stress 
induced proteins are sHSP members of the α-crystallin protein family.  
Mycobacteria possess three classes of α-crystallin genes; acr1, acr2 and acr3, which share 
25-30% homology with each other. Not all mycobacteria species have the same copy number 
or class of genes. For example, M. leprae has only one copy of the acr3 gene, while M. avium 
has four copies of the acr3 gene (one of which may not be functional as it has an IS1245 
insertion sequence within it) and a single gene of the acr2 gene, and M. marinum and M. 
smegmatis each have one copy of each of the three classes.  M. tuberculosis, however, has 
only one copy of acr1 and acr2, and both influence the persistence of infection (Stewart et 
al., 2005). The acr1 and acr2 genes have an overall  similarity of 43% and 55% within the 
α-crystallin domain (Kennaway et al., 2005). 
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Acr1 is encoded by Rv2031c, which is also known as Hsp16.3, HspX or the 16kDa antigen 
(Kennaway et al., 2005).  Kennaway et al. (2005) reported that Acr1 is a dodecamer as shown 
by nanelectrospray mass spectrometry, and using 3-dimentional analysis of negative stain 
electron microscopy forms a tetrahedral assembly with 12 polypeptide chains.  Acr1 is 
associated with bacterial dormancy and its expression is induced by hypoxia (Stewart et al., 
2005), in fact Acr1 is synthesised in larger quantities than any other protein during the early 
stages of hypoxia (Sherman et al., 2001).    
 
Acr2 was originally identified by Ohara et al. (1997) as a new ribosome binding protein and 
named as heat-stress-induced ribosome binding protein (HrpA). This protein is 18kDa and 
is only induced at temperatures higher than 37oC  (Tabira et al., 2000), where it was found 
to be mainly associated with the ribosome 30S subunit.  Tabira et al. (2000) reported that 
HrpA was a sHsp as it has the following features: (i) a low molecular mass of 12-30kDa; (ii) 
the ability to form large oligomeric complexes (9-50 subunit); (iii) involvement in non-ATP 
dependent chaperoning; and (iv) has an α-crystallin domain (conserved carboxyl-terminal 
domain). Furthermore, Tabira et al. (2000) reported that HrpA has 30.2% identity and 43.4% 
homology at the amino acid level to HSP16.3, also known as HspX. Unlike HrpA, HspX is 
induced by hypoxia (Tabira et al., 2000).  
 
Stewart, Wernisch et al (2002) have studied HrpA, also known as an hsp protein encoded by 
Rv0251c, and due to its similarity (41% identity) to the α-crystallin 14kDa antigen (Acr1) it 
was renamed Acr2 as it was the second α-crystallin protein to be identified in M. 
tuberculosis.  It has been reported that during heat shock, Acr2 aids translation initiation due 
to its role in stabilising the 30S ribosome subunit  (Ohara et al., 1997). Acr2 was shown by 
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nanoelectrospray mass spectromertry to form a range of oligomers, composed of dimers and 
tetramers, while electron microscopy showed that a variety of particles sizes are present 
(Kennaway et al., 2005).  
 
Acr2 expression is induced by different stress conditions, including heat shock, oxidative 
stress and phagocytosis by human monocytes and monocyte-derived macrophages 
(Schnappinger et al., 2003; Stewart et al., 2002a; Wilkinson et al., 2005). It also has been 
reported that it is highly expressed during both chronic and acute infection in mice, but its 
deletion does  not impair M. tuberculosis growth in either murine BMDM or in mouse 
organs, although it delays disease progression (Stewart et al., 2005). 
 
Eukaryotic sHSps, such as Hsp90 and α-crystallins have been reported to protect some 
peptidase activities of the active form of the 20S proteasome against oxidative inactivation 
(Conconi et al., 1998). As there are similarities in both structure and function between sHSps 
it is possible that M. tuberculosis Acr1 and Acr2 proteins may play a role in protection 
against nitrosative and oxidative stress, possibly by interacting with the mycobacterial 
proteasome (Forrellad et al., 2013). The fact that acr2 along, with other proteases, is 
positively up-regulated by ClgR, the clp gene regulator, suggests it may play a role in protein 
homeostasis (Estorninho et al., 2010). 
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1.9.2 Role of Acr1 and Acr2 in Infection 
 
Acr1 and Acr2 are members of the crystallin family of molecular chaperones in M. 
tuberculosis, and both are known to contribute to M. tuberculosis infection and virulence, 
although the studies on their roles are inconclusive. Studies investigating the role of Acr1 
have yielded conflicting findings, as one has reported that deleting acr1 significantly 
impaired M. tuberculosis growth in both murine bone marrow-derived macrophages 
(BMDM)  and THP-1 cells (Zhang et al., 1998), and another showed the exact opposite, 
reporting that the deletion increased growth in BALB/c mice and in both resting and 
activated BMDM (Hu et al., 2006).  A third study proposed that Acr1 plays a role in slowing 
M. tuberculosis growth, as its overexpression resulted in reduced growth of BCG within 
murine lungs and liver (Spratt et al., 2010). 
 
Acr1 plays an important role in granuloma formation, and exposing macrophages to Acr1 
resulted in the secretion of CXCL16, which is a CXC type chemokine expressed by many 
APCs, including macrophages (Kim et al., 2001).  This chemokine is important for the 
recruitment of different immune cells that are vital for the development of a granuloma, 
including Tc1 CD8+, NK T cells and Th1 type CD4+ (Bafica et al., 2005; Cooper, 2009). 
CXCL16 is a large trans-membrane protein that is attached to the membrane by a mucin-like 
‘stalk’. The α-crystallin protein activates two A - disintegrin and metalloproteinase (ADAM) 
proteases (ADAM10 and/or ADAM17) that cleave this stalk and release the bioactive 
extracellular domain of CXCL16 (Healy and King, 2012). Healy and King (2012) concluded 
that Acr1 induces the release of CXCL16 via activation of ADAM10/ADAM17, and as a 
consequence recruits more cells to the granuloma facilitating the conditions favourable for 
dormancy. Acr1 induces the tolerogenic phenotype by modulating the expression of PD-L1, 
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Tim-3, indoleamine 2.3 dioxygenase (IDO) and IL-10, leading to the inhibition of DC 
maturation and differentiation via targeting of the STAT-6 and STAT-3 pathways. M. 
tuberculosis has a better survival rate in Acr1 treated DCs as this results in the reduction of 
their antigen uptake and hence a reduction in their ability to activate T cells (Siddiqui et al., 
2014).  
 
Other stresses, such as oxidative stress, phagocytosis and heat shock, can all lead to the 
induction of the acr2 gene (Stewart et al., 2005). Stewart et al. (2005) reported that the 
deletion of acr2 (∆acr2) rendered M. tuberculosis to be sensitive to oxidative stress, although 
it did not impair its growth in mouse bone marrow macrophages. They also added that ∆acr2 
did not affect the bacterial load during mouse infection; however, disease progression was 
less severe and more prolonged. Stewart et al. (2005) have related this to a reduction in 
immune-related pathology resulting from the reduction of immune cell (T-cells and 
macrophages) recruitment to the lungs of the mice infected with ∆acr2. The study observed 
that although ∆acr2 does not affect the growth of M. tuberculosis, shown by a ‘normal’ 
bacterial load for ∆acr2 in the infected mice, it impairs pathogenesis, thus causing less severe 
disease. Stewart et al. (2005) proposed two reasons for this observation: (1) the loss of the 
Acr2 chaperone activity function introduced a significant reduction in the mycobacterial 
peptides available for immune cell activation; and (2) the difference in the pathogenesis 
between the ∆acr2 and the wild type could be due to the physiological characteristics of 
∆acr2. From the observation that the ∆acr2 mutants elicited fewer T cells and CD 11b+ cell 
recruitment to the lungs during the early stages of infection, the authors suggested that there 
should be a shift in the balance within the granuloma from actively replicating immune 
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controlled bacteria to the dormant state, as this would reduce the progressive accumulation 
of immune mediated damage and hence reduce disease severity.  
 
It has been reported that the isolated multidrug acr1 deficient (∆acr1) clinical strain of M. 
tuberculosis isolated from HIV negative patients with chronic pulmonary TB shows no 
difference in replication in murine and human macrophages compared to strain H37rv 
(Timm et al., 2006). The authors concluded that Acr1 is dispensable for bacterial growth 
within the human lung. Therefore, it is possible that the acr1 and acr2 genes are partially 
interchangeable as far as their chaperone functions are concerned, and as the deletion of the 
acr2 gene has a negative impact on the severity of the disease progression, this study will 
further investigate the effect of the deletion of both genes on the fitness for survival in both 
in vitro and in vivo conditions, as well as disease severity and progression. This will be 
helpful in determining if there is a redundancy in the function of Acr1 and Acr2.   
  
1.10   Regulation of Gene Expression   
 
Bacteria, including mycobacteria, normally live in harsh, stressful and constantly changing 
environments. Therefore, in order to survive they must quickly adapt to the various stresses 
exerted by the medium in which they are in. This adaption requires dynamic gene expression 
that responds to the stimuli the bacteria sense. Transcription regulation, controlled by DNA 
binding proteins, mediates the expression of relevant genes in response to extra or intra 
cellular stimuli that result in either the up or down regulation of specific genes. In addition 
to transcriptional repression or activation, post-transcriptional control at the mRNA level is 
also required for switching specific genes on and off in response to corresponding stimuli.  
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A detailed understanding of the mechanisms of gene expression and regulation is directly 
relevant to this study. Examining the roles of Acr1, Acr2 and SsrA in response to stress 
requires a comprehensive review of the current understanding regarding gene regulation in 
mycobacteria, as it is these processes that Acr1, Acr2 and SsrA impact upon most heavily. 
 
1.10.1  Transcriptional Regulation of Gene Expression in the M. tuberculosis 
Complex  
 
Adaptation of M. tuberculosis to environmental changes during infection requires an 
efficient regulatory system that mediates gene expression in response to particular changes. 
Therefore, M. tuberculosis has a host of a very complex regulatory systems with 
redundancies and overlapping functions. The genome encodes more than 140 transcription 
regulators  (Bishai, 1998; Timm et al., 2003), 13  polymerase sigma (σ) factors (Manganelli 
et al., 2004), 11 paired two-component systems, two unpaired (orphan) six response 
regulators (Haydel and Clark-Curtiss, 2004), and 11 protein kinases (Prisic and Husson, 
2014). Studying regulatory systems is very important in order to understand how a successful 
pathogen, such as M. tuberculosis, may overcome the various stresses exerted by a 
surrounding environment. The few regulatory systems that are involved in controlling gene 
expression in response to cold shock, heat shock (Shires and Steyn, 2001; Stewart et al., 
2002b),  oxidative stress (Raman et al., 2001), and hypoxia (Roberts et al., 2004; Sherman 
et al., 2001) are examined.   
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1.10.2 Sigma Factors of the M. tuberculosis Complex 
 
The success of a pathogen to establish infection is determined by its ability to establish itself 
and overcome the harsh and often competitive environment present within the host. M. 
tuberculosis is extremely successful because it is able to adapt to the changing environments 
it finds itself through employing various mechanisms that enable it to re-programme its 
transcriptional machinery to slow down unnecessary metabolic processes and up-regulate 
virulence and stress response pathways needed for survival. Therefore, it adjusts its protein 
synthesis at the transcriptional level based upon the stress signals it senses within the 
surrounding environment. Gene expression in bacteria is regulated at the level of 
transcription initiation, which is mediated by the RNA polymerase (RNAP) holoenzyme 
which consists of five subunits: α2ββ’ω (the core subunit) and a dissociable subunit σ 
(sigma).  M. tuberculosis has 13 sigma factors; SigA, SigB, SigC, SigD, SigE, SigF, SigG, 
SigH, SigI, SigJ, SigK, SigL and SigM. Sigma factors are divided into two main families, 
known as sigma 70 (σ70) and sigma 54 (σ54). SigA and SigB are the principle sigma factors, 
are essential in M. smegmatis, and M. smegmatis mutants are more sensitive to oxidative 
stress.  SigC,  SigD, SigE,  SigG,  SigH, SigI  SigJ, SigK, SigL, and SigM (ECF; 
Extracytoplasmic function) form a subfamily of sigma factors, and SigF  (Manganelli et al., 
1999). SigF is a stress response sporulation sigma factor in Bacillus subtilus (Clarkson et al., 
2004). For the purposes of this study, only a few selected σ70 factors will be elaborated on.  
 
SigA is an essential housekeeping and is involved in enhancing growth within human 
macrophages and during the early stages of lung infection, where it modulates the expression 
of genes that contribute to virulence (Wu et al., 1997; Wu et al., 2004). In the hypervirulent 
strain M. tuberculosis  W-Beijing, gene expression of eis, which encodes the enhanced 
   
 22 
intracellular survival  protein, is regulated by SigA and its expression directly correlates to 
the expression of eis (Shiping et al., 2009). The Eis protein is involved in the suppression of 
the host immune response (Kim et al., 2012).   
 
SigB shares similarity in terms of its amino acid sequence with the primary sigma factor, 
SigA  (Gomez et al., 1998), and it is positively up-regulated by SigE, SigH  and  SigL, which 
can transcribe it using its transcription site (Dainese et al., 2006; Fontán et al., 2009).  M. 
tuberculosis σ mutants are more sensitive to thioridzine, which modulates the expression of 
genes encoding membrane proteins, efflux pumps oxido-reductases and enzymes involved 
in fatty acid metabolism and aerobic respiration,  indicating the need of σ to resist the effects 
of thioridzine (Dutta et al., 2010). A M. tuberculosis sigB mutant showed a defective survival 
response when exposed to cell envelope, oxidative and hypoxic stresses, but attenuation was 
observed in THP1 cells and during mouse and guinea pig infections. Because SigB is 
regulated by many regulatory pathways, it may play a central role in the M. tuberculosis 
stress response (Fontán et al., 2009).  
SigE  regulates the response to cell envelope damage in  M. tuberculosis, as it plays a role in 
the regulation of genes involved in the maintenance of cell envelope integrity and function 
during macrophage infection, and hence the modulation of the inflammatory response 
(Fontan et al., 2008a).  SigE  is dispensable for the replication of M. tuberculosis in human 
pneumocytes but is essential for the arrest of phagosome maturation in THP-1 derived 
macrophages (Casonato et al., 2014). 
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SigH is similar to SigB and regulates the response of thiol oxidative stress and heat shock 
and phagocytosis, leading to the induction of sigB, sigE and the thioredoxin regulon. A long 
induction of SigH resulted in the induction of the ATP-dependent clp proteolysis regulon, 
several members of the mce1 virulence regulon, and the sulfate acquisition/transport 
network (Mehra and Kaushal, 2009). 
 
SigF regulates a  family of proteins that play a role in the immunopathology of M. 
tuberculosis, regulates SigB and SigC protein expression, and also genes that are essential for 
cell wall synthesis and the survival of M. tuberculosis (Mustyala et al., 2015). It is directly 
regulated by phoY1  (Ernest et al., 2007). 
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1.10.3 Two Component Systems 
 
Two component systems (TCSs) are signal transduction mechanisms which are present in 
all prokaryotes except Mycoplasma genitalium (Barrett and Hoch, 1998; Heermann and 
Fuchs, 2008; Stock et al., 2000) and enable them to sense, respond and adapt to various 
stressors surrounding them.  More than three hundred TCSs have been identified across 
approximately one hundred different bacterial species (Barakat et al., 2011). TCSs are 
composed of a sensor histidine kinase (HK), which is a transmembrane protein that senses 
an external stress and transmits a signal into the cell through ATP phosphorylation of a 
corresponding response regulator (RR), which then binds to its cognate promoter DNA 
leading to transcription regulation (Figure 2).  In this manner a TCS allows an organism to 
sense, transduce and initiate a response. The Saccharomyces cerevisiae genome has only HK 
and two RRs and none are found within the mammalian genome (Watanabe et al., 2008).  
 
  
Figure 2 A Two Component System (TCS)  signalling pathway 
Illustration showing the sensor histidine kinase (HK) and its cognate response regulator (RR) of the TCS. In 
the event of the HK senses intracellular signals or environmental such as starvation, cold/heat shock as well as 
antimicrobial compound, it undergoes conformational changes resulting in the autophosphorylation (using ATP 
as phosphate source) of the conversed histidine residue in the receiver domain (C- terminal domain).  In a 
magnesium-dependent manner the phosphoryl group is transferred to an aspartate residue in the amino-terminal 
(N- terminal) domain of the RR. The phosphorylated RR induces structural changes of its output domain 
leading to its involvement in transcription regulation (Marta et al., 2014). 
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The sensor kinase component interacts directly with the signal leading to phosphorylation 
via ATP, and the resulting phosphate is transferred to the HK which then passes the signal to 
the RR leading to the required gene activation in response to the signal (Barrett and Hoch, 
1998). HK/RR signal transduction systems are different to serine/threonine and tyrosine 
phosphorylation in higher eukaryotes (Watanabe et al., 2008). 
 
Unlike Escherichia coli which has over 30 complete TCSs (Marta et al., 2014), M. 
tuberculosis possesses only 11 complete TCSs, and 8 unlinked sensor kinases and response 
regulators (Parish et al., 2003; Prisic and Husson, 2014; Zahrt and Deretic, 2000).  As there 
are so many TCSs, a full account of them all is out of the scope of this study (Table 1). 
Therefore, only relevant selected examples will be elaborated on.   
 
Table 1. List of the complete two-component systems of M. tuberculosis 
TCS Encoded by Regulation Reference 
SenX3/Regx3 Rv0490/Rv091 Regulates phosphate dependent gene 
expression 
(Glover et al., 2007) 
NarL/NarS Rv0844c/Rv0845 Regulation of nitrate metabolism (Malhotra et al., 
2015), 
U/U/TCrA Rv0600c/Rv0601c/R
v0602c 
A unique three proteins two-component 
system unknown function 
(Haydel and Clark-
Curtiss, 2004) 
(Shrivastava et al., 
2009)   
KdpE/KdpD Rv1027/Rv1028c Regulates the response to virulence-
related conditions 
(Freeman et al., 2013)  
TrcS/TrcR   Rv1032c/Rv1033c  
 
(Fontan et al., 2004) 
TcrY/TcrX Rv3764c/Rv3765c Involved in virulence 
 
(Parish et al., 2003), 
PrrB/PrrA Rv0902c/Rv0903c Involved in early intracellular 
multiplication during macrophage 
infection 
(Haydel et al., 2012) 
PhoP/PhoR Rv0902c/Rv0903c Involved in cell wall lipids complex 
production 
(Pérez et al., 2001) 
MprA/MprB Rv0981/Rv0982 Regulation of different genes engaged 
in physiology and pathogenesis 
(Curcic et al., 1994) 
DosS-
DosT/DosR 
Rv3132c/Rv3133c Involvement in hypoxic adaptation (Kinger and Tyagi, 
1993; Ohno et al., 
2003) 
MtrB/MtrA Rv3245c/Rv3246c Proliferation in macrophages; essential for 
M. tuberculosis viability 
(Parish et al., 2003) 
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1.10.3.1 PhoP/PhoR	(Rv0757/Rv0758)		
 
PhoP/PhoR is involved in cell wall complex lipids production and it is required for 
intracellular growth as observed in the mouse model  infection (Pérez et al., 2001). A 
dramatic change in colony morphology and reactivity to the basic dye neutral red has been 
observed in M. tuberculosis DPhoP (Gonzalo Asensio et al., 2006). Deleting PhoP also 
resulted in the production of safe, live-attenuated M. tuberculosis DPhoP, which showed 
better safety and protection than BCG (Martin et al., 2006). PhoP/PhoR is activated in 
response to environmental stimuli and modulates the mycomembrane via the regulation of 
the biosynthesis of lipids and is also involved in the regulation of the ESXI secretion system 
(Frigui et al., 2008; Gonzalo-Asensio et al., 2008). 
 
1.10.3.2 MprA/MprB  
 
The mycobacterium persistence regulator is encoded by Rv0981/Rv0982, and MprA is the 
RR and MprB the sensor HK. This was the first TCS characterised in M. tuberculosis (Curcic 
et al., 1994) and is only induced during macrophage infection and not in broth cultures, 
thereby suggesting it is important for the survival of M. tuberculosis within macrophages 
(Zahrt and Deretic, 2000), although recent data suggest otherwise (Bretl et al., 2012; He et 
al., 2006; He and Zahrt, 2005). MprA/MprB regulates different genes involved in physiology 
and pathogenesis in M. tuberculosis (Bretl et al., 2014; Zahrt et al., 2003) that are required 
for persistent infection (White et al., 2010). It is conserved in all mycobacterium species, 
including M. leprae (Zahrt and Deretic, 2001) and is found upstream within in an operon 
with pepD (encodes an HtrA-like serine protease) and moaB2 (encodes a predicted 
molybdopterin biosynthetic protein) (He and Zahrt, 2005; White et al., 2010).  Recently, 
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MprA/MprB has been identified as being part of the conserved cell envelope stress response 
network and it is negatively regulated by the MprAB extracytoplasmic domain (ECD) (Bretl 
et al., 2014). Bretl et al. proposed that signalling through the MprA/MprB system is inhibited 
by the MprAB ECD under normal stress conditions or under conditions where the proteins 
within the extracytoplasmic space are properly folded. This inhibition is removed when 
exposed to cell envelope stress because the proteins of the extracytoplasmic space become 
either unfolded or misfolded. MprA directly regulates the expression acr2  (Pang and 
Howard, 2007). Pang and Howard concluded that MprA has a direct but complex interaction 
with the acr2 promoter, which contains multiple binding sites and has indirect interactions 
with SigE, SigH and HspR.  For instance, MprA controls a wide variety of genes and its 
function may overlap with other regulatory systems.  
 
MprA expression regulates the expression of sigB and sigE (He et al., 2006) which in turn 
have large regulons. SigE is involved in positive feedback for loop cell wall/membrane 
damaging agents, such as SDS and controls genes that are involved in the modulation of the 
inflammatory response and hence is essential for the virulence of M. tuberculosis (Fontan et 
al., 2008b). MrpA and SigE indirectly regulate one another (Prisic and Husson, 2014; Sureka 
et al., 2007). MrpA/MprB and DosRS-DosT have been reported to co-regulate genes that 
may be involved in the general stress response (Bretl et al., 2012).  This shows how complex, 
redundant and overlapping the response to environmental stress is and the degree of 
overlapping responses to environmental stress that is characteristic of M. tuberculosis. 
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		1.10.3.3			DosS-DosT/DosR	
 
DosS-DosT/DosR or devR-devS- Rv2027c is encoded by Rv3132c/Rv3133c and is involved 
in adaptation to hypoxia (Kinger and Tyagi, 1993; Ohno et al., 2003). DosR was originally 
called devR (differentially expressed in the virulent strain) (Dasgupta et al., 2000; Kinger 
and Tyagi, 1993), and is composed of a RR DosR (dormancy survival regulator encoded by 
Rv3133c) and two sensor kinases, DosS (Rv3132c), a redox sensor and DosT (Rv2027c), a 
hypoxia sensor. The ability of DosT to phosphorylate DosR was first described by Roberts 
et al. (2004). M. smegmatis has DosR and DosT homologues but lacks a DosS homologue 
(Bretl et al., 2011; Lee et al., 2008), whilst M. leprae  lacks the DosR-DosS two component 
system entirely (Gerasimova et al., 2011). dosR and dosS are genetically linked and are 
transcriptionally coupled with each other  together with the downstream gene Rv3134c (a 
putative alanine-alanine-rich protein) (Dasgupta et al., 2000). In contrast, dosT is encoded 
at a different location within the genome. DosR is the best characterised M. tuberculosis RR 
(He and Zahrt, 2005), modulating its own expression and a  48 gene regulon that responds 
to  hypoxia and nitric oxide (Ohno et al., 2003; Voskuil et al., 2003),  and is the primary 
mediator of a hypoxic signal within M. tuberculosis (Park et al., 2003). The 48 genes that 
are up-regulated by DosR are termed the ‘dormancy regulon’ and are clustered into  a small 
number of discrete transcriptional units scattered around the chromosome (Park et al., 2003; 
Zhang et al., 2010), which may facilitate an efficient, rapid and coordinated response to 
environmental stimuli (Bretl et al., 2011). DosR recognises a 18/20-bp palindromic sequence 
that is present upstream of almost all hypoxia and nitric oxide regulated genes (Florczyk et 
al., 2003), including the hypoxic response gene hspX (Park et al., 2003). 
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The promoters of the genes in the dormancy regulon often contain two or more recognition 
sequences, and cooperative binding of these sites is necessary for their induction. 
Phosphorylated DosR binds to three copies of the motif at hspX (Chauhan and Tyagi, 2008). 
Exposure to high levels of nitric oxide and carbon monoxide induces the expression of dosR-
dosS and the genes in the dormancy regulon (Figure 3) (Kumar et al., 2007; Santhosh and 
Paul, 2013).  
 
   
Figure 3. M. tuberculosis dormancy response to hypoxic conditions. 
Schematic diagram illustrating the sensor Histidine Kinase (HK) and its cognate Response Regulator (RR) of 
the Two Component System (TCS). The sensor kinase senses specific environmental signal such as hypoxia, 
nitric oxide (NO), carbon monoxide (CO) and ascorbic acid leading to its autophosphorylation using ATP as 
phosphate source. The phosphoryl group is then transferred in a magnesium-dependent manner to an aspartate 
residue in the RR protein (DosR). Phosphorylation of the DosR leads to the induction and up-regulation of the 
DosR regulon. The DosR regulon control survival of the bacilli in anaerobically-induced state of dormancy  
(Marta et al., 2014). 
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Many studies have described the role of DosR-DoS-DosT system in M. tuberculosis 
pathogenesis. It has been reported that that dosR and other members of it regulon are up-
regulated in M. tuberculosis following infection of human monocytes-derived macrophages, 
murine BMDM and human monocytes (Dasgupta et al., 2000; Haydel and Clark-Curtiss, 
2004; Schnappinger et al., 2003). The clinical highly virulent M. tuberculosis W-Beijing 
strain has been reported to have even higher levels of dosR expression (Reed et al., 2007).  
The immune response to DosR regulon antigens, includes anti-HspX antibodies present in 
the cerebrospinal fluid (CSF) of human TB meningitis patients and the induction of IFN and 
the production of other cytokines in T-cell lines and other immune cells of M. tuberculosis 
infected individuals (Haldar et al., 2012; Tai, 2013). Although proteins from the DosR 
regulon are produced during infection and are immunogenic, its exact role in in M. 
tuberculosis virulence and dormancy remains incompletely understood. This is because 
studies in which dosR, dosS and or dosT have been mutated have variable and provide 
inconclusive results (Converse et al., 2009; Pang and Howard, 2007; Parish et al., 2003). 
Although the expression of the dosR regulon is quickly up-regulated following activation by 
hypoxia, expression decreases over time (Rustad et al., 2009).  
 
1.11   Transcriptional Repressors/Activators 
From the information available from other microorganisms and based on homology at the 
sequence level, there are 31 transcriptional repressors which have been identified within the 
M. tuberculosis genome (Fontan et al., 2004).  
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1.11.1 HspR and HrCA 
 
Two heat shock regulators have been identified in M. tuberculosis; (i) HspR, a transcriptional 
repressor for Hsp70 regulon members, homologous to Streptomcyes HspR; and (ii) HrcA, a 
RR for Hsp60 (GroE) which is homologous to Bacillus subtilis HrcA. These negatively 
control the HSR. HspR is a DNA-binding protein related to the MerR family (group of 
transcription activators) and it recognises inverted repeat sequences (HAIR; heat inverted 
repeat) in the promoter region of the hsp70 operon, resulting in a reduction in transcription 
under normal conditions. In vivo, there is a strong interaction between Hsp70 and HspR 
(Stewart et al., 2001). The Hsp Acr2, encoded by Rv0251c, has a HAIR like domain 71bp 
upstream of its start codon. Acr2, along with Hsp70 and Rv0250, were up-regulated in a M. 
tuberculosis ΔhspR mutant during heat shock (Stewart et al., 2002b). Over expression of 
Hsp70 proteins reduce the survival of M. tuberculosis and impairs its ability to persist 
(Stewart et al., 2001). 
 
The Streptomyces coelicolor dnaK operon encodes DnaK (Hsp70; chaperone machine) and 
HspR (repressor of the operon). HspR represses the dnaK operon by binding to several 
inverted repeat sequences present in the promoter region (dnaKp). DnaK functions as a 
transcriptional co-repressor by binding to HspR at its operator sites. DnaK is involved in 
gene regulation by directly activating the repressor and not by activator inactivation.  Similar 
systems, include DnaK-sigma32 in which DnaK is involved in the regulation of sigma32 
synthesis in bacteria (Chattopadhyay and Roy, 2002; Grossman et al., 1987) and Hsp70-
HSF in humans where Hsp70 may negatively regulate HSF (heat shock transcription factor) 
(Abravaya et al., 1992).  
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The M. tuberculosis HSR is under both negative (via HspR and HrcA) and positive 
regulation (some sigma factors).  Three sigma factors (SigH, SigE and SigB) have been 
reported to be involved in the positive regulation of Hsps. Under heat stress, SigB partially 
controls the expression of the hsp70 operon, acr2 and the chaperons groEL/groES. In 
addition, acr2 expression seems to be controlled by SigE when bacteria are treated with 
diamide (Fontan et al., 2004). In addition to controlling the expression of sigE and sigB 
under heat shock stress conditions, SigH is also the main regulator controlling the expression 
of the hsp70 operon and clpB  (Manganelli et al., 1999).  
 
1.11.2 ClgR the clp Gene Regulator 
 
ClgR, encoded by the clp gene (Rv2745c), is a transcriptional regulator that regulates the 
transcription of more than ten genes, including four protease systems (ClpP1/C, ClpP2/C, 
PtrB and HtrA-like protease Rv1043) and three genes encoding chaperones (Acr2, ClpB and 
chaperonin Rv3269). ClgR is highly up-regulated in M. tuberculosis under conditions such 
as heat stress and during macrophage infection. The regulation of these systems by ClgR is 
essential for M. tuberculosis replication in macrophages during early infection (Estorninho 
et al., 2010). ClgR is highly induced by redox, and  SigH and SigE  overexpression was 
found to be down-regulated in M. tuberculosis ΔclgR;   therefore it may play a role in the 
management of the intra-phagosomal environment (McGillivray et al., 2014). McGillivray 
et al. also observed that ClgR expression correlates with the expression of genes involved in 
sulphate assimilation, hypoxia and reaeration. It was concluded that ClgR has many different 
stress-related functions and is important for M. tuberculosis pathogenicity regardless of its 
role in the induction of the Clp proteolytic pathway. As there are similarities in the structure 
and function between sHsps, it is possible that M. tuberculosis Acr1 and Acr2 proteins may 
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play a role in protection against nitrosative stress, possibly by interacting with the 
mycobacterial proteasome (Forrellad et al., 2013). The fact that Acr2, along with other 
proteases, is positively up-regulated by ClgR (clp gene regulator) suggests that it may play 
a role in protein homeostasis (Estorninho et al., 2010).  
 
1.12  Proteases 
 
Proteolysis in bacteria plays an important role in cellular function, and there are five classes 
of  ATP dependent proteases, including ClpAP, ClpXP, Lon, HsIUV (also known as 
ClpYQ), HflB (FtsH) (Koodathingal et al., 2009). These proteases play a key role in the 
protein quality control system via degrading truncated, misfolded, aggregated or denatured 
proteins.  Clp also plays a role in the regulation of the function of certain regulatory proteins 
within the cell (Russo et al., 2009). In B. subtilis the proteolytic subunit ClpP, along with 
the regulatory ATPase subunit ClpC or ClpX, is required for the normal response to stress, 
the development of genetic competence, and sporulation (Nakano et al., 2002). M. 
tuberculosis has two ClpP proteolytic subunits (ClpP1 and ClpP2) and both are essential for 
in vitro growth, but ClpP1 and ClpP2 are co-expressed in normal conditions and their 
promoter is not induced by heat shock or oxidative stress; both are positively regulated by 
ClgR. ClpP1 and ClpP2 recognise different substrates, as ClpP1 degrades ssrA-tagged 
proteins whereas ClpP2 does not (Personne et al., 2013). ClgR became accumulated in a 
Corynebacterium glutamicum ClpC mutant, indicating that the transcription regulator ClgR 
is also a substrate for both ClpP1 and ClpC (Engels et al., 2005).   
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1.13   Translational Regulation of Gene Expression in Bacteria  
 
Small non-coding RNA (sRNA) are the most available class of translational regulators 
present within bacteria (Lorraine and George, 2013; Papenfort and Vogel, 2009), and another 
sRNA is the 5’-UTR. Recent studies have revealed the role of sRNA, 5¢-UTR, riboswitches, 
antisense transcripts and tmRNA in translational gene regulation. For the purpose of this 
study only tmRNA will be expanded on in section 1.19. 
 
1.14   Regulation of Acr1 and Acr2 Gene Expression 
 
In order for M. tuberculosis to adapt and survive within the hostile environment of a host the 
ability to sense the surrounding and respond appropriately and effectively is required. M. 
tuberculosis has a host of signal transduction systems, including TCSs, Ser/Thr protein 
kinases, and orphaned RRs (Bretl et al., 2011; Cole et al., 1998; Fernandez et al., 2006).  
There are more than 200 M. tuberculosis genes that show rapid changes in expression 
following phagocytosis and a rapid reprogramming occurs involving 400 transcriptional 
changes within 24h of infection (Rohde et al., 2007; Schnappinger et al., 2003).  One of 
many responses M. tuberculosis utilises to overcome the environmental stress experienced 
within a macrophage is to produce stress proteins (Schnappinger et al., 2003) including 
Hsps.  
 
There is experimental evidence that hypoxia may signal the induction of latency (Wayne and 
Sohaskey, 2001). In addition, nitric oxide has been identified as an environmental trigger for 
M. tuberculosis dormancy/persistence (Park et al., 2003; Voskuil et al., 2003). Acr1 is 
   
 35 
known to be associated with LTBI and its role in the survival of mycobacteria in the non-
replicating phase is well established (Cunningham and Spreadbury, 1998). The acr1 gene is 
under the control of the TCS DosS/DosT-DosR.  DosT and DosS are sensors kinases that 
respond to low oxygen tension and nitric oxide, while DosR is the transcriptional regulator 
(Kumar et al., 2007).  This two component regulatory system (dosRS dormancy survival 
regulator and sensor) controls the response to hypoxia in M. tuberculosis and regulates the 
transcription of approximately 50 genes, most of which are predicted to protect against 
hypoxia (Hu et al., 2006; Rohde et al., 2007) and nitric oxide (Converse et al., 2009; Kumar 
et al., 2007). 
 
The expression of acr2 is under the negative control of HspR and positive control of SigH 
and SigE (Stewart et al., 2002b), as well as the MprA/MprB TCS (Pang and Howard, 2007).  
Pang and Howard (2007) studied the effect of heat shock and SDS stress on ∆mprAB mutant 
by analysing mRNA and comparing it to the parental stain. Their study revealed that the 
level of acr2 gene expression was higher under heat shock but lower when subjected to SDS 
stress compared to the parental strain. They also reported that MprA has four binding sites, 
three of which (one overlaps with the house-keeping SigE, SigH and HspR predicted binding 
site) are downstream of the acr2 gene transcriptional start point (TSP) and one of which is 
upstream. PhoP has been reported to be a repressor of acr2 expression under normal growth 
conditions (Singh et al., 2014a), and acr2 is among the genes that have been identified to be 
regulated by the protease Clp regulator ClgR (Estorninho et al., 2010).   
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Regulation systems for:  
Acr1 Acr2 
TCS,  DosS/DoST-DosR (Hu 
et al., 2006) 
Negative control of HspR (Stewart et al., 2002b) 
 Positive control of SigH and SigE (Stewart et al., 
2002b) 
 Positive control of TCS,  MprA/MprB (Pang and 
Howard, 2007) 
 Repressed by PhoP (Singh et al., 2014b) 
 
 Positive control of ClgR (Estorninho et al., 2010) 
 Regulated by protease Clp regulator (Estorninho et al., 
2010) 
 
Table 2. Summary of the different regulatory systems of  M. tuberculosis a-crystalline 
1 and 2 
 
1.15  Stress Response of M. tuberculosis 
 
The ability of M. tuberculosis to survive inside a macrophage by evading its killing 
mechanisms gives it a huge advantage. M. tuberculosis is a very successful pathogen, 
employing a wide variety of tools in order to overcome all the stresses that it encounters 
inside the human body.  M. tuberculosis has many mechanisms to overcome the 
microbiocidal ability of macrophages, including  resistance to toxic compounds, preventing 
phagosome maturation, and preventing the induction of apoptosis (Forrellad et al., 2013). 
The intercellular environment subjects M. tuberculosis to many stresses, examples of which 
include nutrient limitation, hypoxia, oxidative stress, nitric oxide and low pH (Rohde et al., 
2007; Schnappinger et al., 2003; Voskuil et al., 2003).  The response of M. tuberculosis to 
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stress involves a very complex network of gene regulation and a comprehensive review of 
the literature to give a full account of this is beyond the scope of this study. Therefore, only 
what is relevant to the genes under study will be examined.  
 
1.15.1 Heat Shock 
 
Fever and night sweats are symptoms associated with TB infection, and a high body 
temperature is one of defence mechanisms that the body uses to fight the invading microbe. 
Raising the temperature beyond the optimum for M. tuberculosis growth subjects it to stress 
and leads to the mis-folding of proteins, rendering them non-functional and subject to 
degradation. To overcome this issue, M. tuberculosis up-regulates the expression of 
chaperonins, such as Hsp Acr2 and Hsp20.   
  
1.15.2 Response to Acid pH 
 
Inside a non-activated macrophage M. tuberculosis is located within phagosomes where it 
has the ability to block phagosomal maturation, lysosomal fusion, and acidification 
(Clemens and Horwitz, 1995; de Chastellier, 2009; Sakamoto, 2012), but IFN-g activation 
restores acidification and confers anti-mycobacterial activity (Herbst et al., 2011; Vandal et 
al., 2008).  Depending upon the level of activation, the pH of the macrophage compartment 
ranges from 4.5-6.2 (Schaible et al., 1998; Vandal et al., 2009). M. tuberculosis has been 
reported to survive at pH 4.5 in vitro  (Vandal et al., 2008). However, the interpretation of 
Mycobacteria resistance to acid in in vitro experiments is complicated because the survival 
of bacteria in acid is dependent upon the culture conditions, including bacterial density and 
composition of the media (Bodmer et al., 2000; Sung and Collins, 2003).  
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However, studies have shown that the cell wall  forms a physical barrier that prevents toxic 
molecules from entering into the cell (Hett and Rubin, 2008). This plays an important role 
in resistance to acid, and many of the genes that are up-regulated during exposure to acid 
stress are related to the cell wall (Richter et al., 2007; Singh et al., 2005; Singh et al., 2003; 
Tran et al., 2005). OmpA is a pore forming  protein which is encoded by OmpATb and 
induced at pH 5.5 (Raynaud et al., 2002). It is involved in generating a rapid ammonia burst 
leading to neutralisation of the medium pH before exponential growth of M. tuberculosis in 
vitro (Song et al., 2011). In their study, Song et al. (2011) observed the acceleration of M. 
tuberculosis ompATb mutant growth after ammonia was added, suggesting that ammonia is 
one of the mechanisms that M. tuberculosis uses to neutralise an acid environment. However 
in vivo ompATb is not the only mechanism, as it was observed in a mouse infection model 
that there were multiple mechanisms for resisting phagosomal acidification (Song et al., 
2011). This may be because the response to acid stress can be associated with protection 
against other forms of stress, such as SDS and heat shock (Vandal et al., 2009). The TCS  
PhoP/PhoR regulon may also play a role in enabling M. tuberculosis to resist an acidic 
environment, as it contains many genes that are up-regulated during acidic stress, and this 
up-regulation was lost in a phoP mutant (Gonzalo-Asensio et al., 2008).  
 
 1.15.3 Response to Oxidative Stress 
 
The ability of M. tuberculosis to overcome and resist killing by macrophages is vital for its 
virulence. Bactericidal compounds, such as reactive oxygen species (ROS) and reactive 
nitrogen species (RNS) are produced by phagocytes after phagocytosis. Nitric oxide and 
related nitrogen intermediates (RNI) are effective anti-mycobacterial agents and signal-
transducing molecules. RNI play a role in M. tuberculosis gene regulation of expression in 
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vivo, as they up-regulate genes that may be conducive to the survival of TB bacilli in the 
infected host, and along with hypoxia may regulate mycobacterial gene expression via 
overlapping signal transduction pathways (Ohno et al., 2003). Their bactericidal properties 
result from their ability to react with wide range of molecules, including nucleic acids, 
proteins, carbohydrates and lipids. Intracellular pathogens, such as M. tuberculosis, have 
evolved to have counter mechanisms to overcome the damaging effects of oxygen and 
nitrogen intermediates (ROI and RNI, respectively).  
 
M. tuberculosis uses alternative defence mechanisms for oxidative and nitrosative stresses 
other than OxyR mechanism. This is because OxyR; ahpC (alkyl hydroperoxide reductase 
C) regulator, is not functional in all M. tuberculosis complex (MTBC) including M. bovis, 
BCG, M. africanum and M. microti (Deretic et al., 1995). M. tuberculosis uses wide range 
of molecules to either detoxify ROI and RNI before they cause stress or by repairing damage 
they have caused (Sandgren et al., 2009). There are various proteins, including AhpC, 
superoxide dismutase (SOD), KatG, Mel2, Rv2136c, Rv224c, PonA2, Acr1 and Acr2 that 
are directly or indirectly necessary for M. tuberculosis complex species to survive the 
oxidative and nitrosative stresses, and at the same time all also important for virulence.  
Rv2136c, Rv224c, PonA2 are thought to contribute to cell wall integrity, which may suggest 
that the mycobacterial lipid-rich cell envelope can act as an effective barrier against the entry 
of RNI and ROI (Forrellad et al., 2013).  
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 1.15.4   Hypoxia 
Low oxygen is one of many stress conditions that M. tuberculosis encounters in the central 
part of the granuloma  (Cunningham and Spreadbury, 1998). The response to low oxygen 
tension is initially controlled by the TCS DosS/DosT-DosR was describe in section 1.10.3.3.  
The DosR regulon was not found to be essential for virulence in chronic murine infection 
(Bartek et al., 2009), and it was suggested  that M. tuberculosis has evolved to encode DosR 
in order to deal with survival in an anaerobic environment rather than for pathogenesis or 
antibiotic resistance. It has also been suggested that there may be genes other than the DosR 
regulon which contribute to in vitro and in vivo dormancy (Rustad et al., 2008). However, 
the DosR regulon has been reported to be required for metabolic processes from the point of 
entry into the dormancy state and throughout, as it is required for the quick transition 
between hypoxic and aerated environment without damaging or killing the bacterial cell 
(Leistikow et al., 2010). Generally, all studies however agree that DosR is essential for the 
survival of M. tuberculosis in the hypoxic environment, and deletion of dosR blocks the 
initial hypoxic response (Rustad et al., 2008). The DosR regulon includes many genes, and 
prominent amongst them is acr1. Acr1 is highly expressed during hypoxia (Rosenkrands et 
al., 2002) and has chaperonin activity protecting proteins from misfolding during stress 
conditions. It is important for the survival of a phagocytosed M. tuberculosis and it 
accumulates during the latent stationary phase of TB infection (Yuan et al., 1996), 
consequently it is a marker for LTBI (Dubaniewicz et al., 2012). Other regulators also play 
a role in the hypoxic response, including SigE and SigC. 
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1.15.5   Role of Toxin AntiToxin Systems 
The toxin-antitoxin (TA) system is composed of stress-responsive genetic elements (Ramage 
et al., 2009) that are ubiquitous in prokaryotic genomes and provide mechanisms by which 
bacteria can quickly alter their growth rate in response to environmental stress. TA loci were 
first identified in E. coli (Ogura and Hiraga, 1983). The toxin is not a protein secreted to 
target the human host but instead targets the bacterial cellular components. The TA system 
is composed of two parts; the toxin and its antagonist anti-toxin. The toxin is a stable protein 
while the anti-toxin (either a protein or sRNA) is less stable (Unterholzner et al., 2013). 
Under appropriate growth conditions, the anti-toxin binds to its conjugate toxin and inhibits 
its toxin effect. However, when cells are exposed to environmental stressors, such as high 
temperature or starvation, stress-induced proteases degrade the anti-toxin leading to the 
release of the free toxin, which then is free to interact with the target cellular component and 
eventually results in cell death (Lee et al., 2015). TA systems have been reported to be 
important for many cellular functions, such as multidrug tolerance (Korch and Hill, 2006), 
biofilm formation (Wang and Wood, 2011), and cellular growth arrest under stress 
conditions (Yamaguchi and Inouye, 2011). To date there are five classes of TA systems (I-
V) based on their genetic structure and regulation (Unterholzner et al., 2013). Based on how 
an antitoxin (as a protein or sRNA) interacts with the toxin, TA systems are grouped into 
three major groups: (i) in type I systems the antitoxin RNA acts as anti-sense RNA for the 
toxin mRNA, thereby inhibiting its translation; (ii) in type II systems the anti-toxin protein 
neutralises the toxin protein; and  (iii) in type III systems an RNA antitoxin inhibits toxicity 
by binding to the protein toxin to form an RNA-protein complex (Lee et al., 2015; 
Unterholzner et al., 2013), (iv) in type IV, the toxin CbtA interfere with the cell division by 
inhibiting the  cytoskeletal proteins MreB and FtsZ polymerisation (Masuda et al., 2012), 
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(v) in type V the antitoxin GhoS (identified as endoribonuclease) specifically cleaves the 
toxin GhoT which encodes a membrane-lytic peptide (Wang et al., 2012). 
 
  
Figure 4. Different toxin-antitoxin systems based on their mode of action 
Schematic diagrams illustrating the functions of the different Toxin-antitoxin systems; (a) The antitoxin in type 
I acts as anti-sense inhibiting the translation of the toxin; (b) the antitoxin in type II inhibits the toxin toxicity 
by neutralising it in a protein to protein interaction; (c) the antitoxin RNA in type III inhibits the toxicity of the 
toxin by binding to the toxin protein and form RNA-protein complex; (d)  the antitoxin in type IV inhibits the 
polymerisation of the cytoskeletal proteins MreB and FtsZ necessary for the cell division; (e) The antitoxin in 
type V acts as a endoribonuclease cleaving the toxin mRNA preventing its transcription  (Wen et al., 2014) 
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TA systems are highly conserved within the M. tuberculosis complex (Tiwari et al., 2015) 
and  there are 79 TA systems present in the chromosome, 68 of which are well known and 
11 which are novel TA systems. Some are strongly induced in drug-tolerant persisters (Sala 
et al., 2014), while some have been shown to be activated by phagocytosis of TB bacilli by 
macrophages or hypoxia. The M. tuberculosis TA system VapBC30 has been reported to 
regulate cellular growth (Lee et al., 2015),  HigB toxin expression, where in the absence of 
its anti-toxin HigA resulted in growth arrest and cell death (Schuessler et al., 2013), while 
over expression of MazF toxin induced bacteriostasis and enabled M. tuberculosis to adapt 
to oxidative stress, nutrient depletion and exposure to antibiotics (Tiwari et al., 2015) and 
cell cycle regulation (Ramirez et al., 2013). 
 
1.15.6 Role of tmRNA   
 
Protein synthesis, a description of the structure of tmRNA and its function are provided in 
details in section 0 and 0.  In this section selected examples are described to highlight its role 
in the stress response.   
 
The role of transfer-messenger RNA (tmRNA) in gene regulation and its expression in M. 
tuberculosis is not yet fully elucidated and further research is required to have a clear 
understanding of the role of tmRNA in M. tuberculosis. However, tmRNA is ubiquitous, 
highly conserved, and there have been studies to understand its role in other microorganisms. 
In addition to its role as a rescuer for ribosomes, tmRNA is a regulatory RNA which means 
its production and removal must be controlled to ensure appropriate physiological responses.  
It is cell cycle regulated and is important for the control of cell cycle progression in 
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Caulobacter crescentus (Hong et al., 2005), where  the proteolysis of tmRNA substrates is 
required for the correct timing of cell cycle regulated events (Hong et al., 2007). Studies of 
the soil-dwelling, antibiotic-producing bacterium Streptomyces coelicolor (Barends et al., 
2010) reveal that tmRNA mediated trans-translation plays a role in stress management. 
Barends et al. (2010) analysed proteins that were His8-tagged using recombinant tmRNA 
and identified ten target transcripts whose translation was dependent upon tmRNA: DnaK, 
Hsp70, thiostrepton-induced protein A, universal stress protein A, elongation factor Tu3, 
and the cell-cycle control proteins DasR, SsgA, SsgF, and SsgR. Phenotypically, deletion of 
tmRNA from S. coelicolor resulted in inefficient sporulation, and this phenotype may relate 
to the tmRNA-tagging of sporulation regulators, SsgR, SsgA and SsgR proteins (Barends et 
al., 2010).  
 
An in vitro study of C. crescentus  identified 73 tmRNA tagged proteins, including proteins 
involved in DNA replication, recombination and repair (Hong et al., 2007). Deletion of the 
tmRNA gene affects the timing of loss of motility, the initiation of DNA replication, cell 
division, and the production and removal of cell-cycle-regulated proteins. Although this 
function of tmRNA has not been observed in other bacteria, it may be a feature of 
actinomycetes such as Mycobacterium.    
 
 1.16 Protein Synthesis  
 
Protein synthesis is very important for the survival of all living cells, and synthesising protein 
is very expensive in terms of the energy needed, which requires approximately 50% of the 
energy of growing cells. About 20- 40% of the total protein produced by E. coli is used to 
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synthesise ribosomes and other translation factors (Keiler, 2015).  Ribosomes are large 
complexes composed of proteins and RNA, and they are the production machinery of 
proteins.  Protein synthesis starts with copying of the genetic code of a gene (coding for a 
particular protein) present in the genome through a process known as transcription to 
produce mRNA.  
 
  
Figure 5. Protein synthesis 
Illustration of the proteins synthesis phases of initiation, elongation and termination. The bacterial Ribosome 
70S composed of two subunit 50S and 30S.  The initiation complex composed the initiator tRNA; fMet-tRNA 
(Formylmethionine tRNA) at the P-site (production site) interact with start codon of the mRNA by forming 
codon-anticodon duple. Following the binding of the ternary complex of aa-tRNnA-EF-Tu-GTP (aminoacl-
tRNA-elongation facto Tu-GTP) the initiation complex enters the elongation phase.  The GTP is hydrolysed 
and the EF-Tu-GDP and the phosphate (P) detached from the ribosome following successful decoding. Then 
the aa-tRNA moves into the A-site (attachment site). The elongation phase occurs through a process known as 
peptidyl transfer when the nascent peptide chain is transferred from the peptidyl-tRNA in the P- site to the aa-
tRNA in the A-site extending the peptide chain by one amino acid. The translocation of the tRNA-mRNA 
complex is facilitated by the EF-G-GTP from A-and P sites to the P-and E- sites (Exit site). A reversal 
translocation step (dash arrows) can be carried out by EF4-GTP to mobilise stalled ribosomes. The termination 
phase of protein synthesis occurs when the stop codon enters the A- site assisted by release factors. The free 
ribosome now be recycled and the process starts again (Yamamoto et al., 2014). 
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Ribosomes receive mRNA for a specific protein and decode (translate) the DNA code into 
peptides to produce a polypeptide chain, i.e. proteins. The translation process takes place in 
three steps, termed initiation, elongation and termination. The process of protein synthesis 
is a very highly regulated process and is optimised for both correctness of the translation 
(fidelity) and turnover time (Ramakrishnan, 2002). Bacteria ribosomes (70S) are composed 
of two different non-additive sizes subunits, termed 30S and 50S. Each subunit has three 
binding sites for tRNA, termed aminoacyl sites, also known as attachment sites, to which 
aminoacylated tRNA attaches, peptidyl sites, also known as production sites, which hold the 
aminoacylated tRNA transfer the amino acid to the nascent peptide chain and the exit site 
which holds the deacylated tRNA before leaving the ribosome. Therefore, both subunits are 
involved in the translocation of the mRNA from aminoacyl site to the peptidyl site and exit 
site, translating a single codon at a time and adding an amino acid to the nascent polypeptide 
chain ( Figure 5).   
 
Whilst the process of synthesising proteins is very energy expensive, it is vital to produce 
the correct protein in order to serve its biological function within the cell. Therefore, it is 
very important to check the fidelity, a process that takes place in the 30S subunit that binds 
to the mRNA and the anticodon stem-loop of the tRNA, where incoming aminoacylated 
tRNA is checked for binding to the correct mRNA codon. The acceptor arm of the 
aminoacylated tRNA binds to the 50S subunit that catalyses the peptide bond formation 
between the incoming amino acid at the aminoacyl site and the nascent peptide chain at the 
peptidyl site.  
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Because a bacterial cell consumes a lot of energy in making ribosomes and because 
ribosomes are the decoding/translation apparatus, if production stalls then it is more sensible 
for the cell to rescue, and free a stalled ribosome and then recycle it into the protein 
production process. There are multiple reasons and situations for ribosome stalling on an 
mRNA to occur: (i) the ribosome has reached a stable secondary structure on the translated 
mRNA (Tholstrup et al., 2011); (ii) a lack of a charged tRNA for the specific amino acid 
codon; (iii) a stop codon (Sunohara et al., 2004); (iv) a lack of or low level of ribosomal 
release factors  (Garcia-Pineres et al., 2007); (v) a ribosome reaches a cluster of rare codons  
(Li et al., 2006); (vi) as a part of the cell cycle  or metabolic regulations  (Garza-Sánchez et 
al., 2006); and (vii) the mRNA lacks a stop/termination codon  (Klauer and van Hoof, 2012) 
 
1.17 Transfer Messenger RNA  
 
Stalled ribosomes are rescued by a process known as trans-translation, which is mediated by 
tmRNA or SsrA. When a ribosome become stalled because of defective mRNA, tmRNA 
recognises and binds to it and its peptide tag sequence is translated to tag the incomplete 
protein for degradation.  Therefore, tmRNA serves as a global quality control system and 
increases the fidelity of gene expression via promoting the synthesis of full length proteins, 
and it plays an important role in bacterial development, pathogenesis and environmental 
stress responses (Janssen and Hayes, 2012; Keiler and Ramadoss, 2011). Ribosomes are 
targeted by tmRNA not only because of truncated mRNA, as it has been observed that 
tmRNA tagging occurs even on full length proteins and incomplete proteins can be 
synthesised from full length mRNA.  This observation suggests that ribosome stalling, rather 
than mRNA truncation, triggers tmRNA tagging. 
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This type of messenger RNA, also known as 10Sa and SsrA (small stable RNA A) was first 
identified in E. coli by Ray and Apirion (1979). It is conserved in all bacteria, is cell cycle 
controlled (Hong et al., 2005) and its activity is required for normal cellular physiology 
(Hong et al., 2007). It is essential for some bacteria but not all (Huang et al., 2000; Julio et 
al., 2000), and is ubiquitous, as it is found in chloroplasts, eubacteria, and mitochondria of 
some eukaryotes (Andersen et al., 2006; Gueneau de Novoa and Williams, 2004).  It 
combines the properties of mRNA and tRNA, therefore it was renamed tmRNA (Atkins and 
Gesteland, 1996). It was first identified in M. tuberculosis  in 1992 (Tyagi and Kinger, 1992).  
Normally, tRNA does not encode any protein and therefore it is not translated; however, 
tmRNA carries a peptide tag sequence of 10-13 amino acids in its mRNA domain. Therefore, 
tmRNA has a dual function: (1) to free a stalled ribosome at the 3’ end of truncated mRNA; 
and (2) to tag the nascent incomplete protein for degradation (Hayes et al., 2002; Keiler, 
2011) by different protease complexes, including ClpXP, ClpAP, FtsH (Ahlawat and 
Morrison, 2009; Baker and Sauer, 2012; Dziedzic et al., 2010), Tsp and Lon (Choy et al., 
2007). tmRNA binds only to 70S ribosomes and not 30S or 50S subunits or polysomes 
(Komine et al., 1996; Tadaki et al., 1996). Small protein B (SmpB) and tmRNA  (Figure 6) 
are a very important protein quality control mechanism within bacterial cells (Keiler, 2007).  
Control via trans-translation and tagging ensures that incomplete proteins and damaged RNA 
are degraded, prevents the accumulation of non-functional and potentially harmful products, 
and at the same time frees stalled ribosomes to be recycled for more productive translation. 
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1.17.1 Structure of tmRNA 
 
tmRNA size ranges from 230 to 400 nucleotides (Janssen and Hayes, 2012), and in M. 
tuberculosis it is 368 nucleotides; previously it was thought to be 607 nucleotides but 
recently it has been re-annotated and the size reduced by 239 nucleotides. Structural 
variations are seen in some cyanobacteria and proteobacteria, where the functional tmRNAs 
are composed of two non-covalently linked RNA chain k (Keiler et al., 2000). The two 
domains, the tRNA like domain (TLD) and mRNA domain (MLD) are the most conserved 
features of tmRNA.  
 
tmRNA has four pseudoknots (pK1-4) that are present in the TLD and MLD of most 
bacterial species. The role of pk1 in tmRNA function is purely structural, and it can be 
replaced by a variety of hairpin structures which help to stabilise the region enclosed by the 
TLD and MLD, preventing tmRNA misfiling, however deleting pk1 entirely is damaging 
for protein tagging (Tanner et al., 2006; Wower et al., 2009). tmRNA folding and maturation 
seem to be the primary role  of  pk2, pk3 and pK4, not its trans-translational activity (Wower 
et al., 2004). A reduction in the number of pseudoknots does not decrease the tagging 
efficiency of two-piece tmRNA (Gaudin et al., 2002) in α-proteobacteria, cyanobacteria and 
β-proteobacteria (Keiler et al., 2000). 
 
The TLD interacts with the ribosome in the same way as canonical tRNA, and in tRNA the 
stem is extended by a 3’-terminal codon CCA (cytidine-cytidine-adenosine) but can only be 
aminoacylated with alanine (Komine et al., 1994; Ushida et al., 1994). The pk2, pk3 and 
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pk4 form an arc around the head of the 30S subunit and during translocation from the 
aminoacyl to the peptidyl site, the region composed of hp2a to hp2d, and pk1 undergoes 
significant conformational changes, while tmRNA maintains its overall structure (Wower et 
al., 2014). pK1 partially unfolds as the TLD is translocated to the exit site (Fu et al., 2011).  
 
MLD is constructed of a short single strand open reading frame (ORF) for the proteolytic 
tag, and the ORF can contain 8-35 residues (Guidice et al., 2014),  although there are 10 
residues (A)ANDENYALAA in E. coli (Moore and Sauer, 2007) and 12 residues 
(A)ADSHQRDYALAA in M. tuberculosis, with the first (A) carried by the tmRNA. In 
addition, the MLD has a conserved helix (H5) carrying a termination codon (Guidice et al., 
2014).  The MLD differs from canonical mRNA in three aspects: (i) it does not carry any 
start sites upstream to the AUG initiation codon, such as a Shine-Dalgarno sequence; (ii) it 
uses an alanine and sometimes a glycine codon as a resume codon; and (iii) the frame 
selection is determined by the five nucleotides immediately upstream of the resume codon 
(Karzai et al., 2000). 
 
  
Figure 6. Structure of tmRNA 
The diagram on the left shows the secondary structure of tmRNA highlighting the various domains, such as the 
TLD, pseudoknots (PK1, 2, 3 and 4) and the proteolytic tag ORF. On the right is the atomic model for the 
tmRNA-SmpB complex. The tag sequence presented in this diagram is for E. coli not M. tuberculosis.  
(Andini and Nash, 2011) 
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1.17.2 SmpB Function 
 
For tmRNA to function it needs protein cofactors, such as SmpB and EF-Tu (elongation 
factor) and ribosomal protein S1, which bind to either free tmRNA or the tmRNA:SmpB  
complex by connecting the MLD, pk2 and pK3  (Figure 7) (Shi et al., 2011).  SmpB is a 
protein which has high affinity to tmRNA and is encoded immediately upstream of ssrA in 
E. coli (Moore and Sauer, 2005); however, in M. tuberculosis it is separated by Rv3099c, a 
hypothetical protein which may have a related function to the smpB-tmRNA complex   
SmpB plays an important role in tmRNA structure, stability and activity (such as trans-
translation). It has been suggested that the interaction of SmpB with tmRNA is divided into 
two parts: its interaction with TLD to facilitate processing, aminoacylation, binding to the 
ribosome and peptidyl-transfer, and  the interaction with the upstream region of the peptide 
tag sequence to assist in the mRNA function (Kurita et al., 2007). It has also been found that 
SmpB protects tmRNA from RNaseR degradation (which degrades tmRNA from a non-
tRNA-like 3’ end), as it has been observed in C. crescentus that the level of SmpB during 
the cell cycle correlates with ssrA RNA stability, which means SmpB binding controls the 
time of ssrA mRNA degradation (Hong et al., 2005). The level of ssrA mRNA has been 
reported to be significantly reduced in M. tuberculosis ΔsmpB compared to wild type 
(Personne and Parish, 2014). 
 
Kurita et al. (2007) in their study stated that ‘SmpB serves to bridge two separate domains 
of tmRNA to determine the initial codon for tag-translation.’ It has also been reported (Kurita 
et al., 2010) that the C-terminal tail of SmpB has a role in placing the alanyl-tmRNA-SmpB 
complex into the aminoacyl site of the ribosome following hydrolysis of GTP by EF-Tu. 
Kurita et al.  also reported that mutation of the C-terminal tail prevented peptidyl-transfer or 
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analy-tmRNA and aminoacyl-site binding of SmpB. tmRNA also binds to EF-Tu, which 
facilitates a productive interaction with a stalled ribosome. SmpB has also been suggested 
to be involved in the survival of M. tuberculosis within macrophages (Tyagi et al., 1996).      
 
1.17.3 Trans-Translation Process 
 
Ribosome stalling on truncated mRNA is required for tmRNA recruitment, and tmRNA 
tagging is the fate of the majority of the proteins that are synthesised from non-stop mRNA. 
The trans-translation process happens very quickly when there is no codon or an complete 
codon is present at the aminoacyl site, but transfer still can take place when a transcript 
extends up to six nucleotides down-stream the of aminoacyl site codon (Janssen and Hayes, 
2012).  The efficiency of tmRNA action decreases rapidly with the increasing down-stream 
length of mRNA, nearly reaching zero if it exceeds 15 bases (Ivanova et al., 2004). Ivanova 
et al. (2004) also reported that in vivo, tmRNA action does not occur on ribosomes containing 
full length mRNAs.   
 
As it is seen in   Figure 7, before binding to the protein cofactors, tmRNA is first 
aminoacylated with alanine by alanyl-tRNA synthetase. Alanyl-tmRNA binds to SmpB and 
EF-Tu, and enters the aminoacyl site of the stalled ribosome without a codon anticodon 
interaction unlike tRNA (SmpB occupies the position of the anticodon).  The truncated 
polypeptide is transferred to the alany-tmRNA and the complex (nascent polypeptide, 
alanyl-tmRNA complex) is translocated to the peptidyl site and the mRNA is released and 
degraded by RNases. Following the translocation and release of the mRNA, the tmRNA 
peptide tag code sequence is translated. Translation is terminated when it reaches the 
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termination codon at the end of the tmRNA tag ORF, leading to the release of the tagged 
protein and freeing the ribosome. The tmRNA tag at the 3’ end of the tagged polypeptide 
can be recognised by many proteases, including FtsH, ClpAP, ClpXP, Tsp and Lon protease 
(Ahlawat and Morrison, 2009; Choy et al., 2007; Gur and Sauer, 2008; Karzai et al., 2000).  
 
  
Figure 7.  tmRNA function 
Schematic diagram describing the processes involved in freeing the stalled ribosome by the tmRNA. Obtained 
from  http://www.scitopics.com/tmRNA_SsrA_and_trans_translation.html  (Keiler, 2011) 
 
Trans-translation is part of the regulatory network or example the action of RelE and MazF 
(TA systems) which generate vast numbers of truncated mRNAs leading to non-stop 
translation complexes induces stasis, permitting a cell to conserve resources during severe 
stress (Keiler and Feaga, 2014). The ssrA gene encoding tmRNA has also been suggested to 
function as a cell cycle progression controller (Hong et al., 2005), to help survive during 
stress conditions, such as exposure to antibiotics  (Andini and Nash, 2011; Braud et al., 2006; 
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Palečková et al., 2006; Yang and Glover, 2009) heat shock and oxidative stress (Paget et al., 
2001).   
 
1.17.4 Trans-Translation Independent Ribosomal Rescue 
 
The release of a stalled ribosome at the 3’ end of an mRNA lacking a stop codon is essential 
for a bacterium to continue protein synthesis. The tmRNA based trans-translation pathway 
to release such stalled ribosomes is found in almost all bacteria, and is essential in some but 
in others can be inactivated or disabled.  Deleting ssrA in bacteria where it is non-essential 
produces a mildly defective phenotype but its function can be complemented by the ssrADD 
variant (Keiler, 2008; Moore and Sauer, 2007).  The non-essentiality of tmRNA trans-
translation in E. coli is due to the presence of an alternative rescue mechanism mediated by 
the protein YhdL, which has been renamed the alternative rescue factor A (ArfA). ArfA is a 
small protein that allows RF2 (a class-1 release factor that recognises U(A/G)A) to hydrolise 
peptidyl-tRNA on a nonstop translation complex (Figure 8). ArfA is a trans-translation 
backup, and is itself subject to the trans-translation process as it is constructed of a truncated 
mRNA; therefore, in the presence of a functional tmRNA it is tagged and degraded.  
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Figure 8. Alternative pathway for ribosome rescue ArfA and ArfB 
ArfA and ArfB are a backup system for the rescue of stalled ribosomes when the trans-translation process is 
impaired. (a) ArfA recognises the non-stop complex and binds in or near the empty mRNA channel. The 
binding of the ArfA facilitate the binding of the peptide chain release factor 2 (RF2) to the aminoacyl-tRNA 
binding site. RF2 catalyses hydrolysis the hydrolysis of peptidyl-tRNA bond resulting in the release of the 
ribosome, the nascent peptide and the mRNA (there is no tagging for degradation). The arfB does not require 
RF2 to function therefore, it binds directly and catalyses the release of the ribosome along with the nascent 
peptide and the mRNA. 
(Keiler, 2015) 
 
Therefore, ArfA is only needed when the tmRNA trans-translation is disabled or 
overwhelmed, and only then is it produced and it takes over the function or helps tmRNA to 
rescue the stalled ribosomes. Deletion of both ssrA and arfA is lethal for E. coli, and ssrA is 
essential in ΔarfA cells (Chadani et al., 2010). Shigella flexneri  does not possess a gene 
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encoding ArfA and therefore ssrA is essential for its survival, although ssrA can be deleted 
in S. flexneri which express the E. coil arfA gene (Ramadoss et al., 2013). ArfB (YaeJ) is 
another protein paralogue for the release factors (RFs) and directly catalyses peptidyl-tRNA 
hydrolysis within non-productive translation complexes (NTCs) (Chadani et al., 2012) in a 
manner similar to that for tmRN-smpB recognition (Keiler and Feaga, 2014) and is non-
essential in either ssrA+ or ΔssrA E. coli (Handa et al., 2011).  ArfB can function alone to 
rescue stalled ribosomes but ArfA requires the presence of RF2 (Shimizu, 2012). ArfB is 
widely distributed across α, β, γ and δ proteobacteria, bacteriodetes, actinobacteria and 
cyanobacteria, but is absent from firmicutes (Janssen and Hayes, 2012). Its homologue is 
also found in eukaryotes, including human ICT1, which is an essential protein and an integral 
component of the mitochondrial ribosome (Richter et al., 2010). PrfH is another E. coli 
putative stop-codon independent RF although its function may be redundant with ArfB 
(Baranov et al., 2006) and it  is not essential,  as E. coli ΔssrA ΔyaeJ ΔprfH exhibit no growth 
impairment or phenotype compared to E.coli ΔssrA cells under normal laboratory conditions 
(Janssen and Hayes, 2012). C. crescentus ssrA is not essential for its survival and it does 
possess an arfA homologue. Instead, it has been reported to have a protein known as CC1214 
that has homology to E. coli ArfB, and this can hydrolyse peptidyl-tRNA in nonstop 
translation complexes in vitro (Feaga et al., 2014). 
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1.18   Study Rationale 
M. tuberculosis is such a successful pathogen due to the plethora of mechanisms it possesses 
to establish itself and overcome the various stresses it encounters in the harsh environment 
of the human body. The high risk to public health, which has become even greater with the 
occurrence of multidrug resistant strains, necessitates the discovery of new anti-
mycobacterial drug treatments. The ability of M. tuberculosis to persist in the body in a 
dormant state adds to the difficulty in treatment. Therefore, in depth understanding of its 
behaviour is important.  Acr1 and Acr2 are both employed by M. tuberculosis to resist 
different stresses inside the body, as well as to modulate the host response to its benefit and 
to help it persist. Therefore, understanding their role is relevant and important to the 
identification of new targets that can be used to attack this bacterium.  Although these two 
proteins are regulated by different regulation systems and induction of their expression is 
caused by different conditions, they are both known to contribute to M. tuberculosis infection 
and virulence. The ability of M. tuberculosis to remain virulent without Acr1 (Timm et al., 
2006)  may suggest possible redundancy in the functions of Acr1 and Acr2.  Therefore, 
investigating the existence of such redundancy may shed more light on their role and the 
possibility of them or their effects being drug targets. 
 
Another mechanism that is vital for the survival of M. tuberculosis is protein synthesis 
regulation. Rapid adaptation of a pathogen to the environmental changes that it senses and 
responds to within a host is of paramount importance. This includes the regulation of protein 
synthesis, which is a complex and expensive process, and errors in it may be fatal.  The trans-
translation process carried out by tmRNA is the primary quality control mechanism utilised 
by bacteria, regardless of whether they are pathogens. However, in some pathogens tmRNA 
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is essential for their survival and pathogenicity, but it is unknown if tmRNA is essential for 
M. tuberculosis. Therefore, understanding the role of tmRNA in M. tuberculosis may 
establish the potential for this molecule as a mycobacterial drug target (Shi et al., 2011).  To 
date, there is no published data regarding the exact role of tmRNA in the survival of M. 
tuberculosis and how it affects the growth of M. tuberculosis. However, during the course 
of this study an investigation published by Personne and Parish (Personne and Parish, 2014) 
using mutagenesis to try and differentiate between the importance of the different of the 
tmRNA in TB.  M. tuberculosis Acr1, Acr2 and tmRNA have all been identified to be up-
regulated during certain environmental stress conditions, these represent attractive targets 
for investigation. Therefore, this study was designed to investigate the possibility of 
functional overlap and redundancy between Acr1 and Acr2, and to investigate the role of 
tmRNA in the survival of M. tuberculosis by testing the following hypotheses: 
 
Hypothesis A: 
There is some functional redundancy between the two α-crystallins and that one can 
compensate to some extent for the loss of the other. 
 
 
Hypothesis B: 
 Transfer messenger RNA (tmRNA) is involved in the translation of stress proteins during 
the stress response  
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1.19 Aims and Objectives 
Aim A: 
To understand the roles of Acr1 and Acr2 in the stress response of M. tuberculosis, and to 
reveal the degree of functional redundancy. 
Objectives for Aim A: 
1. Make a single mutant of the acr2 gene.  
2. Make a double mutant of the acr1 and acr2 genes.  
3. Compare the phenotypes of the mutants in different environments (heat shock, NRP, 
macrophage infection). Assess if there is a ‘synthetic phenotype’ in the double mutant. 
4. Examine the intracellular localisation of Acr2 by immune-electron microscopy to 
elucidate its location in the cell wall. 
Aim B: 
To examine the role of tmRNA in the translational control of stress responses. 
Objectives for Aim B: 
1. Attempt to knockout tmRNA in wildtype and tmRNA-Hist M. tuberculosis. 
2. Make a tmRNA mutant and examine its phenotype. 
3. Attempt to express WT tmRNA and tmRNA-Hist in M. tuberculosis. 
4. Attempt to identify the target(s) of the tmRNA degradation/translation process by examining 
proteins using His pull-down and LC-MS. 
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Chapter 2 
Methods and Materials 
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2.1 Bacterial strains and growth conditions 
Bacterial strains used: 
• E.coli DH5-α strain for routine cloning applications 
• M. bovis BCG (Bacillus Calmette–Guérin) 
• M. tuberculosis H37Rv 
• M. smegmatis GroEL DC 
All DNA vector construction was carried out in Escherichia coli (DH5α) strain.  E. coli were 
grown at 37oC in Luria-Bertani (LB) broth and agar containing 50µg kanamycin ml-1or 
100µg hygromycin ml-1. Wild type (WT) M. tuberculosis H37Rv, ∆acr1, ∆acr1∆acr2, ssrA-
His merodiploid and ssrA merodiploid strains were grown at 37oC with aeration (slow 
shaking 150 RPM) in Middlebrook 7H9 Broth (Difco) containing 0.1% Tween80 and 10% 
albumin-dextrose-catalase (ADC) or Middlebrook 7H11 (Difco) medium containing 5% 
Oleic acid-albumin dextrose-catalase (OADC) enrichment. Two per cent (2%) sucrose was 
added to media for counter selection of sacB, kanamycin at 15µgml-1 or hygromycin at 
50µgml-1 were added where appropriate.   
 
To grow M. bovis Bacillus Calmette–Guérin (BCG) str. Pasteur, M. smegmatis groEL1ΔC 
and M. smegmatis groEL1ΔCΔlon merodiploid harbouring M. tuberculosis H37rv ssrAHis 
variant, starter cultures were grown in Middlebrook 7H9 broth (Difco) containing 0.1% 
Tween80 and 10% ADC until mid-log. 500ml of Roisin’s broth media containing 0.1% 
Tween 80 was inoculated from the starter culture and incubated shaking at 37oC until OD600 
of 1.0. For different stress condition two hours before the extraction the respective culture 
was either treated with a final concentration of 16ugml-1 Erythromycin, 0.5mM H2O2 or heat 
shocked at 42oC. These stresses were done either individually or in combination. 
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2.2 PCR 
All the PCR products were amplified by Phusion® High-Fidelity DNA polymerase (Thermo 
Scienctific) with a denaturing temperature of 98oC for 10 seconds, an annealing temperature 
varied between 58oC to 70oC for different primers pairs, extension at 72oC with varied time 
(15sec per kb) according to the length of the amplified fragment and final extension at 72oC 
for 7 minutes. A negative control was routinely used. All PCR were run in 1% agarose in 
TAE buffer. The different PCR products for cloning were amplified with primers (Table 3) 
containing relevant restriction sites.  
 
2.3 Ligation 
Before the ligation all the linearised (with the relevant restriction enzymes) vectors were 
treated with Calf intestine alkaline phosphatase (CIAP) and purified using Qiagen PCR clean 
up kit. Also all the PCR products were purified with the same kit. All ligation reactions 
contained 100ng of the vector while insert concentration varied depending on the size of the 
vector and the insert for each reaction. All the ligations reactions were done using T4 DNA 
ligase (Promega) and incubated over night at 4oC.  
 
2.4  E. coli Transformation 
 In 1.5ml Eppendorf tube, 50 µl of E. coli (DH5α) strain competent cells were mixed with 
2µl of the (overnight incubated) ligation mixture and incubated on ice for 30min before they 
were heat shocked at 42oC for 45 seconds and put back on ice for 2 minutes. 450µl of warm 
SOC medium were added to the cells, gently mixed and incubated at 37oC for 1hr. Volumes 
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of 20ul, 50ul and 100ul were spread on LB agar containing 100µg hygromycin ml-1 or 50µg 
Kanamycin ml-1 where appropriate and incubated at 37oC overnight. The resulting 
transformant colonies were sub-cultured onto LB agar containing the relevant antibiotics. 
Finally, the different transformants were PCR screened using the relevant primers Table 3 . 
 
Table 3. Primers list  
Primer Primer sequence Forward Purpose 
no   Reverse   
P1	
5’GCAGGATCCCGAAGGCAAGGTCAAGGTT3’  F 
amplify ssrA gene flank1 with BamH1 
restriction site 
P2	
5’CGAACTAGTCGGTCAGATCACGAAGTTCA3’ R 
amplify ssrA gene flank1 with SpeI 
restriction site 
P3	
5’CAGAGATCTCCAGGAACCGTGTCTTTGTT3’ F 
amplify ssrA gene flank2 with BglII 
restriction site 
P4	
5’CAGTCTAGATGTTTGGGATTGCAAAGTGA3’ R 
amplify ssrA gene flank2 with XbaI 
restriction site 
P5	
5’TGGTGCAACTGCATCTCAAC3’ F 
used for sequencing PG5::hyg/ssrA from 
hyg toward Flank1 
P6	
5’GTACGGGGTTGGTGCTCTC3’ R 
used for sequencing PG5::hyg/ssrA from 
hyg toward Flank2 
P7	 5’GCTGAGCTCTTTCCGATGACGAATGGAAT3’ F 
amplify ssrA gene with its putative 
promoter for pK-ssrA 
P8	 5 ACTGAGCTCGATGCCGTGGAGTGTAGTA3’ R   
P9	 5’TCTGACCGGGAAGTTAATGG3’ F 
sequencing pK-ssrA from within ssrA 
gene 
P10	 5’CAGACTAGCCGTCGCTTAGG3’ R   
P11	 5’TTCCATAGGATGGCAAGATCC3’ F 
detecting Kanamycin gene in pK-ssrA 
and pk-hist-ssrA  
P12	
5’GGCAATCAGGTGCGACAATC3’ R 
also used to screen  pK-ssrA and pK-hist-
ssrA merodiploid 
P13	 5’CACATCACCACCACCACCA3’ F sequencing pK-hist-ssrA 
P14	 5’CGATGCCGTGGAGTGTAGTA3’ R   
P15	 5’GGCGATAGCTGTGTCCAAGT3’ F screening for the deletion of ssrA gene 
P16	
5’GACCCATACAGCGGACTGAC3’ R   
P17	
 5’CACATCACCACCACCACCA3’ F screening for hist tag on pK-hist-ssrA 
P18	
5’CGATGCCGTGGAGTGTAGTA3’ R 
also used to screen  pK-hist-ssrA 
merodiploid 
P19 5’ACTGAGCTCTGGCAGACAACAGGGTCAAT3’ F 
amplify acr1 gene with its putative 
promoter with sacI restriction 
P20 5’GCTGAGCTCACCCAGTGGTCAGTTGGTG3’ R 
site for pK-acr1 also used to check for the 
deletion of acr1 gene 
P21 5’ATCTGATGCGGCCGCAGGCATGGTCTGAGGGTATG3’ F 
amplify acr2  gene with its putative 
promoter with 
P22 5’TCATGTAGCGGCCGCTGCCGTATCGCGAACTACT3’ R NotI restriction site for pK-acr2 
P23 
5’GTCGACACCCAACAGCTTG3’ F screening for the deletion of acr2 gene 
P24 
5’GCCTCGAACACGATGAACC3’ R   
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Primer Primer sequence Forward Purpose 
no   Reverse   
P25	
5’GCG TAG GCG TCT GAA AGA GA3’ F 
To amplify GroEL1 from M. smegmatis 
groEL1ΔC 
P26	
5’GAT CTT GTC GCC TCT TGT CC3’ R  
P27	
5’GAC GAC GAG GGT CGA CAG3’ F To sequence M. smegmatis groElL1ΔC 
P28	
5’ATC CGC AAG ACG CTC AAG3’ R  
P29	
5’GTC GGA TCC CGA TGG TCA ACA TCA ACC AG3’ F 
To amplify lon upstream flank with BamH1 
restriction site 
P30	
5’CGT ACT AGT GCC ATC AGT CCT CCA AAC TT3’ R 
To amplify lon upstream flank SpeI 
restriction site 
P31	 5’CGT AGA TCT GGC TCT CAA CGG TGT TCA TC3’ F 
To amplify lon downstream flank with BglII 
restriction site 
P32	 5’GTC TCT AGA CCT CTT CGT CGA ACG TGA AT3’ R 
To amplify lon downstream flank with XbaI 
restriction site 
P33	  5’GACTACAACGGCTGGGACAT3’ F 
To check for the deletion of lon gen from M. 
smegmatis groEL1ΔC 
P34	  5’GGTCATCAGCATCACCACAC3’ R  
P35	 5’AGG CAA GAG ACC ACC GTA AG3’ F 
To detect the His tag for checking ssrA9His 
expression  
P36	 5’TTA GTG ATG GTG GTG GTG GT3’ R  
			P37	
 
5’CAT GAG CTC GAA TTC GAA ATC GGC ATC ATG CGC 
TT3’ F 
To amplify smpB-Rv3099c-ssrA from  
M. tuberculosis H37Rv to be cloned into 
pKinta 
			P38	
5’TGC GAG CTC AAG CTT TGG CAC GAT ACC TTG GTC 
TG3’ R  
P39	
5’GCTTCTAGAGAATTCCTTTCCGATGACGAATGGAAT3’ F 
To clone ssrA9His into pMV306 expression 
vector 
P40	
5’ACGTTCTAGAAAGCTTCGATGCCGTGGAGTGTAGT3’ R  
P41	
5’GATTCACATCAGCGCCACCACCACCAC3’ F Use for site directed mutagenesis 
P42	
5’GTGGTGGTGGTGGCGCTGATGTGAATC3’ R  
    
  
   
 65 
2.5 Construct screening 
The resulting transformants of various constructs were screened with PCR using relevant 
primers  (Table 3). From each transformation, two successful PCR positive transformants 
were sub-cultured in LB broth with the relevant antibiotics and incubated overnight at 37oC 
with slow shaking. Cells were harvested the following day to extract the plasmid DNA.  
Extracted plasmid DNA was further screened by digestion with the relevant restriction 
enzyme and then sent to ”Eurofins (MWG)” for sequencing using the relevant primers  
(Table 3) .   
 
2.6 Gene replacement of ssrA and acr2  
All manipulations of M. tuberculosis H37rv were done within the class I safety cabinet in 
CL3 laboratory 
2.6.1 Preparing H37rv competent cells 
50ml of 7H9 broth (in 75ml sterile conical plastic flask) was inoculated with a loop full of     
M. tuberculosis H37rv (WT, knock out or merodiploid strain) and incubated for 5 to 7 days 
at 37oC with shaking at low speed.  This culture was used for preparation of the competent 
cells when the OD reached between 0.5-1.0. The culture was transferred to a 50ml Falcon 
tube and spun at 4000RPM for 10min at 37oC. The pellet was re-suspended in 50ml of 37oC 
pre-warmed sterile 10% glycerol and spun again at 4000RPM for 10min. This processes 
were repeated resuspending in decreasing amounts of 10% glycerol, first 12.5ml, then 5ml, 
and finally 1ml. 
   
 66 
 
2.6.2  Electroporation for knockout and plating 
The replacement of the acr2 gene with the hyg gene and the replacement of the ssrA gene 
with the aph gene was done by introducing pSMT183 or PG5ssrA::hyg (Stewart et al., 2001) 
suicide plasmids (plasmids that cannot replicate in mycobacteria) for the acr2 gene or the 
ssrA gene replacement respectively. Four hundred microliters (400ul) of the competent cells 
WT M. tuberculosis H37Rv, M. tuberculosis H37rv merodiploid ssrA or M. tuberculosis 
H37rv merodiploid his-ssrA strains) were mixed with 1µg of the relevant UV light treated 
plasmid DNA. PG5ssrA::hyg was electroporated into WT M. tuberculosis H37rv and the two 
merodiploid M. tuberculosis H37rv with a second copy of wild-type ssrA and with ssrA9His 
variant strains. The mixture was pipetted into a 2mm electroporation cuvette, and the cuvette 
placed into the electroporation pod (in the safety cabinet) and pulsed with 2500 volts. The 
content of the cuvette was transferred to a fresh 10ml 7H9 broth (containing 0.05% Tween80 
and 10% albumin-dextrose-catalase and free of antibiotics) and incubated at 37oC for 24hrs 
with gentle shaking at 150RPM. A negative control using water instead of DNA was also 
routinely carried out. The overnight incubated 10ml 7H9 broth was spun down and the pellet 
of the cells was resuspended in 1ml of fresh 7H9. A volume of 500ul of the resuspended 
cells was evenly spread over the surface of two 7H11 agar plates containing 5% OADC, 
50µg hygromycin ml-1 and 2% sucrose. The plates were incubated at 37oC until 
transformants became visible. 
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2.6.3 Complementation of ssrA gene and plating 
For complementation, pKinta (Stewart et al., 2001) plasmid was used which is a ColE1-
based E.coli plasmid that carries aph kanamycin resistance gene, int gene, encoding an 
integrase, and an attP site from the L5 mycobacteriophage. This plasmid integrates into the 
chromosome in a single copy at the attB site by specific recombination. The ssrA gene was 
introduced into WT M. tuberculosis H37rv   using pK.ssrA plasmid construct to generate a 
strain with two copies of ssrA genes (merodiploid strains). This was also performed with the 
pK.ssrA-9His. The WT M. tuberculosis H37rv   competent cells were prepared as described 
in section 2.6.1, electroporated and plated in the same manner as described in section 2.6.2.  
2.6.4 Complementation of acr1 and acr2 genes and plating 
 The pKinta plasmid was also used to complement the single acr1 and acr2 as well as the 
double genes acr1&acr2 in Dacr1, Dacr2 and Dacr1Dacr2 strains respectively. The 
respective M. tuberculosis H37rv knockout (KO) strains competent cells were prepared as 
described in section 2.6.1, electroporated with the respective gene/s and plated in the same 
manner as described in section 2.6.2.  
 
2.6.5 M. tuberculosis H37rv transformants screening  
Colonies from transformations were individually sub-cultured onto another 7H11 plate 
(divided into 6 or 8 sections). Two to three weeks later DNA was extracted as described in 
section 2.8. The transformants from the complementation plates were PCR screened (primers 
P11&P12) for the presence of kanamycin resistance gene. PCR screening was also 
performed to confirm the deletion using the relevant primers  (Table 3) The PCR products 
were digested using a relevant restriction enzyme to demonstrate that the amplified products 
identity and finally they were sequenced.     
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2.7 Producing BCG str. Pasteur merodiploid harbouring M. 
tuberculosis H37rv ssrA-His variant 
2.7.1 Preparing BCG str. Pasteur competent cells 
 The BCG competent cells were prepared as described in section 2.6.1. 
2.7.2 Preparing M. smegmatis groEL1ΔC competent cells 
From solid 7H11, WT M. smegmatis groEL1ΔC or M. smegmatis groEL1∆CΔlon strain, a 
50ml of broth culture 7H9 (in 75ml sterile conical plastic flask) was inoculated and incubated 
for 48 hours at 37oC shaking at low speed.  This culture was used for preparation of the 
competent cells when the OD reached between 0.5-1.0. The flask containing the culture was 
incubated on ice for 1.5 hours and the culture was transferred to a 50ml Falcon tube and 
made competent as described for M. tuberculosis H37Rv, section 2.6.1, but using ice-cold 
10% glycerol rather than warmed glycerol. 
2.7.3 Electroporation of BCG str. Pasteur with ssrAHis variant 
A pKinta plasmid carrying either ssrA9His or ssrA-6His gene was introduced into BCG Pasteur 
wild type to generate a strain harbouring either M. tuberculosis H37Rv ssrA9His or ssrA6His 
variant in addition to its native ssrA. The BCG str. Pasteur wild type was electroporated and 
plated in the same manner as described in section 2.6.4.   
2.7.4 Electroporating of M. smegmatis groEL1ΔC with ssrAHis 
variant 
The pKinta plasmid carrying either ssrA9His or ssrA6His gene was introduced into                        
M. smegmatis groEL1∆C wild type or M. smegmatis groEL1∆CΔlon to generate a strain 
harbouring either M. tuberculosis H37Rv ssrA9His or ssrA6His variant in addition to its native 
ssrA. The respective M. smegmatis groEL1∆C was electroporated and plated in the same 
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manner as described in section 2.6.3, but, the mixture of competent cells and respective 
plasmid were incubated in ice for 1 minute prior to the electroporation. 
 
2.8   M. tuberculosis H37rv genomic DNA (gDNA) preparation 
A 20ml cultures of M.  tuberculosis H37rv were setup and grown to late log phase. The 
cultures were spun at 3500RPM for 15 min in Falcon tubes. The supernatants were carefully 
poured off and the cell pellets suspended in 1ml GTE solution (25mM Tris-HCl, pH.8.0, 
10mM EDTA, 50mM glucose). The suspended cell pellets were transferred to a 2ml micro 
centrifuge tube and spun for 5min at 13,000RPM. The supernatants were aspirated out and 
the cell pellets resuspended in 450µl of GTE solution. Finally, 50µl of lysozyme (10mg/ml) 
was added to each and gently mixed prior to incubation overnight at 37oC without shaking. 
Following the overnight incubation, the suspensions were heated to 80oC for 2hrs. A volume 
of 100µl of 10% SDS was added to the different suspensions and gently mixed, followed by 
the addition of 50µl of proteinase K (10mg/ml) which was mixed and incubated at 55oC for 
40min. A volume of 200µl of 5M NaCl was added and gently mixed followed by the addition 
of 160µl of preheated cetyltrimethylammonium bromide (CTAB) solution (in 65oC oven), 
this was gently mixed and incubated for 30min at 65oC in water bath. An equal volume of 
chloroform-isoamyl alcohol (24:1 ration) was added, gently mixed and spun for 5min at 
13000RPM. The aqueous upper layer was aspirated and transferred to a new micro 
centrifuge tube to which another equal volume of preheated chloroform-isoamyl alcohol 
(24:1) was added, gently mixed and spun at 13000RPM for 5min. A volume of 800µl of the 
aqueous upper layer was transferred to a new micro centrifuge tube to which a volume of 
560µl of isopropanol was added, gently inverted until the DNA precipitate was seen. The 
DNA was incubated at room temperature for 5min and spun for 10min at 13000RPM. The 
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supernatant was discarded and 1ml of 70% ethanol was added to the pellet, gently inverted 
a few times and spun for 5min at 13000RPM. The supernatant was removed and the pellet 
left to air dry for about 10min. The dried pellets were resuspended with 50µl of DNAse free 
water and stored at 4oC to allow the pellet to resuspend overnight. The concentration of the 
DNA was determined by Nanodrop. For longer storage period the gDNA preps were stored 
at -20oC 
 
2.9 BCG str. Pasteur cytosolic and membrane bound protein 
extraction  
This method was adapted from the method described in Sinha et al., 1995. A volume of 
500ml Roisin’s medium was inoculated 1 in 10 with a BCG str. Pasteur starter culture and 
incubated until it reached an OD600 of 1.0. The culture was split into Falcon tubes and spun 
for 10min at 4000RPM at 4oC. The supernatant was decanted into a clean container and filter 
sterilised. Then a volume of 100ml (20ml at a time) were concentrated using corning® Spin-
X® UF20 concentrator (MW cut-off of 10,000). The spin -X UF6® concentrator was spun at 
4000RPM for 35minutes in 20ml aliquots.  The 100ml of supernatant were concentrated to 
0.5ml to which the appropriate volume of sample buffer was added and the mix boiled for 
5min.   
 
The pellet was washed three times with ice cold Phosphate-Buffered Saline (PBS; 10mM 
phosphate, 150mM NaCl, pH7.4)and resuspended in sonication buffer (50mM Tris-HCl, 
10mM MgCl2, 0.02% Sodium Azide, pH 7.4) containing proteases inhibitors (1mM EGTA 
and 1mM PMSF). As no sonicator was available, the cells were disrupted using a Lysing 
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Matrix system (MP Biomedicals FastProteinTM Blue). A volume of 1ml of the resuspended 
pellet was transferred to the Lysing Matrix tubes, incubated in ice for 5min, transferred to 
the ribolyser and run for 30sec at speed of 6.5 followed by incubation in ice for 5min. Three 
cycles were run with 5min incubation on ice in between. The tubes were spun for 10min at 
13000RPM at 4oC. The supernatants were transferred to new 2ml micro centrifuge tubes and 
spun for 10min at 13000RPM at 4oC and pooled. The cell pellets were washed three times 
with sonication buffer and resuspended in 10ml of Tris-Buffered Saline (TBS; 10mM Tris, 
150mM NaCl, pH7.4). The twice spun pooled supernatant was split into two 5ml 
ultracentrifuge tubes and spun at 150,000g (35000RPM) for 90min at 4oC. The supernatants 
(Cytosolic) were aspirated and stored at -20oC until needed. The plasma membrane pellets 
were resuspended in 5ml TBS and spun again at 150000g for 90min (this step was done 
twice). After two further washes with TBS the pellets were resuspended in TBS, pooled and 
stored at -20oC.   
 
2.10 ssrA-His variant tagged protein extraction and purification  
2.10.1 Protein extraction 
The BCG str. Pasteur or M. smegmatis groEL1∆C or M. smegmatis groEL1∆CΔlon 
merodiploid harbouring either pk.ssrA9His or pK.ssrA6His transformants were grown in a 
volume of 400ml Roisin’s medium containing 30µg-1 Kanamycin to an OD600 of 1.0. The 
cultures were transferred to 50ml Falcon tubes and spun for 10min at 4000RPM. The 
supernatants were discarded and the pellets were washed three times with ice cold PBS.  
Finally, the pellets were resuspended in ice cold lysis buffer (70mM Hepes pH8, 20mM 
Imidazole, 650mM NaCl) containing 1mM PMSF protease inhibitor, 1mM EGDTA (sigma) 
and 0.02% Sodium Azide (sigma). A volume of 1ml of the resuspended pellet was 
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transferred to the Lysing Matrix tubes, incubated on ice for 5min, transferred to the ribolyser 
and run for 30sec at speed of 6.5 followed by incubation on ice for 5min. Three cycles were 
run with 5min incubation on ice in between. The tubes were spun for 10min at 13000RPM 
at 4oC and the supernatants transferred to a new 2ml micro centrifuge tubes and spun for 
10min at 13000RPM at 4oC and pooled.   
 
2.10.2 ssrA-His variant tagged protein extraction  purification 
The 1ml His TrapTM HP (GE Healthcare Life Sciences) column was first equilibrated by 
washing with 5 ml (five fold volume) with binding buffer (70mM Hepes pH8, 20mM 
Imidazole, 500mM NaCl, 0.1mM β-mercaptoethanol). The culture supernatant (described in 
section 2.10.1) was passed through the column with a flow rate of 1ml per min. Then washed 
with five times the sample volume of binding buffer. The protein was eluted with 5ml of 
elution buffer (60mM Hepes pH8.0, 400mM Imidazole, 150mM NaCl, 3% Glycerol) at flow 
rate of 1ml min-1. The eluate was collected into a series of 0.5 ml aliquots. The amount of 
the protein in each eluate aliquot was checked by NanoDropTM and by visualising on a 12% 
acrylamide gel. The protein band from aliquot with the most protein was selected and sent 
for identification by mass spectrometry.   
 
2.11 Western Blot 
2.11.1  Protein Sample Preparation 
An appropriate volume lysate or His TrapTM HP column elute was mixed with an equal 
volume of sample buffer (50mM Tris HCl pH6.8, 2% w/v SDS, 5% v/v 2-mercaptoethanol, 
10% v/v glycerol, 0.05% w/v bromophenol blue) and boiled for 5minutes. 
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2.11.2   Protein Gel Preparation 
All the protein electrophoresis was performed using 12% acrylamide pH8.8 (resolution part) 
and 3% acrylamide pH6.8 (stacking part). 
2.11.2.1   Resolving gel (12%) 
For two 1mm gels (7mmx8mm) a volume of 10ml resolving gel was prepared containing 
4ml of 30% acrylamide gel solution, 2.5ml of 1.5 M Tris HCl buffer pH8.8, 3.3ml sterile 
protease free RO water, 100µl of 10% ammonium persulfate (APS, freshly prepared) and 
100µl of 10% SDS. Prior to pouring the gel into the mould a 10µl of 
Tetramethylethylenediamine (TEMED (Thermo ScientificTM) was added and thoroughly 
mixed. 1ml of water saturated n-butanol was added to prevent it from drying. The resolving 
gel was poured first and left to polymerise. 
 
2.11.2.2   Stacking gel (3%) 
For two 1mm gels (7mmx8mm) a volume of 3 ml stacking gel was prepared containing 
0.5ml of 30% acrylamide gel solution, 0.38 ml of 0.5M Tris HCl buffer pH6.8, 2.1ml sterile 
protease free RO water, 30µl of 10% APS, freshly prepared), 30µl of 10% SDS. Prior to 
pouring the gel into the mould a 3ul of TEMED was added and thoroughly mixed. Before 
pouring the stacking gel mixture the water saturated n-Butanol was removed by inverting 
the gel mould rack on a paper towel. After pouring the stacking gel on top of the resolving 
gel the combe was placed and the gel left to polymerise. Finally, the gel cassette was 
assembled into the electrophoresis tank. 
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2.11.3   Protein sample Loading and Electrophoresis  
Before loading the samples, the wells were washed with the running buffer (0.05M Tris, 
0.055M 0.1% SDS) and up to 20µl of pre-mixed and boiled protein sample were pipetted 
into the corresponding well and run at 150V for 1hr.  
 
2.11.4   Protein Gel staining 
After the electrophoresis was complete the gels were removed from the cases stained for 30 
minutes in Coomassie Blue stain while shaking.  Then the stain was removed and the gel 
was destained with 10 % glacial acetic acid, 30 % methanol until protein bands became 
visible. 
 
2.11.5   Protein Gel blotting 
The second gel was transferred to a PVDF membrane using semi-dry blotting unit. The gel 
was removed from the cassette and placed into transfer buffer (0.303% Tris HCl, 1.44% 
Glycine, 20% Methanol).  The PVDF was activated first by dipping it into absolute Methanol 
for 30seconds then placed into transfer buffer. Two blotting papers were cut to the size of 
the gel and left soaked into the transfer buffer. The first blotting paper was put on the surface 
of the blotting unit, the wet PVDF membrane was layered on top of it followed by the gel 
then the second wet blotting paper. Finally, the unit was closed and run for 30minutes to 
45minutes at 20 V. 
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2.11.6   Membrane Blocking 
The PVD membrane was blocked in 10% fat free milk solution in TBS (0.08% NaCl, 0.03% 
Tris HCl pH7.6) containing 0.1% Tween20 for 1hr at room temperature while shaking.  
 
2.11.7   Primary Antibodies Treatment 
The blocked membrane was transferred to a 50ml Falcon tube containing 5ml of primary 
antibody diluted to an appropriate concentration (1 in 1000 or 1 in 5000) in 3% fat free milk 
solution in TBS (0.08% NaCl, 0.03% Tris HCL pH7.6) containing 0.1% Tween20 and rolled 
for 1hr followed by rinsing three times (10 minutes each) in approximately 10ml TBS 
containing 0.1% Tween 20 buffer. 
 
2.11.8   Secondary  Antibodies (HRP conjugate) Treatment 
Secondary antibodies were diluted to 1:5000 or 1:10000 in 5 ml 3% fat free milk solution in 
TBS (NaCl 0.08%, 0.03% Tris HCL pH7.6) containing 0.1% Tween 20 and added to the 
Western blot and left rolling for 1hr before washing as with the primary antibody. 
 
2.11.9   Western Blotting Development 
The blot was developed using ClarityTM Western ECL (Bio Rad) substrate. The signal was 
detected either by using photo sensitive (X-ray) film or using a FluoroChemQ imaging 
system. 
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2.12   In vitro Stress Assays  
The M. tuberculosis H37Rv strains were grown in 7H9 until mid-log phase. The OD was 
adjusted to a standard OD.  
2.12.1   Hypoxia  
One millilitre of culture at OD 0.47 was dispensed in triplicate into 2ml tubes. 400ml of 
sterile liquid paraffin was layered on top of the 1ml of culture and the tube was closed tight. 
The tubes were incubated at 37oC without shaking. At each time point (10 days, 20 days and 
30days) the respective tubes were removed and the paraffin layer was carefully removed. 
The tube content was carefully and slowly mixed by pipetting up and down and a sample of 
50ul taken and serially diluted.  Three 20ul from each dilution were cultured. 
 
2. 12.2  Heat shock 
One millilitre of culture at OD 0.17 was dispensed into 2ml O-ringed screw capped tubes in 
duplicate and transferred to 53oC water bath. At each time point (15min, 30min, 45min, 
60min, 90min and 120 min) a tube was removed from the water bath and gently mixed and 
a 20ul sample serially diluted out to 10-6. Three 20ul from each dilution was spotted 
separately on 7H11 agar plates. The plates were sealed by tape, bagged and incubated at 
37oC for up to 8 weeks. A time 0 sample was also done by taking a sample of 20ul from the 
adjusted OD culture, diluted and cultured the same way as described above. 
 
2.12.3  pH 
One millilitre of OD 0.4 culture was dispensed into 2ml O-ringed screw capped tube in 
duplicate, the tubes spun down and the supernatant was discarded. The cells pellets were 
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washed with sterile PBS once to remove the 7H9 residual and the cell pellets resuspended in 
1ml of sterile water. A 100µl aliquot of the washed cells was added in triplicate to Roisin’s 
minimal medium with pH adjusted to pH 6.6 and pH 4.4 and incubated without shaking. 
After 7 days of incubation the tube content was gently mixed and a 20µl aliquot taken and 
serially diluted to 10-6 and cultured on 7H11 agar for up to 8 weeks. For T0, 100µl of the 
washed pellets was added to 1ml of sterile water which was diluted and cultured as described 
for the different pH samples.  
 
2. 12.4  H2O2 
A cell pellet from 1 ml of culture, OD 0.4, was washed with sterile PBS to remove the 
residual 7H9 and resuspended in 1ml of sterile water. Aliquots of 100µl of cells were added, 
in triplicate, to 1ml Roisin’s containing H2O2 at 0mM, 10mM and 20mM and incubated at 
37oC without shaking. After 2hours of incubation the content of the tube was gently mixed 
and a sample of 20ul was taken and serially diluted out to 10-6 and plated onto 7H11 plates 
and sealed with tape. For T0 100µl of the washed pellets was added to 1ml of sterile water, 
diluted and cultured as described for the different H2O2concentrations samples.  
 
2.13   THP-1 Cell infections 
2.13.1  THP-1 cell preparation 
THP-1 cells, a human monocyte-like cell line (ATCC® TIB-202™), was obtained from in-
house stocks. THP-1 cells were cultured in Roswell Park Memorial Institute (RPMI) 1640 
medium supplemented with 200mM L-glutamine, and 10% Foetal Bovine Serum (FBS) and 
incubated in 5% CO2 at 37oC.  Cells were routinely propagated into 75 cm2 flasks (BD 
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falcon). For assays, THP-1 cells were seeded at a density of between 1x105 cells/ml and 
1x106 cells/ml in 24-well tissue culture plates. To promote differentiation, cells were 
centrifuged and re-suspended in fresh media to a concentration of 1x106 cells per ml and 
treated with final concentration of 100nM Phorbol 12-myristate 13-acetate (PMA) (P8139, 
Sigma). After treatment with PMA, 200µl of cell suspension was immediately added 96-
well plates. The cells were dispensed in an array of 6 wells per strain to be tested (3 wells to 
be lysed for colony forming unit (CFU) counts and 3 wells for infected cells viability 
control), with 6 separate wells for the non-infected cells viability controls. Cells were 
incubated for 3 days to allow them to differentiate and stick to the well surface. Before 
infection, cells were washed three times with warm PBS then 100µl of warm RPMI with10% 
FCS, 10mM L-glutamine and 10mM pyruvate) medium was added.  
 
2.13.2  Infection with M. tuberculosis 
The different M. tuberculosis H37Rv strains were grown to mid log phase and ODs adjusted 
and diluted in warm RPMI (with 10% FBS) medium.  An appropriate volume of the diluted 
culture was added to the respective wells to give a multiplicity of infection (MOI) of 0.1.  At 
each time point (2hours, 24hrs, 48hrs and 7 days) a plate was taken from the incubator, all 
the wells were washed with warm PBS and 50µl of 1% triton added to three of the wells and 
the lysate serially diluted and plated onto 7H11 and incubated for up to 8 weeks for the viable 
M. tuberculosis count. The other wells and the 6 wells for the non-infected control were 
fixed with 4% Formaldehyde, placed overnight in formalin chamber before being stained 
with 0.5% Crystal Violet to determine the number of THP-1 cells present post infection at 
each time point.   
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2.14   RNA extraction 
M. smegmatis groEL1DC and merodiploid variants were grown in 10ml of 7H9 Broth 
overnight. Two hours prior to harvesting the cultures were treated with either 16ug ml-1 
erythromycin or 0.5mM H2O2.  The RNA was extracted using ThermoFisher Scientific 
Trizol®Plus RNA purification system. All the steps carried out according to the kit protocol. 
Trizol reagent is a monophasic solution of phenol guanidine isothiocyanate which maintains 
the RNA integrity but, at the same time disrupt cells and dissolve its components and acts as 
highly efficient RNase inhibitor during cell lyses.  
 
2.15 Reverse Transcriptase Polymerase Chain reaction (RT-
PCR) 
2.15.1  First-strand complimentary DNA (cDNA) Synthesis 
The cDNA was generated using Invitrogen SuperScriptTMIII reverse transcriptase and 
Invitrogen random hexamer primers. The RNA samples were treated with DNase prior to 
the RT. The first-strand cDNA synthesis was done in two steps.  
Step1 
In a total volume of 13ul, 1 µg of DNase treated RNA, 200ng of random primers, 1µl of 
10mM dNTPs mix (dATP, dGTP, dCTP and dTTP) were mixed and heated to 65oC for 
5minutes. The tubes were briefly spun and incubated on ice for 1 minute.  
Step 2 
The mixture from step1, 4µl of 5X First-strand buffer, 1 µl of 0.1M DTT, 1µl (40units) of 
Invitrogen RNase OUTTMTM and 1µl (200units) of Invitrogen SuperScriptTMIII RT were 
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added and gently mixed. The mixture was incubated for 5minutes at 25oC. Then incubated 
at 50oC for 30 minutes and 55oC for another 30 minutes. Finally, the mixture was incubated 
at 75oC for 15 minutes to inactivate the enzyme.  
2.15.2  PCR 
The cDNA was amplified using the Phusion® High-Fidelity DNA polymerase 
Initial denaturation  98oC for 2.5min 1 cycle 
Denaturation 
Annealing  
Extension 
98oC for 10sec 
60oC for 10sec 
72oC for 10sec 
 
25 cycles 
Final extension 72oC for 2min 1 cycle 
 
 
2.16   Site directed mutagenesis 
To modify the ssrA9His to ssrA6Hisprimers P41&P42  (Table 3) containing the bases require 
to be restored and its complementary were designed using PrimerX 
(http://www.bioinformatics.org/primerx/cgi-bin/DNA_1.cgi) . Two separate PCR reactions 
for each primer were carried out using Phusion® High-Fidelity DNA polymerase (Thermo 
Scientific). The pK.ssrA9His was the template using the following protocol: 
Initial denaturation  98oC for 2.5min 1 cycle 
Denaturation 
Annealing  
Extension 
98oC for 10sec 
67oC for 10sec 
72oC for 2.5min 
 
25 cycles 
Final extension 72oC for 7min 1 cycle 
 
The PCR products from both tubes were pooled and denatured at 95oC for 30second and left 
to cool. The mixture was treated for 2hours at 37oC with DpnI restriction enzyme to degrade 
the parental strands. This enzyme degrades only the methylated template DNA leaving the 
newly synthesised PCR product. A volume of 5ul of DpnI treated DNA was used to 
transform E.coli DH5α and transformants were screened as described in section 2.4. 
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2.17   Electron microscopy 
2.17.1  Fixation 
The WT M. tuberculosis H37rv was grown shaking for 90 days to allow slow oxygen 
depletion. A volume of 1ml was spun down in polypropylene O-ringed 2ml tubes at 
13000RPM for 5minutes. The supernatant was removed and the cell pellet re-suspended in 
1ml of 4% formaladehyde, 0.2% glutraldehyde. The tubes were tightly closed and kept in a 
formalin chamber overnight. 
 
2.17.2  Blocking   
The fixed WT M. tuberculosis H37rv were spun at 13,000RPM for 5minutes, the fixative 
removed and the cell pellet was washed three times in PBS pH7.4. After the last PBS wash 
the pellet was resuspended in 1ml 1% agar prepared in water (at just above gelling point) 
and immediately spun at 13000RPM for 30second before cooling at 0°C. Small blocks of 
agar containing embedded bacteria were cut and incubated in 3ml of 2% uranyl acetate for 
30 minutes at room temperature. The gel blocks were then rinsed 3 times in 5ml of water.  
 
2.17.3 Dehydration and Embedding  
The rinsed uranyl acetate treated agar blocks were dehydrated in an ethanol series of 
concentrations 50% and 70% in 5ml with three changes for each. The dehydrated agar blocks 
were transferred to London Resin (LR) at 2:1 ratio (LR white to 70% Ethanol) and incubated 
for one hour at room temperature, before transferring to pure LR white and incubating for 1 
hour. Finally, the samples were moved to fresh LR and incubated at room temperature 
overnight with gentle shaking. Blocks were incubated twice in LR white for one hour each 
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before transferring to gelatine capsules, and placing in the centre, filling with LR white and 
securely closing.  Carefully the capsules were transferred to an oven and baked for 24hours 
at 50oC. 
 
2.17.4  Sectioning 
Ultrathin sections were cut at the University of Sussex by Dr Julian Thorpe  
 
2.17.5  Immunogold Staining of LR white sections for EM  
The block was blocked with goat serum diluted 1 in 10 with 0.05M Tris-buffered saline 
(TBS), pH 7.6 for 30minutes at room temperature. The grids were drained and transferred to 
the primary antiserum, anti-Acr2 or Anti-Acr1 rabbit polyclonal or in control rabbit diluted 
1 in 10 and 1 in 1000 in TBS containing 1% (W.V) Bovine Serum Albumin (BSA) and 
0.01% (w/v) sodium azide for one hour at room temperature. The grids were rinsed three 
times in TBS containing 1% (w/v) BSA followed by incubation for one hour at room 
temperature in 1:15 goat anti-rabbit IgG gold conjugate (10nm) (Biocell) diluted in the 
TBS/BSA/sodium azide mix. The grids were then rinsed four times for 10 minutes each in 
TBS/BSA and then four times for 5minutes each in distilled water. Finally, the sections were 
counter stained with lead citrate. 
 
2.17.6  Electron Microscope Imaging. 
The immunogold stained ultrathin sections were examined by Dr Robert Francis 
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2.2 Materials 
2.2.1 Media  
 
LB (Luria-Bertani )Agar 
 
15g  Tryptone 
5g  Yeast extract 
5g  NaCl 
1%  agar 
1L  Dist. H2O2 
 
 
LB (Luria-Bertani ) Broth 
 
15g g Tryptone 
5g  Yeast extract 
5g  NaCl 
1L  Dist. H2O2 
  
 SOC Medium Super optimal broth with catabolic repressor (250 mL 
Total Volume) 
 
1. 25g   Yeast Extract 
5 g   Tryptone 
0.15g   NaCl 
0.00 g   KCl 
0.51 g   MgCl2 
2.5 mL  MgSO4 
Autoclaved the solution  
Added 10 mL of 20 % Glucose 
Adjust to pH7 and Add water to 250ml  
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7H9   Broth 
Prepared as the manufacturer instruction. Before used ad final concentration 
of 10% ADC (Albumin Dextrose Catalse), 0.1% Tween80 were aseptically 
added. 
 
 7H11 Agar 
The agar was prepared as the manufacturer instruction. Before pouring a final 
concentration of 5% ODAC was aseptically added.  
 
 7H11 with 2% Sucrose and 50 µg/mL Hygromycin 
The agar was prepared as the manufacturer instruction. Before pouring a final 
concentration of 5% ODAC (Oleic Acid Albumin Dextrose Catalse), final 
concentration of 2% sucrose and the appropriate antibiotic concentration were 
aseptically added.  
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 Roisin’s medium 
1.0 g   KH2PO4 
2.5 g   Na2HPO4 
5.9 g   NH4Cl 
2.0 g   K2SO4 
1 ml   Trace element Solution 
0.5 ml  1M CaCl2 
0.5 ml  1M MgCl2 
5 ml   Glycerol 
2ml   Tween 80 
After adjusting the pH to 6.6 it was filter sterilised and stored at 
4oC 
 
1000X Trace elements Solution amount per litre 
80 mg  ZnCl2 
400 mg FeCl3-6H20 
20 mg  CuCl2-2H2O 
20 mg  MnCl2-4H2O 
20 mg  Na2B4O7-10H2O 
20 mg  (NH4)6Mo7O24-4H20 
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2.3.2 Buffers 
 
TAE Buffer:  
Tris Acetate EDTA Buffer with 2.0 M Tris acetate, 0.05 M EDTA, pH 8.2 - 
8.4 (at 25°C) 
 
Transfer Buffer  
25 mM Tris  
190 mM glycine  
20% methanol  
 
Tris buffered Saline (TBS) + 0.1% Tween 20 
20 mM Tris pH 7.5  
150 mM NaCl  
0.1% Tween 20  
 
 
TE Buffer 
 
Tris 1 M 
EDTA 0.5 M 
Water to 100 mL 
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Protein Extraction and purification Buffers 
  
Lysis Buffer   
 
70mM   Hepes pH8 
20mM   Imidazol 
650mM   NaCl 
10%   Glycerol 
0.5mM   β -mercaptoethanol 
  
Binding Buffer for protein purification by Nickel column 
 
70mM   Hepes  
20mM   Imidazole 
500mM  NaCl 
0.1mM    β -mercptoehanol 
pH 8.0 
 
 
  
Elution Buffer for protein purification by Nickel column 
 
60mM   Hepes 
400mM   Imidazole 
150mM   NaCl 
3%    Glycerol 
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SDS PAGE Staking Gel Buffer 
0.5M   Tris HCL pH6.8 
0.4% w/v  SDS 
  
SDS PAGE Resolving Gel Buffer 
1.5M   Tris HCl pH8.8 
0.4%w/v SDS 
 
SDS PAGE Sample Buffer 1X 
 
50mM   Tris HCl pH6.8 
2% w/v  SDS 
5% v/v  β - mercaptoethanol or 41.6 mM DTT 
10% w/v  Glycerol 
0.05%   Bromophenol blue 
 
 
SDS PAGE Running/Tank buffer 10X 
 
0.5M   Tris  
0.55M   Glycine  
1%   SDS 
 
  
 Blocking Buffer   
10% w/v  fat free milk in TBS 0.1% Tween20 
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 2.3.3 Stains 
Ponceau stain 
0.2% (w/v) Ponceau S  
5% glacial acetic acid  
 
  
 Coomassie Brilliant Blue staining solution 
 
1% g/v of Coomassie Brilliant   
Methanol (50% [v/v]) 
Glacial acetic acid (10% [v/v]) 
H2O (40%) 
Stir the solution for 3-4 hours and then filter through Whatman filter paper. 
Store at room temperature. 
 
 2.3.4. Gels 
Agarose (Sigma-aldrich) 
 Acrylamide gel 
30% Acrylamide gel BioRad 
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3.3.4 Restriction Enzymes Used 
 
EcoRI (Promega) 
HindIII (Promega) 
BamH1 (Promega) 
SpeI (Promega) 
SacI (Promega) 
BgalII (Promega) 
XmnI (New England Biolabs; NEB) 
PpuMI (New England Biolabs; NEB) 
 
 
 
 3.3.5 Media and supplements Source 
 
7H11 Agar (Difco) 
7H9 Agar (Difco) 
ADC (Sigma) 
OADC Difco 
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Chapter 3 
Genetic manipulation of the ssrA gene 
to understand the function of the 
mycobacterial tmRNA  
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3.0 Introduction  
In this chapter, it was attempted to investigate the role of the mycobacterial transfer 
messenger RNA (tmRNA), encoded by the ssrA gene. tmRNA, also known as the 10Sa 
RNA, is a highly conserved gene across bacterial species, which is up-regulated in stress 
conditions and possesses features of both tRNA and mRNA. The similarity between tRNA 
and ssrA based on the gene sequence in M. tuberculosis H37rv was first described by Tyagi 
and Kinger in 1992 (Tyagi and Kinger, 1992).  The mRNA function of the ssrA was first 
demonstrated in E. coli by Tu et al., in 1995.  However, tmRNA has dual functions: (1) to 
free the stalled ribosome at the 3’ ends of truncated mRNA, and (2) to tag the nascent 
incomplete protein for degradation (Hayes et al., 2002; Keiler, 2011) by different protease 
complexes including ClpXP, ClpAP, FtsH (Ahlawat and Morrison, 2009; Baker and Sauer, 
2012; Dziedzic et al., 2010), Tsp and Lon (Choy et al., 2007). In E.coli, it has been shown 
that an accessory protein, SmpB, is also required for tmRNA to fully function (Karzai et al., 
2000; Shimizu and Ueda, 2002) and the deletion of SmpB produced a similar phenotype to 
that observed in cells lacking  ssrA (Karzai et al., 1999). 
 
Deletion of the ssrA gene can affect viability, response to environmental stress and virulence 
in various bacteria (Keiler and Ramadoss, 2011). For example, disruption of the ssrA gene 
in E.coli can lead to a slower growth rate and reduction in motility on semi-solid agar 
(Komine et al., 1994), inhibition of λ-P22 Hybrid phage growth (Retallack et al., 1994), and 
negative regulation of some protease activity (Kirby et al., 1994; Retallack et al., 1994). 
ssrA RNA can also function as a cell cycle progression controller (Hong et al., 2005), to help 
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survive exposure to antibiotics, (Andini and Nash, 2011; Braud et al., 2006; Palečková et 
al., 2006; Yang and Glover, 2009) heat shock and oxidative stress (Paget et al., 2001). The 
ssrA gene also plays a role in Salmonella (enterica) typhimurium pathogenicity (Julio et al., 
2000) and is essential for the growth of Shigella flexneri (Keiler, 2007) and Neisseria 
gonorrhoeae  (Huang et al., 2000). 
 
Studying the antibiotic producing actinomycete, Streptomyces coelicolor, Barends et al 
(Barends et al., 2010) revealed that tmRNA mediated trans-translation plays a role in stress 
management. Barends et al, analysed proteins that were histidine-tagged using recombinant 
tmRNA and identified 10 target genes whose translation is dependent on tmRNA: “Dnak 
heat shock protein 70, thiostrepton-induced protein A, universal stress protein A, elongation 
factor Tu3, and the cell-cycle control proteins DasR, SsgA, SsgF, and SsgR”.    Although 
this function of tmRNA has not been observed in other bacteria, we hypothesised that it may 
be a feature of actinomycetes that may thus also occur in mycobacteria.  
 
At the beginning of this project, there were few studies on the function of tmRNA in 
mycobacteria (Andini and Nash, 2011; Shi et al., 2011) but none reporting the gene 
replacement of ssrA. This chapter describes work to elucidate the function of the tmRNA in 
M. tuberculosis H37Rv. The specific objectives were to: 
1. Attempt to knockout tmRNA in wild-type M. tuberculosis H37Rv 
 
2. Attempt to knockout tmRNA in M. tuberculosis H37rv which was made merodiploid 
by the introduction of a second ectopic copy of the wild-type ssrA or by a 
recombinant ssrA in which the codons encoding the protease recognition tag had 
been replaced with codons encoding histidines (tmRNA-His) 
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3. Express tmRNA-His in knockout or merodiploid strains of M. tuberculosis and 
identify his-tagged proteins by LC-MS. This would: 
a. Define the protein substrate repertoire of the tmRNA tagging system for 
protease degradation. 
b. Identify if tmRNA is involved in the expression of chaperone and other stress 
proteins as demonstrated in the actinomycete, Streptomyces 
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3.1  Construction of a suicide vector to knockout ssrA (PG5ssrA::hyg)   
The suicide vector PG5 was used as the parent vector for the ssrA gene knockout construct. 
PG5 contains the hyg gene and sacB gene as well as an aph kanamycin resistance gene and 
does not replicate in mycobacteria. The ssrA gene’s upstream and downstream flanks were 
PCR amplified using primers 3&4 (1027bp) and 1&2 (1254bp) respectively  (Table 3). The 
flanks were directionally cloned (downstream flank at BglII/XbaI and upstream flank at 
BamHI/SpeI restriction sites) into PG5, flanking the hyg gene in the same orientation as in 
the mycobacterium genome flanking the ssrA gene. The resulting plasmid was PG5ssrA::hyg  
(Figure 9) 
 
Figure 9. PG5ssrA::hyg construct 
 PG5ssrA::hyg map showing the hygromycin gene sandwiched by the ssrA flanking DNA. Hygromycin is the 
selection marker and SacB enables the counter selection against the plasmid backbone.  
 
To confirm that the right fragments were cloned in the final construct, it was digested using 
the respective restriction enzyme used to clone that particular fragment. Further confirmation 
pG5ssra::Hyg
8217 bp
BamHI - 4753 - G'GATC_C
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of the orientation for the flanking DNA sequence and for the integrity of the plasmid 
sequence was provided by sequencing (data not shown). 
 
Figure 10. pG5ssra::Hyg plasmid screening 
The gel (1% agarose, TAE) picture shows the result of the PG5ssra::Hyg digestion that confirms the cloning 
of the respective flanks. The lanes are as follows: The two flanks released from pG5ssra::Hyg digested with 
the BamHI, SpeI, BglII and XbaI at same time (lane 1), linearised pG5ssra::Hyg with BglII (lane 2), linearised 
pG5 (lane 3) and undigested pg5ssra::Hyg (lane 4). 
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3.2  Deletion of the ssrA gene from WT M. tuberculosis H37rv  
 
 To delete the ssrA gene, the WT M. tuberculosis H37rv was electroporated with 
PG5ssrA::hyg. The transformants were recovered on 7H11 containing 50µg hygromycin ml-
1 and 2% sucrose and supplemented with 5% Oleic Acid Albumin Dextrose Complex 
(OADC). Only the recombinants where double cross-over gene replacement has taken place 
should grow on this selection. This is because the single cross over integration of the plasmid 
would include the sacB gene and its product will convert sucrose to levans which is toxic to 
bacterial cell. Five transformant colonies were produced from two independent 
transformations which were performed on cells with good transformation efficiency. These 
transformants were screened by PCR to amplify the region starting from outside of the ssrA 
gene flanks (cloned into PG5ssrA::hyg) and travelling inward across the ssrA gene, using 
primers P15&P16  (Table 3). All the colonies produced a PCR product of 3805bp, indicative 
of the fact that the ssrA gene was not deleted. If a deletion/gene replacement had occurred a 
product of 4315bp would have been produced    (Figure 11&Figure 12). Further confirmation 
of the absence of gene replacement was provided by the digestion of the PCR fragment with 
BglII. The digestion did not show the expected bands that should be shown in the event that 
the gene replacement has taken place  (Figure 15). 
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Figure 11. The ssrA deletion PCR product BglII digest schematic diagram 
 This diagram visualises the restriction digestion of the regions amplified from the outside flanks of the ssrA 
gene and across it in order to screen for its replacement with the hyg gene in the ssrA merodipliod. BglII cleaves 
the ssrA gene downstream flank cloned into PG5ssrA::hyg vector just few bases downstream of the hgy gene 
to produce two fragments of 1833bp (extended downstream flank) and 2501bp (containing extended upstream 
flank sequence plus hyg gene sequence. 
 
  
Figure 12. PCR to screen the transformants for ssrA gene replacement. 
 The gel (1% agarose, TAE) picture shows the PCR products amplified from M. tuberculosis H37rv 
transformants, transformed with PG5ssrA::hyg, by using the primers (P15&P16) that anneal at sites outside of 
the flanking sequence and travel inward across the ssrA to give a 3805bp product for wild-type ssrA and a 
4315bp product. All the screened isolated clones in lane 1- lane 7 showed 3805bp band indicating that the ssrA 
gene was not replace by hyg. 
  
ssrA	 Rv3099c	Rv3098c	Rv3097c	
BglII	
2501bp	1883bp	
Rv3099c	Rv3098c	Rv3097c	
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B	
smpB	
smpB	
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P15	P16	 4315bp	
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3.3  Generation of ssrA merodiploid M. tuberculosis H37Rv. 
 
 
 
Figure 13. pK.ssrA construct 
pK-ssrA construct map showing the ssrA gene cloned at the SacI site. This construct was introduced into M. 
tuberculosis H37rv wild type to produce the ssrA merodiploid strain.  The map also shows the location of the 
peptide tag within the ssrA gene sequence as well as the location of primers P11&P12 (used to detect aph gene) 
annealing sites. 
  
It was suspected that the ssrA may be essential for viability. One way to test this was to 
attempt ssrA deletion in a merodiploid strain with a second copy of the ssrA gene.  The 
second copy of the gene was introduced into the wild type M. tuberculosis H37rv genome 
using the integrating plasmid pKINTA (Stewart et al., 2001). This plasmid integrates at the 
attB integration site far from the native site of the ssrA gene within the M. tuberculosis 
genome. The construct, pK.ssrA  (Figure 13) was generated by cloning the PCR amplified 
pK.ssrA
6052 bp
XmnI - 575 - GAAnn'nnTTC
proteolytic tag - 657
PpuMI - 901 - rG'GwC_Cy
SacI - 1198 - G_AGCT'C
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SacI - 6052 - G_AGCT'C
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n
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ssrA gene with its putative promoter (using primers P7&P8 (Table 3) to amplify a fragment 
of 1192bp) into the SacI site of pKINTA. M. tuberculosis H37rv was transformed with 
pK.ssrA by electroporation and plated onto 7H11 containing kanamycin. The integration of 
the plasmid was confirmed by PCR to check for the presence of the aph gene sequence using 
primers P11&P12 (Table 3) to amplify 581bp fragment. PCR products from a successful 
pK.ssrA transformant screening, using primers 11&12, is shown in  Figure 14. 
 
 
Figure 14. Amplification of the aph gene to demonstrate integration of pK.ssrA 
construct to make ssrA merodiploid M. tuberculosis 
The gel (1% agarose, TAE) picture shows the result of the PCR products from M. tuberculosis H37rv wild type 
transformants electroporated with pK-ssrA.  Lanes 1 – 4 show a positive PCR amplification of a 581bp 
fragment using the primers 11&12 that indicate the presence of the aph gene in the 4 selected transformants. 
Lane 5 is a positive control using the pk-ssrA construct and lane 6 is the negative control using wild type M. 
tuberculosis H37rv genomic DNA. 
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3.4  Deleting the in situ ssrA gene from the ssrA merodiploid M. 
tuberculosis H37rv strain 
 
The ssrA merodiploid M. tuberculosis H37rv strain was used in the third attempt to delete 
the ssrA gene by transformation with the PG5ssrA::hyg suicide plasmid. Twenty individual 
colonies were picked and sub-cultured into 7H11 plate (containing 50µgml-1 hygromycin 
and 15µgml-1 Kanamycin) out of which four were PCR screened using primers P15&P16 to 
amplify the region from the outside of the flanking sequences (that were cloned into PG5 
ssrA::hyg vector) and inward across the ssrA gene. These primers were designed to produce 
a fragment of 3805bp if no gene replacement took place or 4334bp if the gene was replaced 
with the hyg gene. The PCR products were digested with BglII and as it is shown in the 
schematic diagram (Figure 11) the digest should produce two fragments of 2501bp and 
1833bp.  
 
Three of the four transformants produced 4334bp PCR fragments indicative of gene 
replacement and one produced 3805bp (refer to lane 4 in Figure 12). All the four PCR 
products in lane 1 to 4 (for transformants no 2, 6, 8 and 3 respectively) were validated by 
cutting with BglII. The digest as explained in the schematic diagram in   Figure 11  should 
produce two fragments with sizes of 2501bp and 1833bp if gene replacement has occurred. 
From the gel picture in  Figure 15 it can be seen that transformants 2, 6 and 8 (Lane 1, 2 &3) 
had PCR fragments that were cut into two fragments (2501bpand 1833kb) indicative of the 
ssrA gene replacement with the hyg gene. However, the PCR product from transformant 3 
(lane 4,    Figure 15 was not cut indicative of the presence of the ssrA gene. 
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 Figure 15. PCR screening of PG5ssrA::hyg 
 The gel (1% agarose TAE) picture shows the BglII digest of the PCR products amplified from M. tuberculosis 
H37rv transformants that were electroporated with PG5ssrA::hyg using primers (P15&P16) that anneal at sites 
outside of the flanking sequences cloned into PG5ssrA::hyg and inward across the ssrA gene.  The PCR product 
in lane 5 is an example of the 4334bp PCR product amplified from transformant 2, 6 and 8 before digestion.  
The PCR product in lane 4 is from transformant 12 which is 3805bp and its size remained unchanged after 
treating it with BglII which is indicative of the wild-type ssrA and no ssrA gene replacement.  The two bands 
seen in lanes 1, 2 and 3 are the result of BglII digestion of 4334bp amplified (from transformant 2, 6 and 8 
respectively) indicating that the ssrA gene was replaced by the hyg gene. 
  
3.5  Construction of a ssrA9His variant gene and integrating construct 
 
To test whether the protease degradation tagging function of tmRNA was essential and also 
to define the tmRNA substrate repertoire, it was necessary to build a construct that would 
express a variant ssrA in which the sequence encoding the protease tag (QRDYALAA) was 
replaced with sequence encoding histidines. The peptide tag sequence was replaced with 
codons encoding 9 histidines and compensatory mutations were made in the surrounding 
sequence to maintain the structure of the tmRNA molecule (sequence 1&2,   Figure 16). To 
achieve this, the 343bp DNA sequence including the XmnI and PpuMI restriction sites of 
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the ssrA gene was synthesized by “Eurofins MGW” (the sequence was received cloned into 
a plasmid named as “pEXA-ssrA-HIS tag”) and sub-cloned from the pEXA-ssrA HIS tag 
plasmid to the pK-ssrA construct similarly digested with XmnI and PupMI in order to release 
the wild type ssrA fragment containing the peptide tag sequence. The final construct, 
pK.ssrA9His (Figure 17), was first screened by PCR using primers P17&P18 (Table 3. Primers 
list) and then confirmed by sequencing. The integrative pK.ssrA9His was electroporated into 
M. tuberculosis H37rv and transformants were screened for both the existence of the aph 
gene (as described earlier) and the histidine tag sequence using P11 &P12 (Table 3. Primers 
list) 
 Sequence (1) from wild type ssrA (ADSHQRDYALAA) 
GGATGCGAGGGGCT (XmnI restriction site) 
GAACGGTTTCGACTTCGCGCATCGAATCAAGGGAAGCGTGCCGGTGCAGGCAAGAGACCACC
GTAAGCGTCGTTGCGACCAAATAAGCGCCGATTCACATCAGCGCGACTACGCTCTCGCTGC
CTAAGCGACGGCTAGTCTGTCAGACCGGGAACGCCCTCGGCCCGGACCCTGGCATCAGCTAG
AGGGATCCACCGATGAGTCCGGTCGCGGGACTCCTCGGGACAACCACAGCGACTGGGATCGTC
ATCTCGGCTAGTTCGCGTGACCGGGAGATCCGAGCAGAGGCATAGCGAACTGCGCACGGAGAA
GCCTT (PpuMI restriction site) GAGGGAATGCCGT  
 
 Sequence (2) from his-ssrA (ADSHHHHHHHHH) 
GGATGCGAGGGGCT (XmnI restriction site) 
GAACGGTTTCGACTTCGCGCATCGAATCAAGGGAAGCGTGCCGGTGCAGGCAAGAGACCACC
GTAAGCGTCGTTGCGACCAAATAAGCGCCGATTCACATCACCACCACCACCACCACCATCAC
TAATGGTCGTGTGGTGTGGCAGACCGGGAACGCCCTCGGCCCGGACCCTGGCATCAGCTAGAG
GGATCCACCGATGAGTCCGGTCGCGGGACTCCTCGGGACAACCACAGCGACTGGGATCGTCAT
CTCGGCTAGTTCGCGTGACCGGGAGATCCGAGCAGAGGCATAGCGAACTGCGCACGGAGAAGC
CTT (PpuMI restriction site) GAGGGAATGCCGT  
 
 Figure 16. ssrA and ssrA9His variant sequence 
Comparison of the sequence of the native M. tuberculosis ssrA and its variant ssrA9His.  The sequences 
shown are not the complete sequence of the ssrA but, just the segment 102bp upstream and 202bp 
downstream form the peptide tag stop codon TAA. The 16bp region downstream of the stop codon in 
the ssrA variant was modified in the ssrA9His variant to maintain the RNA structure to as near to the 
native ssrA. The codons for QRDYALAA were replaced with codons for 9 histidines. The sequence in 
red is the wild type ssrA tag sequence (sequence 1) and the ssrA9His variant tag sequence (sequence 2). 
The underlined sequence is the 9 Histidines sequence. 
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Figure 17. pK.ssrA9His construct 
pK.ssrAHis construct map showing the ssrA9His gene cloned at SacI site. This construct was introduced into M. 
tuberculosis H37rv wild type to produce the Hist-ssrA merodiploid strain.  The map also shows the location of 
the His-tag within the ssrA gene sequence as well as the location of primers P11&P12 (to detect aph gene) and 
primers P17&P18 (to detect the His-tag sequence) annealing sites. 
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Figure 18. Screening for pK.ssrA9His M. tuberculosis H37rv merodiploid 
The gel (1% agarose, TAE) picture shows the result of the PCR product from M. tuberculosis H37rv wild type 
transformants electroporated with pKssrA9His. The left hand side of the gel picture shows a positive PCR 
amplification of 581bp fragment from transformants 1-5 using primers P11&P12 indicating the presence of the 
aph gene. The right hand side of the gel shows a positive PCR amplification of 526bp fragment from the same 
transformants respectively indicating the presence of the histidine tag sequence. 
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3.6  Attempt to delete the ssrA gene from the ssrA9His expressing M. 
tuberculosis H37rv strain 
 
 Having demonstrated that it was possible to delete the in situ ssrA gene from a merodiploid 
M. tuberculosis H37Rv, we attempted to delete ssrA from a strain complemented with the 
ssrA9His variant, which is intended to confer the ribosome recycling function of the tmRNA 
but replace the protease tagging function with a His-tagging function. 
 
Electroporation of the ssrA9His H37rv strain with the PG5 ssrA::hyg vector and selection on 
hygromycin/sucrose 7H11 resulted in only 7 colonies all of which showed the presence of 
the wild-type ssrA gene.  All of them showed a <4kb ssrA gene region PCR fragment upon 
screening as before and further, the product did not cut with BglII restriction enzyme (data 
not shown). This indicated that the protease tagging function of the tmRNA may be essential 
to M. tuberculosis H37rv viability and alternatively the alterations to the ssrA to introduce 
the histidine codons may have altered the other functions of the tmRNA in addition to the 
protease tagging role. 
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3.7  Experiments to detect ssrA tagged substrate proteins using 
mycobacteria expressing a  ssrAHis  
The fact that the deletion of ssrA from M. tuberculosis H37rv was only achieved in a 
merodiploid strain carrying a second wild-type copy of ssrA was strongly indicative that it 
is an essential gene and also that the two main functions of tmRNA may both be essential 
for viability. Without the ability to study the phenotype of ssrA mutant strains, further study 
in this project to understand tmRNA function in mycobacteria focused on the detection of 
His-tagged proteins produced in a merodiploid carrying the wild-type ssrA in addition to a 
His-tagging variant ssrA. Several different expression constructs of the ssrAHis variant were 
made which included variations of the ssrA sequence alongside expression with and without 
the upstream genes that include the smpB gene. These expression constructs were 
transformed into two host strains, M. bovis BCG and Mycobacterium smegmatis groEL1ΔC 
(Noens et al., 2011) and the resultant recombinant strains are listed in  Table 4.  The M. 
smegmatis groEL1ΔC strain lacks the natural histidine rich C terminal of its GroEL which 
can hamper His purification in mycobacteria and was obtained from the European Molecular 
Biology Laboratory (EMBL) Hamburg. Some of the ssrAHis constructs were also 
transformed into M. smegmatis groEL1ΔCΔlon	 which	 lacks	 the	 Lon	 protease. The 
following sections describe the attempts to purify His-tagged ssrA substrate proteins using 
these different mycobacterial recombinant strains. 
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Merodiploid  The construct harboured Integrative/Replicative 
BCG9HisA pK-ssrA9His  Integ/Native promoter 
BCG9HisB pMV306-ssrA9His Integ/hsp promoter 
BCG9HisC pK-smpB-Rv3099c-ssrA9His Integ/native promoter 
BCG9HisD pMv261-smpB-Rv3099c.ssrA9His Rep/hsp promoter 
BCG9HisE pMV361- smpB-Rv3099c.ssrA9His Integ/hsp promoter 
M. smegmatis groEL1∆C9HisA pK-ssrA9His  Integ/Native promoter 
M. smegmatis groEL1∆C9HisB pMV306-ssrA9His Integ/hsp promoter 
M. smegmatis groEL1∆C9HisC pK-smpB-Rv3099c-ssrA9His Integ/hsp 
M. smegmatis groEL1∆C9HisD pMv261-smpB-Rv3099c.ssrA9His Integ/native promoter 
M. smegmatis groEL1∆C6HisH pMV361- smpB-Rv3099c.ssrA9His Integ/ native promoter 
M. smegmatis groEL1∆C6HisI pK-smpB-Rv3099c-ssrA6His Integ/ native promoter 
M. smegmatis groEL1∆C6HisJ pMv261-smpB-Rv3099c.ssrA6His Rep/native promoter 
M. smegmatis groEL1∆CΔLon6HisK pK-smpB-Rv3099c-ssrA9His Integ/native promoter 
M. smegmatis groEL1∆CΔLon6HisL pMv261-smpB-Rv3099c.ssrA9His Rep/ native promoter 
M. smegmatis groEL1∆CΔLon6HisV pK-smpB-Rv3099c-ssrA6His Integ/native promoter 
M. smegmatis groEL1∆CΔLon6HisW pMv261-smpB-Rv3099c-ssrA6His Rep/ native promoter 
 
Table 4. M. bovis BCG and Mycobacterium smegmatis groEl1ΔC (M. smegmatis groEl1 ΔC) 
merodiploid strains harbouring different expression ssrAHis vectors. 
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3.7.1   Purification of His-tagged proteins from (BCG9HisA) pK.ssrA9His lysate 
 				
The BCG9HisA merodiploid was grown in a volume of 500ml of Roisin’s minimal media 
containing 30µg ml-1 of kanamycin until an OD of 1. The culture was spun and the cell pellet 
was 3 times washed in ice cold PBS.   The cells were re-suspended in a lysis buffer 
containing protease inhibitors (1mM PMSF and 1mM EGTA) and mechanically disrupted. 
The lysate was twice spun before passing through the 1ml nickel column.  The protein 
concentration in the eluted sample was measured using the Nanodrop spectrophotometer. 
The highest protein concentration obtained was 0.4mg/ml.  Two of the His pull-down 
samples were run in 12% polyacrylamide gels along with neat BCG str. Pasteur merodiploid 
lysate, wild-type BCG and M. tuberculosis H37rv wild-type neat lysate. Figure 19 shows a 
coomassie stain of the gel and reveals that the nickel column has purified a smear of proteins 
of a wide molecular mass range but dominated by a dense band at approximately 55kDa. A 
replicate gel was transferred to PVDF membrane. The membrane was blocked with 10% 
milk (dissolved in 0.1% Tween 20 TBS buffer) and treated with anti-his HRP conjugated 
antibodies (1 in 1000) and developed using ClarityTM Western ECL Blotting substrate.  
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 Figure 19.Western blot and Protein gel for nickel column purified protein from 
BCG9HisA 
Picture (A) Western blot for detection of histidine tagged protein (as a result of possible ssrA tagging) seen in 
picture B.   Lane 1&2 are the histidine column purified protein.  Lane 3,4 and 5 are the neat lysate from BCG 
str. Pasteur merodiploid (BCG9HisA), wild type BCG and wild type M. tuberculosis H37rv respectively. Lane 6 
is the positive control for histidine tag using the recombinant Acr1 protein.  The bands seen in picture (B) lane 
1-6 correspond to the lanes on picture (A) 
  
The Western Blot showed anti-His immunoreactivity only for the histidine column purified 
proteins and the neat lysate of the BCG merodiploid (BCG9HisA). The non-nickel purified neat 
lysate of BCG wild type and M. tuberculosis H37rv had no immunoreactivity, which 
indicated the absence of any naturally histidine rich protein background.  The nickel purified 
protein was subjected to trypsin digest and LC-MS and the data analysed by mascot to 
identify the proteins.  
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 Figure 20. Mascot result 
BCG str. Pasteur merodiploid  (BCG9HisA) lysate was passed through nickel column to pull down any 
possible histidine tagged protein. The obtained protein was analysed by mass spectrophotometry. The 
predominant identified protein was GroEL1.  The letters in red are the amino acids identified by the 
mass spectrophotometry and the black letters are those predicted when compared to Mycobacteria 
proteins database. 
	
Mascot results indicated the presence of a dominant protein, GroEL1, which is an abundant 
non-essential heat shock protein (Figure 19). The most obvious feature of GroEL1 is that it 
has a histidine rich C-terminal in its genomic coding sequence. This feature may help explain 
why it is purified on the nickel column and why it is reactive with anti-His antibodies in the 
Western blot. The reason why no positive band can be seen in the BCG str. Pasteur wild-
type and M. tuberculosis H37rv may be because these wild-type cultures were not stressed 
sufficiently to produce a detectable level of GroEL1 which is a stress inducible chaperone. 
This would suggest that expression of the altered ssrA induces a stressed state in the 
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recombinant mycobacterium. Further attempts were made using different BCG merodiploids 
harbouring different  (Table 4). These are described in the following sections. 
 
3.7.2   Detection of ssrA9His His-tagged protein in M.  smegmatis groEL1ΔC harbouring 
pKssrA9His, pMV261.ssrA9His and pMV361.ssrA9His expression vectors     
The failure to pull down any ssrA9His His-tagged proteins in BCG str. Pasteur other than the 
naturally occurring His-rich GroEL1 may have been due to the abundance of GroEL1 either 
saturating the nickel column or masking the detection of less abundant proteins by LC-MS. 
To counter this potential problem, Mycobacteria smegmatis  groEL1ΔC (Noens et al., 2011), 
lacking the histidine  rich C terminal region, was obtained from the European Molecular 
Biology Laboratory (EMBL) Hamburg in Germany. The genotype of the strain was checked 
by PCR and sequencing of the GroEL1 gene, which confirmed removal of the terminal 
histidine residues (data not shown). Although this was a different species of mycobacteria 
we anticipated that the Mycobacterium. tuberculosis H37rv ssrA would be functional in this 
strain. Merodiploids of Mycobacterium smegmatis groEL1ΔC were produced using the same 
construct as before (pKssrA9His) and also several new constructs in which the ssrA9His variant 
gene was cloned under the control of other mycobacterial promoters in the replicative shuttle 
vectors pMV261 (Bolla et al., 2012) and integrative pMV306 (Greendyke et al., 2002)   
(Table 4). The resultant merodiploids were grown as described above in the BCG section 
(3.7.1). Protein was isolated from the cultures and nickel columns used to pull down any his-
tagged proteins. Very little protein was purified from the column as viewed by coomassie 
staining (an example is shown in Figure 21) and Western blotting with an anti-His antibody 
did not reveal any His-tagged proteins (an example is shown in   Figure 22).  
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 Figure 21. SDS-PAGE of whole cell lysates and His-tag purified proteins from M. 
smegmatis GroEl1ΔC and M. smegmatis groEl1ΔC merodiploids harbouring 
constructs that express ssrA9His. 
SDS-PAGE shows coomassie stained whole lysate (lane 2, 4 and 6) from M. smegmatis groEL1ΔC, M. 
smegmatis groEL1ΔC9HisA (harbouring pK.ssrA9His) and M. smegmatis groEL1ΔC9HisB (harbouring 
pMV261.ssrA9His) respectively. Lanes 1, 3 & 5 show the nickel column pull down for the respective strains. 
 
 
 
Figure 22.Western blot for detection of the histidine tagged protein from M. 
smegssrA9HisB  and M. smegssrA9HisA  His-pull down preps. 
Western blot for the detection of histidine tagged protein in the nickel column pull down fractions from M. 
smegmatis groEL1ΔC, M. smegmatis groEL1ΔC9HisA (harbouring pK.ssrA9His) and M. smegmatis 
groEL1ΔC9HisB (harbouring pMV261.ssrA9His) in lanes 1, 3 & 5 respectively. Lanes 2,4, and 6 are the whole 
lysate from the respective strains.  Lane 7 is a his-tagged positive control protein. 
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3.8  Co-expression of the smpB gene with ssrA9His  
 
The constructs for the expression of ssrA9His that were used in the previous section did not 
include its binding protein, SmpB, encoded by the smpB gene.  SmpB protein is not essential 
for the aerobic growth of M. tuberculosis (Personne and Parish, 2014), which indicates that 
it might be dispensable for the tmRNA tagging. SmpB has been shown to be an important 
factor for determination of the initial codon for tag-translation in E.coli and damaged SmpB 
failed to promote peptidyl transfer (Konno et al., 2007). Also, deleting the smpB gene led to 
the absence of tmRNA in Streptomyces coelicolor ΔSmpB suggesting it may be required for 
tmRNA accumulation (Yang and Glover, 2009). To accommodate for the possibility that the 
co-expression of smpB with the tmRNA9His variant may increase the tagging efficiency, 
smpB was cloned along with the ssrA in co-expression constructs. 
 
As shown in  Figure 23 , Rv3099c  (a hypothetical protein) is located in-between ssrA and 
smpB. These three genes are all oriented in the same direction in a putative single 
transcriptional unit suggesting that they may be functionally related in the tmRNA protein 
tagging system. Therefore, to avoid any possible transcriptional defects, the whole segment 
containing the smpB, Rv3099c and ssrA was PCR amplified using primers P37&P38 and 
cloned into pKinta to produced pK-smpB-Rv3099c-ssrA (Appendix 8.8) employing the same 
protocol as in section (3.3). The primers used to amplify this segment contained SacI and 
EcoRI at the 5’ of the forward primer and SacI and HindIII at the 5’ of the reverse primer to 
allow for the cloning in of pKinta, and the subsequent sub-cloning into pMV261 (replicative 
expression vector containing hsp promoter) and pMV361 (integrative expression vector 
containing hsp promoter). Then the native ssrA gene was replaced with the ssrA9His variant 
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using the same strategy as described in section (3.5). The resulting construct was designated 
pk-smpB-Rv3099c-ssrA9His (Figure 24). From this plasmid the smpB-Rv3099c-ssrA9His 
fragment was cleaved using EcoRI and HindIII restriction enzymes and directionally cloned 
in front of the heat shock promoter (hsp60) in pMV361 (Appendix 8.9) plasmid as well as 
into the pMV261 plasmid to produce pmv261-smpB-Rv3099c-ssrA9His (Figure 25).  
 
 
Figure 23. Schematic diagram (A)  showing the position of smpB, MSMEG_2092 and 
MSMEG_2093 (tmRNA) and their orientation on the M. smegmatis genome obtained from 
http://mycobrowser.epfl.ch/smegmasearch.php?gene+name=smpB&submit=Search 
 
Schematic diagram (B) showing the position of smpB, Rv3099c and ssr (ssrA) and their 
orientation on the M. tuberculosis genome obtained from 
http://tuberculist.epfl.ch/quicksearch.php?gene+name=smpB&submit=Search.  
A
B
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Figure 24. pk-smpB-Rv3099c-ssrA9His construct 
pK-smpB-Rv3099c-ssrA9His construct map showing the smpB-Rv3099c-ssrA9His gene complex cloned at the 
SacI site.  The map shows the location of the Hist-tag within the ssrA gene sequence.   
 
 
 Figure 25. pMV261-smpB-Rv3099c-ssrA9His construct 
pmv261-smpB-Rv3099c-ssrA-9His construct map showing the smpB-Rv3099c-ssrA9His gene complex 
directionally cloned at HindIII and EcoRI sites. This construct was introduced into M. smegmatis groEL1DC 
parental strain and M. smegmatis groEL1DC Δlon to produce smpB-Rv3099c-ssrA9His merodiploid strains.    
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These constructs were used to transform M. smegmatis groEL1DC using the procedures 
described in section (3.3) to produce merodiploids harbouring either pK-smpB-Rv3099c-
ssrA9His  or pmv261-smpB-Rv3099c-ssrA-9His  (Table 4). The successful merodiploids were 
grown and harvested as described in section (3.7.2).  
 
3.9  Validation of ssrA9His expression in the M. smegmatis groEL1ΔC 
merodiploids harbouring pk.smpB-Rv3099c-ssrA9His or pMV261-smpB-
Rv3099c.ssrA9His expression vectors 
 
Before embarking on the protein purification experiments from the “new” merodiploids 
harbouring pk.smpB-Rv3099c-ssrA9His and pMV261-smpB-Rv3099c.ssrA9His, it was decided 
to check for the expression of ssrA9His by RT-PCR.  The merodiploids and the parent strain 
(M. smegmatis groEL1ΔC) were inoculated into 10ml 7H9 containing 10% ACD and 0.1% 
Tween 80 in triplicate and incubated shaking at 37oC overnight. Two hours before extracting 
the RNA the replicate cultures were treated thus: 
1. A final concentration of 16ugml-1 erythromycin was added to one of the three 
cultures for each strain. This was done because it was reported that exposure to 
ribosome targeting antibiotics increases expression of tmRNA in Mycobacteria 
(Andini and Nash, 2011)    
2. A final concentration of 0.5mM of H2O2 was added to stress the culture 
3.  Untreated     
 RNA was extracted using the ThermoFisher Scientific Trizol®Plus RNA purification 
system. The RNA samples were DNAase treated before the RT-PCR was performed.  The 
cDNA was used as the template to detect the presence of the his-tag sequence. Positive 
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detection of an 80 bp product would confirm the presence and expression of ssrA9His in the 
respective merodiploid using primers P35&P36 (Table 3). No amplification should result 
from the native ssrA transcript.  
 
As seen in the agarose gel (Figure 26), the no reverse transcriptase control for  DNA 
contamination in the RNA (lanes 10, 11 &12) did not show a band thereby confirming that 
no DNA was present in the RNA samples prior to  RT PCR and therefore, all the PCR 
products were from the mRNA transcripts only.  Two positive controls were used (lanes 13 
and 14 pk.smpB-Rv3099c-ssrA9His and pMV261.smpB-Rv3099c-ssrA9His DNA) to check the 
PCR primer specificity and the amplification. They were also used to double check that the 
constructs do have the ssrA9His variant constructs. Both constructs showed the expected 80bp 
band although an 600bp product is also observed in the pK.smpB-Rv3099c-ssrA9His (lane 13) 
construct. This could be due to the primers having a non-specific binding to a sequence 
within the pKinta plasmid.  
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 Figure 26. PCR of cDNA from RT PCR of different RNA preps from M. smegmatis 
groEl1ΔC and M. smegmatis groEl1ΔC ssrA merodiploids harbouring either pk.smpB-
Rv3099c-ssrA9His or pMV261-smpB-Rv3099c.ssrA9His 
Lanes 10, 11 and 12 show the PCR result for the no reverse transcriptase control for DNA contamination in 
the RNA sample. Lanes 1, 4 and 7 show no amplification products from RT-PCR of RNA from M. smegmatis 
groEl1ΔC wild type either untreated, treated with 16µgml-1 erythromycin, or treated with 0.5mM H2O2 
respectively.  RT-PCR of the M. smegmatis groEl1ΔC merodiploid harbouring pk.smpB-Rv3099c-ssrA9His 
(lane 2; no treatment, lane5; 16µgml-1 Erythromycin, lane8; 0.5mM H2O2) show the expected band for the 
presence of the His-tag sequence confirming the expression of ssrA9His variant in all the preparations. RT-PCR 
of the M. smegmatis groEl1ΔC merodiploid harbouring pMV261-smpB-Rv3099c.ssrA9His (lane 3; no treatment, 
lane 6; 16µgml-1 Erythromycin, lane 9; 0.5mM H2O2) shows the presence of the His-tag confirming the 
expression of ssrA9His in two of the preps but, the third failed to amplify. The two positive controls of plasmid 
DNA amplified 80bp indicating the presence of His-tag in the constructs but pk.smpB-Rv3099c-ssrA9His (lane 
13) showed other bands of 600 which was absent in pMV261-smpB-Rv3099c.ssrA9His (lane 15). The negative 
control PCR mix with no template added (lane 14) produced no product indicating that the reagents were free 
from DNA contamination. 
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RT-PCR of RNA (Figure 26) from the M. smegmatis groEl1ΔC merodiploid harbouring 
pK.smpB-Rv3099c-ssrA9His  (lane 2; no treatment, lane 5; 16µgml-1 erythromycin, lane 8; 
0.5mM H2O2) and  the M. smegmatis groEl1ΔC merodiploid harbouring  pMV261.smpB-
Rv3099c.ssrA9His (lane 3; no treatment, lane 9; 0.5mM H2O2) showed the expected band (80 
bp) for the presence of the His-tag sequence confirming the expression of ssrA9His variant in 
all the recombinant strains. However, one of the samples from M. smegmatis groEl1ΔC 
harbouring pMV261.smpB-Rv3099c.ssrA9His (lane 6, erythromycin treated) failed to amplify 
an ssrA product which may have been due to the presence of inhibitors in this sample.  
 
3.10  Detection of ssrA9His variant His-tagged proteins using M. smegmatis 
groEL1 ΔC harbouring pK.smpB-Rv3099c-ssrA9His, pMV261.smpB-
Rv3099c-ssrA9His  expression vectors     
After it was confirmed that the ssrA9His variant was being expressed in the M. smegmatis 
groEl1ΔC merodiploids harbouring pK.smpB-Rv3099c-ssrA9His and pMV261.smpB-
Rv3099c-ssrA9His expression vectors, the strains were grown as described before in section 
(3.7.2) but, either with single or combined stress condition/s (heat shock at 42oC and sub 
lethal concentration of erythromycin (16ugml-1) and H2O2 (0.5mM)) for three hours prior to 
protein extraction. The protein extraction was carried out as described in section (3.7.2). 
Unfortunately, as previously experienced, western blotting showed no band for any His-
tagged protein (Data not shown). Thus, co-expression of the SmpB protein and Rv3099c 
with ssrA9His did not increase His-tagging of protein substrates. 
This negative result raised another question: could it be possible that the tagged protein was 
degraded?   One of the proteases that is directly involved in the degradation of the tmRNA 
tagged-proteins is the Lon protease which is encoded by the lon gene. This protease is an 
   
 121 
ATP-dependent protease that has the ability to recognise determinants in the N- terminal of 
tmRNA-tagged proteins (Choy et al., 2007).  Choy et al showed that deleting Lon caused 
the accumulation of the His6-tagged proteins in mutants harbouring a tmRNAHis6 variant. 
Although, this work was done in E. coli, M. smegmatis has the Lon protease, therefore, it 
was decided to delete lon in M. smegmatis groEL1DC and repeat the experiments with the 
ssrAHis expression. 
 
3.11  Deletion of the lon (MSMEG_3582) gene from  M. smegmatis 
groEL1ΔC  
 
M. tuberculosis H37rv and BCG str. Pasteur do not have the lon gene but it is present in M. 
smegmatis groEl1ΔC. Therefore, it was possible that the Lon protease was involved in 
degradation of the His-tagged protein. Therefore, the lon gene was deleted from M. 
smegmatis groEL1ΔC using a one-step knockout strategy using pG5 suicide plasmid as 
describe in section (3.2). The lon gene flanks were PCR amplified with the relevant 
restriction enzymes at both ends to clone them in  to flank the hygromycin gene on pG5 
(Figure 27).  
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Figure 27. The pG5lon::hyg  construct for gene-replacement of M. smegmatis 
groEl1ΔC Δlon. 
PG5lon::hyg map showing the hygromycin gene flanked by DNA from the lon gene genome region. 
Hygromycin is the positive selection marker and SacB is the counter selection.  
 
The pG5Lon::hyg construct was introduced into M. smegmatis groEl1ΔC by electroporation. 
The resultant clones were screened for the absence of the lon gene by PCR and confirmed 
by restriction digestion and sequencing (Figure 29). 
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Figure 28. Lon gene homologous recombination schematic diagram 
Diagram (A) illustrates the location of the lon gene in M. smegmatis groEl1ΔC genome. Diagram (B) illustrates 
the addition of a BglII site in the knockout strains which would give a restriction pattern of the PCR product 
between primers P34/P33 enabling the differentiation between the wild-type and gene-replacement genotypes. 
  
Two clones gave a PCR product of 6350bp indicative of lon gene replacement by 
hygromycin (as illustrated in  Figure 28). The PCR products were then restriction digested 
with BglII which produced three fragments of  2837bp, 1880bp and 713bp confirming the 
gene replacement of lon (Figure 29).   
 
lon	 MSMEG_3584	MSMEG_3580	
		
A	
B	 		
MSMEG-3584	MSMEG_3580	 hyg	
2837bp	1880bp	
BglII	 BglII	
713bp	
5430bp	 P33	
P34	 P33	
P34	
6350bp	
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Figure 29. PCR amplification and Bglll digest to determine gene-replacement of lon. 
Agarose gel (1%) picture showing the BglII restriction digest of the PCR fragment amplified from the outside 
flanks of the lon gene using primers (P33&P34). The clone with the successful gene replacement (Lane 4 and 
5) produced a fragment of 5430bp whereas the wild type (lane 3) produced a fragment of 6350bp. The Bgll 
digest of the fragments in lane 1 & 2 produced the expected bands of 2837bp, 188pb and 713bp to verify the 
gene replacement. 
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3.12  Detection of ssrA9His variant tagged protein using M. smegmatis 
groEl1ΔCΔCΔlon harbouring pK.smpB-Rv3099c-ssrA9His,pMV261.smpB-
Rv3099c-ssrA9His  expression vectors     
 
M. smegmatis groEl1ΔCΔLon was transformed with either pK-smpB-Rv3099c-ssrA9His or 
pmv261-smpB-Rv3099c-ssrA9His   to produced merodiploid strains harbouring wild-type 
ssrA and ssrA9His genes and designated as M. smegmatis groEl1ΔCΔlon9HisK and M. 
smegmatis groEl1ΔCΔlon9HisL respectively. The successful merodiploids were grown and 
harvested as described earlier in section (3.7.2). The protein was extracted as described in 
section (3.7.2).  Once again, western blotting for the His-tagged proteins indicated 
unsuccessful pull-down of any tagged protein (Data not shown). This suggested that the Lon 
protease was not the cause for failure of detecting any ssrA9His tmRNA variant tagged 
protein.  
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3.13  The construction of the ssrA6His  gene construct 
 
 In the ssrA9His variant gene used above, the proteolytic tag   ADSHQRDYALAA Stop 
sequence was replaced with   ADSHHHHHHHHH Stop in which glutamine and arginine 
were lost. Wower and colleagues (Wower et al., 2014) produced a M. tuberculosis 
tmRNA6His variant that had tagging activity in E. coli. The tmRNA6His variant tag sequence 
they presented was ADSHQRHHHHHH which was different to the Tag used in the present 
study so far as it retained the glutamine and arginine and replaced the DYALAA codons of 
the proteolytic tag with six histidine codons.   To accommodate for a possible negative effect 
of losing the codons for glutamine and arginine which may be important for the tmRNA 
variant tagging efficiency or its stability, I restored these codons in a modified construct. 
Site directed mutagenesis (section 2.16) was used to change the sequence of the ssrA9His 
variant tag from ADSHHHHHHHHH Stop to ADSHQRHHHHHH Stop (Figure 30). This 
variant gene was designated as ssrA6His. 
Version 1 ssrA9His sequence (ADSHHHHHHHHH) 
GGATGCGAGGGGCT (XmnI restriction site) 
GAACGGTTTCGACTTCGCGCATCGAATCAAGGGAAGCGTGCCGGTGCAGGCAAGAGACCACCGTAAGCGTCGTTGCGAC
CAAATAAGCGCCGATTCACATCACCACCACCACCACCACCATCACTAATGGTCGTGTGGTGTGGCAGACCGGGAACGC
CCTCGGCCCGGACCCTGGCATCAGCTAGAGGGATCCACCGATGAGTCCGGTCGCGGGACTCCTCGGGACAACCACAGCG
ACTGGGATCGTCATCTCGGCTAGTTCGCGTGACCGGGAGATCCGAGCAGAGGCATAGCGAACTGCGCACGGAGAAGCCT
T (PpuMI restriction site)GAGGGAATGCCGT  
Version 2 ssrA6His sequence (ADSHQRHHHHHH) 
GGATGCGAGGGGCTGAACGTTTCGACTTCGCGCATCGAATCAAGGGAAGCGTGCCGGTGCAGGCAAGAGACCACCGTAA
GCGTCGTTGCGACCAAATAAGCGCCGATTCACATCAGCGCCACCACCACCACCATCACTAATGGTCGTGGGGTGGGGCA
AAACGGGAACGCCCTCGGCCCGGACCCTGGCATCAGCTAAAGGGATCCACCGATGAATCCGGTCGCGGGACTCCTCGGG
ACAACCACAGCGACTGGGCTCGTCATCTCGGCTAGTTCGCGTGACCGGGAGATCCGAGCAGAAGCATAGCGAACTGCGC
ACGGAAAAACCTTGAGGGAATGCCGT  
  
Figure 30.  ssrA6His variant sequence compared to ssrA9His variant 
The ssrA9His variant was modified to restore the glutamine and arginine codons of the tag sequence.  
Version 1 is the sequence of the ssrA9His variant with 9 Histidine (Two CAT and seven CAC codons). 
Version 2 is sequence modification after site directed mutagenesis containing 6 Histidine (five CAC 
and one CAT codon). The underlined sequences in red are the ssrA9His tag sequence (version 1) and the 
ssrA6His tag sequence (version2).   
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The mutagenesis was directly done on pk-smpB-Rv3099c-ssrA9His and pmv261-smpB-
Rv3099c-ssrA-9His. The resulted plasmids were propagated into E. coli DH5α, extracted and 
sent for sequencing to confirm the restoration of the arginine and glutamine codons 
(Appendix 8.9).  The sequencing confirmed the intended mutations and the constructs were 
designated as pK-smpB-Rv3099c-ssrA6His and pMV-smpB-Rv3099c-ssrA6His   which then 
were introduced M. smegmatis groEL1ΔCΔlon  (Table 4). These constructs were also 
introduced into M. smegmatis groEL1ΔC but due to the time shortage it was not possible to 
continue further work with these four.  
 
Four successful transformants were selected for protein extraction; two harbouring pK-
smpB-3099c-ssrA6His designated M. smegmatis groEL1ΔCΔlon6HisV I & IV and two 
harbouring pMV-smpB-3099c-ssrA6His designated M. smegmatis groEL1ΔCΔlon6HisW 2 & 3.  
All the four merodiploid were grown in different stress conditions as described in section 
(3.10) and harvested as previously described in section (3.7.2).  Again western blotting 
indicated the absence of any His-tagged protein in the bacterial whole lysate and there was 
no protein pulled down by the nickel column (Data not shown).  
 
Despite this disappointment, it was observed that the merodiploids showed a growth 
phenotype. The merodiploid M. smegmatis groEL1ΔCΔlon6HisV and M. smegmatis 
groEL1ΔCΔlon6HisW   failed to grow on 7H11 without glycerol, unlike the parental strains 
and the previous merodiploid. Therefore, this was further investigated by doing a growth 
curve comparing M. smegmatis groEL1ΔC, M. smegmatis groEL1ΔCΔlon and M. smegmatis 
groEL1ΔCΔlon6HisV    
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3.14  Growth Phenotype of Mycobacterium smegmatis Δlon6HisV 
  
The growth phenotype of M. smegmatis groEL1ΔCΔlon6HisV was observed in the carbon 
source limited media, so it was decided to perform a growth curve by growing the different 
strains in 7H9 containing 0.4% glycerol and 0.1% Tween 80 without the addition of any 
antibiotics. M. smegmatis groEL1ΔCΔlon6HisV IV merodiploid was selected to compare its 
growth rate with the parental strain M. smegmatis groEL1ΔCΔlon and the wild type M. 
smegmatis groEL1ΔC. As shown in the growth curve  (Figure 31), M. smegmatis 
groEL1ΔCΔlon6HisV grew much slower and has a very long lag phase compared to M. 
smegmatis groEL1 ΔC and M. smegmatis groEL1ΔC Δlon.  
 
Figure 31. M. smegmatis groEL1 ΔC, M. smegmatis groEL1ΔC Δlon and M. smegmatis 
groEL1ΔCΔlon6HisV (ssrA6His variant merodiploid) growth curves by OD 600.  
M. smegmatis groEl1 ΔC, M. smegmatis groEL1ΔCΔlon and M. smegmatis groEL1ΔCΔlon6HisV IV were grown 
in 7H9 containing 0.4% glycerol and 0.1% Tween 80 only and incubated at 37oC shaking. Each point is an 
average OD600 of 3 biological replicates. The error bars are the standard error of the mean. 
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There is a slight difference in the generation time between Mycobacterium smegmatis Δlon 
and its parental strain M. smegmatis groEL1ΔC (85 and 101 minutes respectively). In 
contrast, the M. smegmatis groEL1ΔCΔlon6HisV IV merodiploid had a doubling time of 125 
minutes. The difference in the generation time between the M. smegmatis groEL1ΔCΔlon 
and its parent M. smegmatis groEL1ΔC suggests that deleting the lon gene may have slightly 
impaired it in the conditions used in this experiments.  Furthermore, the difference in the 
generation time between M. smegmatis groEL1ΔC Δlon6HisV IV merodiploid and its parent 
Mycobacterium smegmatis groEL1ΔC Δlon may also suggest that harbouring the ssrA6His 
variant may be the cause for the very long lag phase and slower generation time. 
 
Figure 32. M. smegmatis groEL1ΔC, M. smegmatis groEL1ΔC Δlon and M. smegmatis 
groEL1ΔCΔlon6HisV (ssrA6His variant merodiploid) growth curves by cfu.  
M. smegmatis groEl1 ΔC, M. smegmatis groEL1ΔCΔlon and M. smegmatis groEL1ΔCΔlon6HisV IV were grown 
in 7H9 containing 0.4% glycerol and 0.1% Tween 80 only and incubated at 37oC shaking. Miles and Misra 
counts were done on LBA. Each point is an average log10 of 3 biological replicates. 
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The resumption of the almost similar growth to the wild and the parent strains after the long 
lag phase suggested some kind of changes occurred in the merodiploid that enabled it to 
grow almost as normal.  It was hypothesized that these changes could have been due to a 
mutation of the M. tuberculosis H37rv tmRNA ssrA6His   variant to inhibit its expression or 
through the induction of compensatory mechanisms to overcome the burden caused by its 
presence.  
 
To test for the possibility that the merodiploid may excise or destroy the entire plasmid, the 
growth curve was repeated with M. smegmatis groEL1ΔCΔLon without kanamycin and four 
different clones M. smegmatis groEL1ΔC Δlon6HisV (I&IV) and M. smegmatis 
groEL1ΔCΔlon6HisW (2 & 3) with 50µg of kanamycin to prevent the loss of the plasmid and 
maintain the expression of M. tuberculosis ssrA6His variant. 
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Figure 33. M. smegmatis groEL1ΔC, M. smegmatis groEL1ΔC Δlon and M. smegmatis 
groEL1ΔC Δlon6HisV (ssrA6His variant merodiploid) growth curves by OD 600.  
 
M. smegmatis groEL1ΔCΔLon, M. smegmatis groEL1ΔC Δlon6HisV I & IV and M. smegmatis 
groEL1ΔCΔlon6HisW 2 & 3 growth curves by OD600. These strains were grown in 7H9 containing 0.4% glycerol 
and 0.1% Tween 80 only and incubated at 37oC shaking. M. smegmatis groEL1ΔCΔLon    was grown without 
adding kanamycin as media control. The reset of the merodiploids were grown in the presence of 50µg of 
kanamycin. 
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As shown  in Figure 33,    M. smegmatis groEL1ΔCΔLon grew as previously seen    
replicating the earlier result of the first growth curve shown in Figure 31. In contrast, 3 of 
the merodiploids grown in the presence of kanamycin did show a very long lag phase again 
replicating the earlier result of M. smegmatis groEL1ΔCΔLon6HisIV (Figure 31). However, 
one of the four failed to grow. These observations suggested that different clones respond 
differently to the stress imposed by the presence of M. tuberculosis tmRNA ssrA6His variant. 
The variability in the length of the lag phase between the different clones of merodiploids 
could also be due to the variability in the level of expression of M. tuberculosis H37rv 
tmRNA ssrA6His. The presence of kanamycin might have some effect too as it might cause 
ribosome stalling even though the merodiploids have the aph gene as a selection marker. 
Kanamycin may add further stress that might contribute to the slow growth or may increase 
the expression of ssrA6His leading to even to slower growth. The CFU count was also 
performed to check the viability of M. smegmatis groEL1ΔCΔlon6HisVI, which maintained a 
growth rate of 5x103 to 3x104   cfu/ml up to day 4 but then showed no growth on day 5. It is 
possible that the merodiploid became non-viable or non-culturable at this point but this will 
require further work in the future to confirm.  
 
The viable count was done on LBA plates with and without kanamycin. All the merodiploids 
grew in the presence of the kanamycin and there was no difference in the CFU count on 
LBA plates with and without kanamycin. This indicates that the merodiploids did not lose 
the plasmid.  
In an attempt to verify the suggestion that the merodiploid harbouring the M. tuberculosis 
tmRNA ssrA6His variant were being modified, 10 individual colonies from the CFU count 
plate of M. smegmatis groEL1ΔCΔlon6HisV IV   late log phase (grown in the absence of 
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Kanamycin) were picked. Each colony then was streaked on LB agar without antibiotics and 
then on another LB agar containing 50µgml-1 kanamycin and incubated for two days.  All of 
the picked colonies grew on both plates indicating they still possessed the aph gene and 
hence the plasmid. Then a colony PCR was done to amplify the cloned construct which was 
then sent for sequencing. The sequencing results did not indicate any sequence changes that 
might be seen as a cause for the overcoming of the effect of the presence of the M. 
tuberculosis H37rv ssrA6His variant. 
Taken together, these observations and finding may suggest: 
1. The presence of the M. tuberculosis H37R vssrA6His had an impact on the growth rate 
of the harbouring merodiploid that is possibly due to the essentiality of the tmRNA 
tagging function 
2. The failure to detect any His-tagged protein may have been due to the cessation of 
the growth of the bacterial cells expressing M. tuberculosis ssrA6His and as a result 
there was no detectable accumulation of the tagged protein 
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3.15 Discussion 
 
Understanding the function of tmRNA in M. tuberculosis H37rv is very important as it might 
open a window to finding new drug targets. One important approach to assign function to a 
gene/DNA region is to delete it and then observe any phenotypic changes in the bacterium. 
Unfortunately, we were unable to delete the ssrA gene that encodes the tmRNA of M. 
tuberculosis H37rv unless we provided a second functional copy elsewhere on the genome. 
It was not possible to delete the ssrA when a second recombinant was provided with the 
protease tag coding sequence replaced by a sequence encoding a run of histidines (ssrA9His). 
This suggested that tmRNA is essential in M. tuberculosis H37rv and moreover that the 
protease tagging function of tmRNA is an essential function. However, there are two points 
that might initiate a doubt in this conclusion.  Firstly, when the knockout construct 
(pG5hyg::ssrA) was made the size of the M. tuberculosis H37rv tmRNA had been annotated 
to have a sequence size of 607bp but, recently this was corrected to 338bp. This means that 
this construct would have deleted 269bp from downstream of the tmRNA as well as the 
intended gene and in doing so might have negatively affected the downstream genes. This 
might have a negative impact on the viability of the transformed M. tuberculosis H37rv and 
hence no transformants with the gene replacement would be detected.  Therefore, a revisit 
of the strategies used in the attempt to delete ssrA in this study must be done in order to clear 
any doubts about the conclusion that tmRNA is an essential molecule. In addition, a recent 
paper published since the experiments in the present study were started, demonstrated that 
the deletion of smpB in M. tuberculosis H37rv  (Personne and Parish, 2014) did not affect in 
vitro growth. This might suggest that tmRNA is not essential for rescuing the stalled 
ribosome. This would necessitate the presence of an alternative ribosome recycling 
mechanism in mycobacteria, but none have so far been identified.  E. coli possesses 
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alternative ribosome rescue proteins, namely;  ArfA, (Alternative ribosome-rescue factor A) 
which is encoded by the yhdL gene and shown to have properties consistent with tmRNA- 
independent system (Chadani et al., 2010) and ArfB, (YaeJ) paralogous to the release factors 
(RFs)  (Chadani et al., 2012) and the putative stop-codon independent release factor known 
as PrfH whose function could be redundant with ArfB (Baranov et al., 2006). 
Expressing E. coli ArfA in Shigella flexneri  made it possible to delete  its ssrA which is 
essential (Ramadoss et al., 2013). ssrA is not essential for the survival of Caulobacter 
crescentus ssrA and it does not have an arfA homolog but has been reported to have a protein 
known as CC1214 that had homology to E. coli ArfB and could hydrolyse peptidyl-tRNA in 
nonstop translation complexes in vitro (Feaga et al., 2014). Thus, future work in 
mycobacteria should include studies to identify alternative ribosome recycling systems 
 
Personne and Parish also demonstrated the deletion of ssrA from a merodiploid strain of M. 
tuberculosis H37rv carrying a second recombinant ssrA which had a double glycine instead 
of a terminal double alanine in the protease tag sequence. This recombination showed no 
effect on growth and no effect on mutant sensitivity to a ribosome inhibitory drug 
Pyrazinamide (PZA) suggesting that tmRNA protease tagging is not an essential function in 
M. tuberculosis H37rv but that ribosome rescue is.   These findings are in contrast to those 
in the present study where it was possible to delete ssrA from wild type-ssrA merodiploid, 
however, it was not possible to delete it from ssrA9His variant merodiploid which replaced 
the protease tag with a run of histidines. One study in support of an essential function for the 
protease tagging role of tmRNA is that the Clp protease itself is essential for bacterial 
viability (Sassetti et al 2003; Raju et al 2011). Perhaps this contradiction may suggest that 
ssrADD variant tagged proteins are more easily degraded by other protease systems than the 
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His tagged proteins.   These contrasting results could also be explained if the ssrA9His 
produced a completely non-functional tmRNA that was unable to interact appropriately with 
the translation machinery. 
 
The other aspect of this chapter was an attempt to identify the protein substrates of the 
tmRNA tagging system. The first approach was to replace the wild-type ssrA with ssrA9His 
and then purify the His-tagged protein repertoire of the cell and identify by LC-MS. As 
explained above, this strain was not viable, so it was attempted to purify His-tagged proteins 
from merodiploids carrying both the wild-type and His-variant ssrA genes. This study failed 
to identify any His-tagging of truncated proteins despite an exhaustive set of experiments in 
which ssrA His-tagging genes (His6 and His9) were expressed from different promoters, 
from episomal vectors, from integrated constructs, in a GroEL1 mutant background, and in 
a Lon protease deficient background. Towards the end of these experiments we observed 
that expression of His-tmRNA was detrimental to bacterial growth in media with low 
glycerol content. One possible explanation for this is that tmRNA protease tagging and ClpP 
degradation is so important that even a proportion of truncated protein being His-tagged is 
damaging to the cell. Indeed, this is consistent with observations in Caulobacter crescentus 
ssrA mutants (Keiler and Shapiro, 2003) in which slow growth in limited medium was 
related to the disruption of cell cycle as a result of the absence of the wild type ssrA tagging 
activity and not due to the accumulation of stalled ribosomes because an ssrADD variant did 
not complement the growth defect. It was also noticed that the Caulobacter crescentus  
ssrADD merodiploid  showed a similar effect but not as strong as the effect seen in 
Caulobacter crescentus DssrA suggesting tagging not ribosome rescue is the reason for the 
phenotype. In some other bacteria in which the ssrA is non essential, deleting it produced a 
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mildly defective phenotype and its function can be complemented by the ssrADD variant   
(Keiler, 2008; Moore and Sauer, 2007).  Further supportive of this is that E.coli  ssrA mutants 
showed a growth defect under nutrient starvation (Oh and Apirion, 1991) (Komine et al., 
1994). This may indicate the possible involvement of M. tuberculosis tmRNA in cell growth 
regulation directly by (1) interacting with the respective growth factor by tagging it for 
degradation thereby directly interfering with its expression or (2) indirectly via regulation of 
its regulatory mechanisms or (3) by leading to accumulation of un-degraded truncated 
proteins that interact with many cellular proteins and disrupt the physiology of the cell. 
Alternatively, the results are also consistent with ssrAHis producing a non-functional tmRNA 
that interacts appropriately with the translation machinery and inhibits translation. 
 
Further work is clearly needed to elucidate the role of tmRNA.   Analysis of the accumulation 
of tagged proteins in ssrADD and ssrAHis expressing mycobacterial strains will help to 
understand the contrasting results reported in this and the study of Personne et al 2014. In 
addition, research should incorporate analysis of the interaction of tmRNA with the 
translation machinery possibly with an affinity tagged tmRNA (not His!) to pull down 
interacting proteins and RNAs. 
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Chapter 4 
Ultrastructural localisation of α-
crystallins in M. tuberculosis complex 
bacteria   
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4.0 Introduction  
M. tuberculosis H37rv is a successful pathogen due to its ability to evade and resist the 
killing mechanisms employed by the immune system of its host. Indeed, it is able to persist 
in the body for decades in an apparently dormant state which is often termed latent 
tuberculosis infection (LTBI).  This persistent M. tuberculosis H37rv infection occurs in the 
majority of the 2 billion people who are infected with M. tuberculosis H37rv worldwide. 
Thus understanding how M. tuberculosis H37rv is able to resist stress and maintain viability 
in latent TB is important to the development of novel control therapies.  
 
There are many conditions that are potentially hostile to the bacterium during infection: for 
example, nutrient starvation; hypoxia; temperature; reactive nitrogen intermediates; reactive 
oxygen intermediates and low pH. Molecular chaperones represent one group of proteins 
that are prominent in the bacterial stress response to any condition that results in the 
denaturation of proteins. In chapters 4 and 5 of this thesis I study two small heat shock 
proteins (sHSP) belonging to the α–crystallin family of chaperones - Acr1 and Acr2. 
The α–crystallins like Acr1 and Acr2 protect other proteins from thermal aggregation 
although they may not prevent the loss of enzyme activity in the target protein.  They act in 
an ATP-independent manner and therefore, they are frequently developmentally regulated 
normally when and where metabolic activity is minimal, such as in the eye lens (Arrigo and 
Simon, 2010).  α–crystallins are reported to be found in sporulating microorganisms where 
they are involved in the assembly of the spore’s outer coat (Henriques et al., 1997). Although 
M. tuberculosis H37rv does not sporulate, both acr1 and acr2 genes have been reported to 
be up-regulated in non-replicating M. tuberculosis H37rv (Stewart et al., 2005) but, their 
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role in M. tuberculosis survival and pathogenicity is complex and remains poorly 
understood.  
The Acr1 protein (also known as the 16kDa antigen) is one of 5 proteins that were identified 
by mass fingerprinting and immunodetection in the lysate of M. tuberculosis grown under 
low oxygen conditions (Rosenkrands et al., 2002). It is reported to be required for optimal 
mycobacterial growth within macrophages (Yuan et al., 1996)   and is up-regulated during 
hypoxia   (Desjardin et al., 2001). Acr1 is under the control of the two component response 
regulator known as DosR (Rv3133c/Rv3132c) which upregulates over 50 genes in response 
to microaerophilic conditions or low concentrations of NO (Voskuil et al., 2004).    
 
Acr2 is a paralogue of Acr1 which shares 30% overall homology in amino acid sequence to 
Acr1 and 41% homology when comparing the residues of the α-crystallin core. Acr2 was 
first described as a stress protein that associated with the ribosomal fraction of heat stressed 
M. tuberculosis (Ohara et al., 1997; Pang and Howard, 2007; Stewart et al., 2002a; Tabira 
et al., 2000). The acr2 gene is transcriptionally upregulated more than any other gene during 
heat shock (Stewart et al., 2002b) and is under the control of regulatory systems that 
coordinate its gene expression in response to a variety of different stresses including 
starvation, palmitic acid, diamide or hydrogen peroxide (H2O2), nitric oxide, naïve and 
activated macrophages and detergent (Kennaway et al., 2005; Wilkinson et al., 2005).  The 
mechanisms of Acr2 regulation have been studied in detail. It is regulated by the repressor 
HspR and the activator ClgR in response to heat/denatured protein (Estorninho et al., 2010; 
Stewart et al., 2002b)   and by the sigma factor SigE and the two component response 
regulator MprA/B in response to cell surface stress such as surfactant  (He et al., 2006; 
Manganelli et al., 2004; Pang and Howard, 2007; XiaoZhen et al., 2011).  It is also regulated 
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by the two-component system PhoP which is important for mycobacterial virulence (Singh 
et al., 2014a). Further indicative of its importance in infection, acr2 expression is  
upregulated during the first 24hrs post-infection of the macrophage (Wilkinson et al., 2005).  
 
There is little detail on the roles or substrates of the a–crystallins other than their general 
function as molecular chaperones. Some insight into the role of Acr1 has been gained by 
examination of its subcellular location. Electron microscopy has shown that Acr1 may be 
associated with fibrous peptidoglycan-like structures, intracellular and peripheral clusters as 
well as the cell envelope. Its association with the cell envelope is strongest in stationary 
phase bacteria under hypoxia and it has been suggested that the chaperone may play an 
important role in thickening and stabilising the cell structure helping the cell to survive the 
hypoxic environment (Cunningham and Spreadbury, 1998). Although M. tuberculosis is a 
non-capsule producing bacteria, it has been observed to be surrounded by capsule-like 
structure which is seen as electron-transparent zone (ETZ) in pathogenic mycobacteria (M. 
tuberculosis and M. avium) but absent in non-pathogenic mycobacteria (M. smegmatis and 
M. aurum). Acr1 has been identified to be among the major presumed “capsular” proteins of 
M. tuberculosis (Daffé and Etienne, 1999).  
 
Before this thesis, there was no evidence that the Acr2 protein was similarly involved in the 
thickening or maintenance of the cell wall, rather that it may be important for maintenance 
of the protein synthesis machinery under stress conditions. Evidence for this was derived 
from its apparent purification with ribosomes from mycobacteria exposed to high 
temperature (Ohara et al., 1997; Pang and Howard, 2007). However, its induction by 
regulators that respond to cell surface stress (MprA/B and SigE) may indicate some 
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involvement in cell wall biology as well as being a ribosome chaperone. Further evidence to 
support its cellular function would be provided by knowledge of its subcellular localisation. 
In contrast to Acr1, up to the date of writing this thesis, there is no such data regarding Acr2 
localisation.   
One of the main hypotheses of this thesis is that there is functional redundancy between the 
two α-crystallins. This chapter attempts to add information to test this hypothesis by 
comparing the subcellular localisation of the α-crystallins.   
The specific objectives of this chapter are to, 
1. Detect Acr1 and Acr2 in different cellular fractions (culture supernatant, cell pellet, 
cytosolic and plasma membrane factions) by Western blot. 
2. Examine the intracellular localisation of Acr2 by Immuno-electron microscopy. 
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4. 1.  Localisation of α-crystallins by Western blotting in M. bovis BCG 
sub-cellular fractions 
 
It was not possible to use M. tuberculosis H37rv for the cell fractionation and protein 
extraction due to the technical difficulties related to the volume of culture required inside 
the CL3 laboratory. Therefore, BCG str. Pasteur, the close M. tuberculosis relative, was used 
instead making it possible to do the required work in the CL2 laboratory where the required 
facilities and permissions exist.  A starter culture of BCG str. Pasteur was grown in 7H9 
containing 10% ADC and 0.1% Tween 80 to mid log out of which a volume of 500ml of 
Roisin’s minimal medium was inoculated. This medium was important because it does not 
contain albumin like 7H9, which would interfere with the cellular protein analysis. The BCG 
culture was grown for 4 weeks until late log phase OD 1.0. The cells were harvested, lysed 
and the lysate was fractionated using ultracentrifugation at 35000RPM, 2hours for each step.  
The four fractions that were obtained were (1) culture supernatant, (2) solid cell pellets after 
cell disruption (3) cytosolic and (4) plasma membrane fractions. The fractions were run on 
12% SDS PAGE (picture not shown) and the proteins transferred to PVDF membrane. The 
α-crystallin proteins were detected by Western blot using the respective polyclonal 
antibodies. 
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4.1.2 Western blot localisation of α-crystallin 1 in subcellular fractions of BCG 
  
 
 
 Figure 34: Detection of Acr1 by Western in different BCG culture fractions 
Western blot showing the presence of Acr1 protein (16 kDa) in the BCG culture supernatant, 
solid cell pellet, cytosolic and plasma membrane fractions (lanes 1-4 respectively). Lane 5 
is the positive control of BCG whole lysate. 
 
Western blotting showed the presence of Acr1 in all the subcellular fractions tested (Figure 
34). Although this technique is only semi-quantitative at best, Acr1 appeared to be most 
abundant in the cell pellet and plasma membrane fractions. From the intensity of the 
immunoreactivity detected, the Acr1 concentration seemed to be lower in the cytosolic and 
culture supernatant fractions. The detection of Acr1 in the plasma membrane fraction may 
indicate its association with the plasma membrane components or its associated proteins.  
Thus Acr1 appears to be widely distributed in the cell and its presence in the cell pellet and 
plasma membrane fraction is consistent with the previous electron microscopy studies which 
indicated its presence in the cell wall (Cunningham and Spreadbury, 1998). It’s presence in 
the supernatant could result from lysis of bacteria in the culture but it is also reasonable to 
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assume that cell wall associated proteins may be shed into the culture from whole replicating 
bacteria 
 
 
Figure 35. Detection of Acr2 by Western blotting in different BCG culture fractions 
 Western blot showing the presence of Acr2 protein (18kDa) in the solid cell pellet and 
plasma membrane fraction (lane 2 and 4 respectively) and its absence in the culture 
supernatant and cytosolic fractions (lane 1 and 3 respectively). Lane 5 is the positive control 
of BCG whole lysate. 
 
  
Unlike Acr1, Acr2 was only detected in the solid cell pellet and plasma membrane fractions 
(Figure 35). This suggests that Acr2 functions exclusively in the plasma membrane and cell 
wall compartments in the bacterium and is not secreted from the cell nor required in the 
cytoplasm. The result may also support the idea that Acr2 is required for the process of 
protein synthesis via its interaction with the ribosome 30S subunit. The finding in the present 
study agrees with what Ohara and colleagues reported, that the 18-kDa ribosome associated 
protein HrpA (synonymous with Acr2) was found in the membrane and ribosome fractions 
(Ohara et al., 1997) . In the present study, further fractionation of the plasma membrane 
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fraction was not performed and therefore, although the findings are consistent with Ohara, 
they cannot confirm the association of Acr2 with the ribosome.  
 
4.1.3. Localisation of Acr1 and Acr2 in M. tuberculosis H37rv by immuno-electron 
microscopy 
 
Visualising the distribution of Acr1 and Acr2 using immuno-electron microscopy was 
carried out using an aged culture of M. tuberculosis H37Rv. Acr1 is highly expressed in 
stationary phase and Acr2 is also known to be expressed in non-replicating bacteria (Stewart 
et al., 2005; Yuan et al., 1996). WT M. tuberculosis H37rv was grown in 7H9 containing 
10% ADC and 0.01% Tween 80 and incubated for 90 days shaking at 37oC. The culture was 
spun down and the cell pellet resuspended in 4% formaladehyde and 0.2% glutaraldehyde. 
After fixation overnight, the cells were washed and embedded in LR white acrylic resin as 
described in the methods (section. 2.17). LR white is hydrophilic and thus allows for the 
interaction between antibodies in solution with antigen in the embedded samples. Ultrathin 
sections were cut and stained with rabbit anti Acr1 and Acr2 serum and goat anti-rabbit 
secondary antibody conjugated to 10 nm gold particles as described in the methods (Section. 
2.17). 
  
 
The specificity control, using non-immune rabbit serum in place of the primary antiserum to 
check for non-specific binding of the antibodies (Figure 36), showed some non-specific 
binding but at a very low gold particle density of <1 particles per 0.12µm area.  This gives 
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good confidence that most of the particles seen in the Acr1 and Acr2 specific immuno-gold 
staining is due to specific binding of the primary or secondary antibodies.  
 
 
 
Figure 36. Immunogold electron micrograph of M. tuberculosis H37rv stained with 
non-immune rabbit serum (specificity control) 
The micrographs for the control testing for the non-specific binding of primary and secondary antibodies. The 
samples slides were treated with only the secondary anti-bodies-Gold particle conjugate.   
 
  
The ultrastructural preservation of the cells was inadequate with bacterial outlines visible 
but without visible membranes in most places. The reason for this was that osmium tetroxide 
could not be used to stain membranes as electron dense structures because osmium has the 
effect of masking antigenicity. It was attempted to retain as much membrane structure as 
possible by using uranyl acetate staining en bloc but this produced only low contrast staining. 
The cell wall was not well defined and in most micrographs is visible as an electron 
translucent zone surrounding the bacteria although occasional areas with better preservation 
of the layers were present. The staining for both Acr1  (Figure 37) and Acr2 (Figure 38) 
produced a significantly higher density of gold particles (27 and 15 gold particles per 0.12µm 
respectively)  than staining performed with a non-immune rabbit serum in place of the Acr1 
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and Acr2 primary antisera (Figure 36). This indicated that the Acr1 and Acr2 
immunoreactivity was specific for the intended antigens. 
  
Acr1 immunoreactivity was mostly associated with the cytoplasmic region of the bacteria 
although there was also a lower level of staining visible on the periphery of the cells (Figure 
37). The latter may indicate staining of the cell wall and this is consistent with the findings 
of Spreadbury et al  (Cunningham and Spreadbury, 1998). 
 
Figure 37.  Acr1 immunogold electron micrograph 
Immunogold Electron Micrograph showing the localisation and distribution of Acr1 immunoreactivity in M. 
tuberculosis H37Rv. The M. tuberculosis was grown in 7H9 containing 10% ADC and 0.1% Tween80 and 
incubated for 90 days shaking at 37oC. Although the preservation process was not good enough to show cell 
wall details, the bacillus cell wall appears as an electron translucent zone surrounding the darker cytoplasmic 
part of the cell. Acr1 immunoreactivity is associated with both the cytoplasmic area and the cell periphery. The 
density of the gold particle is 27 particles per 0.12µm.  
 
Acr2 immunoreactivity contrasted with Acr1 because it was clearly associated with the 
periphery of the cell, particularly the clear electron translucent zone that surrounded the 
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bacteria which is presumed to be the cell wall (Figure 38). There was very little Acr2 gold 
staining associated with the cytoplasm of the bacteria. 
  
 
 
 Figure 38. Acr2 immunogold electron micrograph 
 Immunogold Electron Micrograph showing the localisation and distribution of Acr2 in M. tuberculosis 
H37Rv. M. tuberculosis was grown in 7H9 containing 10% ADC and 0.01% Tween 80 and incubated for 90 
days shaking at 37oC. Although the preservation process was not good enough to show cell wall details, the 
bacillus cell wall appears as an electron translucent zone surrounding the darker cytoplasmic part of the cell.  
Acr2 immunoreactivity was associated with the cell wall and not the cytoplasm. The density of the gold particle 
is 15particles per 0.12mµ . 
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4.2 Discussion 
The α-crystallins Acr1 and Acr2 are small heat shock proteins (sHSPs) that function 
primarily as molecular chaperones preventing improper protein association (Abgar et al., 
2001). They are able to bind to non-native proteins under various stress situations leading to 
inhibition of their irreversible aggregation and prevention of cell damage (Lindner et al., 
2000).   These proteins belong to a class of heat shock proteins known as holdases and they 
bind to their protein clients in an ATP-independent manner. When the stress condition is 
lifted the bound proteins are released for refolding with the help of the foldases  (Basha et 
al., 2012; Haslbeck et al., 2005). They are promiscuous chaperones which means they can 
bind to a wide range of unfolded proteins (Tyedmers et al., 2010).   Expression of both Acr1 
and Acr2 proteins increases in resposne to conditions such as stationary phase and various 
stresses although there are key differences in the stresses which induce their expression 
indicating that they may have different roles in the cell (Rosenkrands et al., 2002; Stewart 
et al., 2005) (Yuan et al., 1996).   
  
  
Cunningham and Spreadbury (1998) in their study concluded that the Mycobacteria may 
adapt to hypoxic condition by developing a thick cell wall. Using Immunogold electron 
microscopy, they have shown the distribution pattern and localisation of Acr1 in M. bovis 
BCG bacilli that were incubated anaerobically for different lengths of time.  They compared 
the localisation of Acr1 in cells grown for 4, 12 and 26 weeks.  They observed that after 26 
weeks, Acr1 is localised at various parts of the cell including in the cell wall, and in fibrous 
structures and peptidoglycan like fibres. After incubating for 4 weeks, the Acr1 was seen 
clustered and associated with the cytoplasm and the periphery of the cell. After 12 weeks of 
incubation, Acr1 was shown to be more heavily localised in the cell periphery. In the present 
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study, M. tuberculosis H37rv was incubated for 12 weeks with shaking to allow gradual 
depletion of oxygen and nutrients and entry of the bacterium into stationary phase. The Acr1 
immunogold electron microscopy showed staining in the cytoplasm of some cells and some 
heavier peripheral staining in other cells.  Although the cells in my study were grown for 90 
days, the similarity of the result to cells from various aged cultures in Spreadbury and 
Cunningham’s study, suggests that different populations of bacilli existed within my 90 
days’ culture. In other words, some of the M. tuberculosis cells were still replicating and had 
not switched to a non-replicating state where staining in the periphery is more pronounced. 
Unfortunately, it was not possible to view the fibrous details of the cell which may not have 
been preserved during the processing of the cells either at the fixation or dehydration step or 
may not be visible due to the low contrast of the sections. 
 
The immune-electron microscopy of M. tuberculosis H37rv was supported by Western 
blotting of subcellular fractions of stationary phase BCG, which showed that Acr1 was 
present in the cytoplasmic, cell wall and plasma membrane fractions as well as in the culture 
supernatant. Therefore, Acr1 seems to be present throughout the bacterial cells in growth 
conditions when there is presumably less metabolic activity in the cells.  Given the fact that 
Acr1 acts in an ATP independent manner, it could be the best option to transport and protect 
essential proteins for survival in this low metabolic state. 
 
That Acr1 was found in the culture supernatant may be an important observation with regard 
to its potential as a vaccine antigen as this appears to be an important quality of most 
mycobacterial vaccine candidates that give protection, e.g.,  Esat-6, Cfp10, Ag85A/B 
(Langermans et al., 2005; Maue et al., 2007; Xu et al., 2008). Acr1 is known to be 
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immunogenic and it has been reported to provide high long term protection against M. 
tuberculosis infection in mice when used in multistage subunit vaccine containing Acr1, 
ESAT6, Ag85B and MPT64 (Niu et al., 2015). Also Acr1 protein alone that was purified 
from the M. tuberculosis cell lysate, protected the mice against aerosol challenge and 
improved protective efficacy of BCG, when used as a booster vaccine. However, 
recombinant Acr1 protein expressed in E. coli was used alone as a prophylactic vaccine, 
failed to protect mice against aerosol challenge. This suggests that Acr1 may chaperone one 
or more immunogenic and protective antigens (Taylor et al., 2012).  Because Acr1 is a 
chaperone which acts in an ATP independent manner in non-replicating “dormant” cells, its 
potential as a chaperone/carrier of important dormancy antigens may be important in efforts 
to produce a vaccine against latent tuberculosis. 
 
In contrast to Acr1, Acr2 seems to be distributed almost exclusively on the periphery of the 
cells in the electron translucent zone, that we presume to be the cell wall, or on the cell 
membrane beneath it. One previous study suggested that Acr2 is a ribosome binding protein 
(Ohara et al., 1997) aiding translation initiation because it was associated with 30S subunit 
of the ribosome (Ohara et al., 1997; Stewart et al., 2002a; Tabira et al., 2000). The data in 
the present study does not support this because if Acr2 was associated with ribosomes, one 
would expect it to be localised in the cytoplasm. Here, the Western blotting and immune-
electron microscopy indicate that Acr2 associates with the plasma membrane (and cell wall) 
and it is possible that membrane fractions containing Acr2 co-migrated with ribosomes in 
the study by Tabira, which led to the conclusion that Acr2 was associated with the ribosome. 
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Acr2 is known to be upregulated in various stress conditions especially in heat shock and 
stresses such as surfactant which are associated with damage to the cell surface. Indeed, two 
of the regulators that control its expression, SigE and MprA/B, are known to govern the cell 
surface stress response. Thus the localisation of Acr2 to the cell wall and plasma membrane 
makes sense, implicating Acr2 as a major chaperone important for maintenance of the 
mycobacterial cell wall during stress. Just as for Acr1, the ATP-independence of Acr2, 
unlike many other classes of chaperone, makes it perfect for this function on the external 
periphery of the cell.  
 
Thus, the localisation of Acr1 and Acr2 to different areas of the bacterial cell suggests that 
these two holdase chaperones have different cellular functions. However, there is some 
overlap in their subcellular localisation, as both can be found in the cell wall/periphery of 
stationary phase bacteria (although Acr2 appears more abundant). Thus there is potential for 
some level of functional redundancy. This will be further investigated by examining the 
phenotype of α-crystallin mutant strains of M. tuberculosis H37rv in Chapter 5. 
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Chapter 5 
Gene replacement of the M. 
tuberculosis α-crystalline genes and 
phenotypic characterisation of the 
mutant strains 
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5.0  Introduction 
The immuno-electron microscopy and Western blotting experiments explained in chapter 4 
suggested that the two α–crystallin chaperones under investigation were not localised in the 
same manner in the cell. Acr1 was found in all the subcellular fractions and the electron 
micrographs showed its wide distribution all over the cytoplasm of the cell and the cell wall.  
In contrast, the Acr2 was only detected in the cell pellet and plasma membrane fractions 
(further fractionation was not done to determine which fraction of the plasma membrane) 
and the electron micrographs showed an almost exclusive distribution in the cell wall/plasma 
membrane with little or no staining in the cytoplasm or nucleolus.   Although this difference 
in cellular location must represent a difference in function, the overlap in distribution in the 
cell wall could still allow for some functional redundancy in this peripheral area of the cell. 
The classic approach to associate phenotypes to genes is to generate knockout mutant strains 
and compare the phenotypes of mutant and wild-type.  Deletion of acr1 has previously been 
performed in M. tuberculosis H37rv in two different studies   and the mutants were shown 
to be partially attenuated for growth in macrophages and have an altered growth phenotype 
in mice in which infection reached a higher bacterial load (Hu et al., 2006; Yuan et al., 
1996). Deletion of acr2 was also performed in M. tuberculosis H37rv and this mutant was 
shown to be moderately attenuated in human macrophages, and in mice caused an infection 
which reached a similar bacterial load but with altered pathology and reduced loss of animal 
weight (Stewart et al., 2005; Wilkinson et al., 2005).  
 
If there is functional redundancy for Acr1 and Acr2, deletion of one chaperone may be 
partially compensated by the remaining paralogue. In this chapter, an acr1 M. tuberculosis 
H37rv mutant strain and its wild-type parent were obtained from a collaborating laboratory; 
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St. George’s Hospital laboratory (London), and the acr2 gene was deleted from both to give 
isogenic single mutants in acr1 and acr2 and a double mutant deleted of both acr1 and acr2. 
This chapter further describes the genetic complementation of these mutants and presents 
and interprets data obtained from different stress assays and macrophage infection used to 
test for a phenotypic difference between the different mutants. In particular, the focus was 
on whether the double mutant had a greatly reduced resistance/survival to any stress which 
may indicate redundancy between Acr1 and Acr2. 
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5.1. Gene replacement 
5.1.1.   a-crystalline 1 gene knockout   
 
The strains M. tuberculosis H37rv wild type and M. tuberculosis H37rv ∆acr1 (∆hspX) 
mutant (Hu et al., 2006) were the parental strains for the single deletion (∆acr2) and double 
deletion (∆acr1 ∆acr2) respectively. The un marked deletion of the acr1 gene in M. 
tuberculosis H37rv ∆acr1 (obtained from St. George’s  Hospital laboratory, London) was 
checked using primers that amplified the acr1 region (primers P19&P20,  Table 3) to 
produce a 591bp (435bp, 148bp upstream and 8bp downstream) DNA product in WT M. 
tuberculosis H37rv but a 156bp product in the acr1 deletion mutant (Figure 39).  Figure 40 
shows that PCR of the M. tuberculosis H37rv ∆acr1 single mutant (lane 2) and a M. 
tuberculosis H37rv ∆acr1∆acr2 double mutant (made later in the chapter) (lane 4) produced 
<250bp (the smallest product size in the 1kb DNA ladder) products, which is consistent with 
deletion of the acr1 gene sequence (156bp). In contrast, when M. tuberculosis H37rv wild-
type (lane 1) and M. tuberculosis H37rv ∆acr2 single mutant (lane 3) strain DNA was used 
as template, the amplified PCR size was consistent the expected 591bp product size 
indicative of the presence of the wild-type  acr1 (Figure 40) 
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Figure 39. Schematic diagram illustrating the position of acr1 in the M. tuberculosis 
H37rv genome and PCR primers for verifying the deletion of acr1 
Diagram (A) illustrates the position of the acr1 gene in M. tuberculosis H37rv genome. Diagram (B) illustrates 
the unmarked deletion of acr1 gene. Primers 19 and 20 (Table 1) were used to verify deletion of the acr1 gene. 
 
Figure 40. Deletion of acr1 gene - confirmation by PCR 
Gel (1% agarose, TAE) picture showing PCR products using DNA templates from M. tuberculosis H37Rv 
wild type, M. tuberculosis H37Rv ∆acr1 single mutant, M. tuberculosis H37Rv ∆acr2 single mutant and M. 
tuberculosis H37Rv ∆acr1∆acr2 double mutant strains to confirm the deletion of acr1 gene. The primers P19 
and P20 produce a 596bp PCR product in the M. tuberculosis H37Rv wild-type strain (lane 1) and the M. 
tuberculosis H37Rv ∆acr2 single mutant (lane 3). The M. tuberculosis H37Rv ∆acr1 single mutant (lane 2) 
and M. tuberculosis H37Rv ∆acr1∆acr2 double mutant (lane 4) produced a smaller 156bp product consistent 
with the loss of the acr1 gene.  
 
acr1	 Rv2032	Rv2030c	A	
Rv2032	Rv2030c	
B	
156bp	
P20	
P19	
P19	
P20	
596bp	
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The deletion of acr2 was done using the suicide plasmid construct known as pSMT183 
which was constructed and described by Stewart et al (2005). This plasmid is used in a one-
step knockout strategy with the hyg gene as a positive selection marker and the sacB gene as 
counter selection marker. The deletion of the acr2 gene after electroporation with pSMT183 
was confirmed by PCR screening of the transformant colonies growing in the presence of 
50µg hygromycin ml-1 and 2% sucrose of 7H11 agar supplemented with 5% Oleic Acid 
Albumin Dextrose Complex (OADC). The PCR primers (P23 and P24   Table 3) were 
designed to anneal outside the flanking regions of the acr2 gene and amplify across the acr2 
region. These primers should produce a fragment of 4361bp if the gene was replaced with 
the hyg gene or 3711bp if it was not  (Figure 41)  
 
 
Figure 41. Genome position of the acr2 gene and the PCR based strategy for 
verification of acr2 gene replacement. 
Diagram (A) illustrates the position of acr2 gene in the M. tuberculosis H37Rv genome and the position of the 
primers used to amplify from the outside of the cloned flanks of acr2 in the recombination vector, pSMT183, 
inward across the acr2 gene. Diagram (B) illustrates the genomic arrangement and PCR products after acr2 is 
replaced by the hyg gene.  BglII digestion of the putative acr2 gene replacement products give 3 restriction 
fragments of 2375bp, 1330bp and 656bp, confirmatory of gene replacement. 
acr2	 Rv0252	Rv0250c	Rv0249	
BglII	BglII	
2375bp	1330bp	
Rv0252	Rv0250c	Rv0249	
		
hyg	
656bp	
A	
B	
3711bp	 P23	P24	
P23	P24	 4361bp	
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Four transformants colonies were screened for acr2 deletion and an example PCR to 
demonstrate gene replacement in one colony is shown in Figure 42. This figure shows the   
4361bp PCR products indicative of gene replacement to make the M. tuberculosis H37Rv 
∆acr2 single mutant strain (lane 3) and M. tuberculosis H37Rv ∆acr1∆acr2 double mutant 
strain (lane 4). For comparison, PCR using WT M. tuberculosis H37rv (lane 1) and M. 
tuberculosis H37Rv ∆acr1 single mutant (lane 2) strains as template produced single 
products 3711bp, indicative of the presence of the acr2 gene.   
 
Figure 42. PCR screening for the acr2 gene deletion 
Gel (1% agarose, TAE) picture shows the PCR products amplified by using primers P23&P24 that were 
designed to anneal outside the flaking regions of the acr2 genes and amplify inwards across it. wild type M. 
tuberculosis H37rv (lane 1) M. tuberculosis H37rv ∆acr1 single mutant (lane 2) strains produced 3711bp PCR 
products which indicated the presence of the acr2 gene. Lanes 3 and 4 show 4361bp products which indicate 
the replacement of the acr2 gene with the hyg gene to produce the M. tuberculosis H37rv ∆acr2 single mutant 
(lane 3) and M. tuberculosis H37rv ∆acr1∆acr2 double mutant (lane 4) strains.  These are the same PCR 
products digested with BglII restriction enzyme shown  in Figure 43. 
 
To further confirm the gene replacement, the resulting PCR products were digested using 
BglII restriction enzyme which would produce different restriction fragments in wild-type 
and disrupted genomes  (Figure 41&Figure 43)  
The agarose electrophoresis in   (Figure 43). shows that the PCR products from the WT M. 
tuberculosis H37rv   (lane 1) and M. tuberculosis H37rv ∆acr1 single mutant (lane 2) strains 
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produced two BglII restriction fragments, however, three fragments are seen in lanes 3 and 
4 indicative of replacement of the acr2 gene to produce the M. tuberculosis H37rv ∆acr2 
single mutant and M. tuberculosis H37rv ∆acr1∆acr2 double mutant strains respectively. 
 
 
Figure 43. Confirmation of acr2 gene deletion by Bgl11 digest of PCR products 
encompassing the acr2 region 
Gel (1% agarose, TAE) picture shows the result of BglII digest of the PCR product of the region from outside 
of the acr2 gene flanks inward across the target gene. The PCR products from wild type M. tuberculosis H37rv 
(lane 1) and M. tuberculosis H37rv ∆acr1 single mutant (lane 2) strains produced two bands of 3705bp and 
656bp. The PCR products from the M. tuberculosis H37rv ∆acr2 single mutant (lane3) and M. tuberculosis 
H37rv ∆acr1 ∆acr2 double mutant (lane 4) strains produced three restriction fragments of 2375bp, 1330bp and 
656bp indicating the replacement of the acr2 gene with the hyg gene.  
  
The PCR products from M. tuberculosis H37rv ∆acr2 single mutant and M. tuberculosis 
H37rv ∆acr1∆acr2 double mutant strains were also sent for sequencing to further confirm 
the replacement of the acr2 gene with the hyg gene as well as to check for any undesired 
mutation that might have occurred in the surrounding sequence during the crossover process.  
The sequence has confirmed the replacement of the acr2 gene with the hyg gene and ruled 
out the presence of undesired mutation (Apendix 8.7). 
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5.1.2. Confirmation of the absence of α-crystallin expression in M. tuberculosis H37rv 
∆acr1, M. tuberculosis H37rv ∆acr2 and M. tuberculosis H37rv ∆acr1 by Western 
blotting 
  
The absence of α-crystallin protein in the mutant M. tuberculosis H37rv strains was tested 
by Western blotting using polyclonal antibodies to acr1 and acr2.  Therefore, one clone of 
each knockout mutant was grown in 20ml of 7H9 with 0.1% Tween 80 and 10% ADC until 
late log phase. The cultures were spun down and re-suspended in 1ml of sterile PBS followed 
by boiling for 10min before taken out of the Cat.3 laboratory. Cell lysates were prepared as 
described in the methods (2.9), proteins separated on 12% acrylamide gels by SDS-PAGE 
(2.11), transferred to PVDF membranes and probed with the respective primary antibodies 
(1 in 1000) followed by secondary HRP conjugated antibodies (1 in 10,000).  The 
chemiluminescent substrate used was ECL. a-crystallin 1 was not detected in M. 
tuberculosis  H37rv Δacr1 (Figure 44 A, lane 2) as well as in M. tuberculosis  H37rv Δacr1 
Δacr2  (Figure 44 A, lane 4) but was detected  in M. tuberculosis H37rv Δacr2  (Figure 44A, 
lane 3) and WT M. tuberculosis H37rv ( Figure 44A, lane 1). a-crystallin 2 was not detected 
in M. tuberculosis  H37rv Δacr2 ( Figure 44B, lane 2) nor was it detected in M. tuberculosis  
H37rv Δacr1 Δacr2  ( Figure 44B, lane 4) but detected  in M. tuberculosis H37rv Δacr1  
(Figure 44B, lane 3) and WT M. tuberculosis H37rv (Figure 44B, lane 1). This result further 
confirmed the successful gene replacement of the α-crystallins in their respective knockout 
mutants.   
  
   
 163 
  
Figure 44. Western detection of Acr1 and Acr2 in different knockout strains and WT 
M. tuberculosis H37Rv. 
(A) Western blot for Acr1 protein in WT M. tuberculosis H37rv (lane 1); M. tuberculosis H37rv Δacr1 (lane 
2); M. tuberculosis H37rv Δacr2 (lane 3); and M. tuberculosis H37rv Δacr1 Δacr2 (lane 4) 
(B) Western blot for Acr2 protein in WT M. tuberculosis H37rv (lane 1); M. tuberculosis H37rv Δacr1 (lane 
3); M. tuberculosis H37rv Δacr2 (lane 2); and M. tuberculosis H37rv Δacr1 Δacr2 (lane 4) 
 
5.1.3. Constructing acr1, acr2 and acr1&acr2 expression constructs for 
complementation of mutants strains 
The integrating mycobacterial plasmid, pKINTA, used in Chapter 3, was also the backbone 
plasmid the for expression of acr1, acr2 and both acr1 and acr2 to complement M. 
tuberculosis H37rv ∆acr1, M. tuberculosis H37rv ∆acr2 and M. tuberculosis H37rv ∆acr1 
∆acr2 strains. To construct the pK-acr1 construct, the acr1 gene with its putative promoter 
(596bp) was PCR amplified using primers P19&P20  (Table 3) containing SacI restriction 
enzyme sequences at both ends and non-directionally cloned into pKINTA at the SacI 
restriction site (Figure 45). To construct the pK-acr2 construct, the acr2 gene with its 
putative promoter (713bp: 219bp upstream, 480bp acr2 gene and 14bp downstream) was 
PCR amplified with primers P21&P22  (Table 3) containing NotI restriction enzyme 
sequences at both ends and non-directionally cloned into pKINTA at the NotI site (construct 
not shown). To construct the pK-acr1acr2 construct, the acr2 gene with its putative promoter 
was cloned at the NotI site in the pK-acr1 construct  (Figure 46)  Therefore, pK-acr1acr2 
has both α-crystallin genes each with its own putative promoter. The finished constructs 
were screened and confirmed by PCR and digestion with the relevant restriction enzymes 
(Figure 47). 
												1													2										3												4	 
A
H
								1																	2														3																		4	 B
H
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 Figure 45.  pK-acr1 construct  
Construct map showing the acr1 gene with its putative promoter cloned at SacI site. This construct was 
introduced into M. tuberculosis H37rv Δacr1 to compliment the acr1 deletion.    
  
  
Figure 46.  pK-acr1acr2 construct  
Construct map showing the acr1 and acr2 genes with their putative promoters cloned at the SacI and NotI sites 
respectively. This construct was introduced into M. tuberculosis H37rv Δacr1 Δacr2 to compliment the acr1 
and acr2 mutations.    
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Figure 47.  Confirmation of pk-acr1, pk-acr2 and pk-acr1&2 plasmid construction by 
restriction digest 
Gel (1% agarose, TAE) picture shows the screening result for the cloning of acr1 and acr2 with their native 
promoters into pKinta. The different constructs were digested with SacI alone (lane 3), Not I alone (lane 1) or 
SacI&NotI (lane 2) of pk-acr1 (lane 3) pK-acr2 (lane 1) and pk-acr1&acr2 (lane 2).  The fragments excised 
from the different constructs confirm the presence of right sized cloned fragments of acr1 and its native 
promoter (596bp) in pk-acr1, acr2 and its native promoter (713bp) in pk-acr2 and acr1&acr2 (double band) 
in pk-acr1&acr2. The top fragments (4870bp) are the pKinta backbone.  
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5.1.4. Confirming the reconstitution of α-crystallin expression in M. tuberculosis 
H37rv ∆acr1, M. tuberculosis H37rv ∆acr2 and M. tuberculosis H37rv ∆acr1&2 
respective complemented strains 
 
PCR screening was used to confirm the integration of the integrative plasmids carrying the 
respective α-crystallin genes into the attB site to restore the function of the deleted native 
genes. Following successful electroporation with pK-acr1, pK-acr2 and pK-acr1acr2, the 
transformants were selected (Kanamycin resistant) and grown in broth to late log phase 
before collection of cells, lysis and SDS-PAGE and Western blotting as in (2.11). Expression 
of α-crystallin 1, as it is shown in Figure 48 was restored in M. tuberculosis  H37rv Δacr1 
comp (lane 3) & M. tuberculosis H37rv Δacr1 Δacr2 comp (lane7), whereas it was absent 
in the knockout strains  M. tuberculosis H37rv Δacr1 and M. tuberculosis H37rv Δacr1 
Δacr2 (lane 2 & 6) respectively 
  
 
Figure 48: Western blot detection of Acr1 showing complementation of Acr1 
expression in null mutants. 
 Acr1 expression is restored in M. tuberculosis H37rv Δacr1 comp, which carries pKacr1, (lane 3) and in M. 
tuberculosis H37rv Δacr1 Δacr2 comp, which carries pKacr1acr2 (lane 7). Acr1 is absent in the empty 
knockout strains (M. tuberculosis H37rv Δacr1, lane 2 & M. tuberculosis H37rv Δacr1 Δacr2, lane 6).  Wild 
type H37rv lane 1 and M. tuberculosis H37rv Δacr2 (lane 4) M. tuberculosis H37rv Δacr2 comp (pKacr2) 
(lane 5).   
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Western blotting  (Figure 49) also confirmed the successful expression of α-crystallin 2 in 
the respective strains M. tuberculosis H37rv Δacr2 comp (lane 4) and M. tuberculosis H37rv 
Δacr1Δacr2 comp (lane 6) which carry pKacr2 and pKacr1acr2 complimenting constructs 
respectively.  
 
 
Figure 49. Western blot detection of Acr2 showing complementation of Acr2 
expression in null mutants. 
Acr2 protein was detected in acr2 mutant strains which had been complemented with the pkacr2 and 
pkacr1acr2 constructs (M. tuberculosis H37rv Δacr2 comp lane 4 & M. tuberculosis H37rv Δacr1Δacr2 comp 
lane 6). Acr2 immunoreactivity was absent in the respective empty knockout strains (M. tuberculosis H37rv 
Δacr2 lane 5 & M. tuberculosis H37rv Δacr1Δacr2 lane 7).  Wild type M. tuberculosis (lane 1); M. tuberculosis 
H37rv Δacr1 (lane 2); M. tuberculosis Δacr1 pKacr1 (lane 3).   
 
The expression of alpha crystalline 2 in the double complimentary strain M. tuberculosis 
H37rv Δacr1Δacr2 comp (Figure 49) is not as strong as alpha-crystalline 1 in the M. 
tuberculosis H37rv Δacr1Δacr2 comp (Figure 49).  This level of expression may not be 
enough to restore the function of the native acr2 in stress conditions.  
 
 
 
  
   
 168 
5.2 Growth of the α-crystallin mutants in shaken broth culture 
 
To investigate the effect of the loss of one or both genes on the growth of the different 
mutants in comparison to the wild type, two biological replicates of each strain were 
inoculated into 7H9 containing 10% ADC and 0.1% Tween80. An OD 600 reading and 
samples for viability counting were taken at certain time points during a three weeks’ period. 
As seen in the OD growth curve (Figure 50),  M. tuberculosis H37rv Δacr2 has similar 
growth as the WT M. tuberculosis H37Rv.   However, M. tuberculosis H37rv Δacr1 and M. 
tuberculosis H37rv Δacr1Δacr2  have  a slower growth curve which plateaus at a much lower 
OD value (Figure 50). 
 
 
Figure 50. Growth curve (OD 600) of WT M. tuberculosis H37rv and α-crystallin knockout mutants 
grown in 7H9 containing 10% ADC and 0.1% Tween80. Two biological replicate for each 
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Although there is a distinctive difference in the shape of   M. tuberculosis H37rv Δacr1 and 
M. tuberculosis H37rv Δacr1Δacr2 OD growth curve from the WT M. tuberculosis H37rv 
and M. tuberculosis H37rv Δacr2, the strains appear to have similar growth when assessed 
by viability count   Figure 51. It has previously been reported that the M. tuberculosis 
H37RvΔacr1 has the same growth rate as the wild type M. tuberculosis H37rv (Yuan et al., 
1998).  Therefore, the observed slow OD growth curve shape could be misleading and may 
be the result of high aggregation as a result of the loss of a-crystallin 1. 
 
Figure 51. Growth curve (viability assessed by cfu) of WT M. tuberculosis H37rv and α-crystallin 
knockout mutants grown in 7H9 containing 10% OADC and 0.1% Tween80. Two biological replicate 
for each. 
 
If the acr1 mutant strains are more aggregative (clumpy) than the other strains including the 
WT M. tuberculosis H37Rv, further phenotypic experiments involving quantitative 
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assessment of bacterial numbers may be affected. Therefore, it is necessary to take into 
account such possibility when interpreting the experiments in this chapter.  
  
5.3  Heat Shock resistance of the acr1, acr2 and acr1acr2 mutant M. 
tuberculosis H37Rv 
 
 
This experiment tested for the effect of the loss of one or both acr genes on the ability of the 
mutant to resist killing by heat in comparison to the wild-type. The different strains were 
grown to mid log phase and the OD adjusted to 0.2 for all of them. Each culture was split 
into two duplicates of 1ml for each time point.  This means for each sampling point two 
tubes for each strain were removed from the water bath, sampled and then discarded. This 
was done to enable sampling without affecting the culture temperature during the process 
and also to minimize the risk of culture contamination via repeated sampling.   It was not 
possible to process more than duplicate samples for each strain at each time point. It was 
noted that any delay in plating by putting the samples on ice to enable more replicates to be 
processed resulted in great variation in the replicates dependent on how long the samples 
had rested on ice. However, despite the absence of statistical analysis, it was clear that the 
strains lacking, M. tuberculosis H37rv Δacr1 and M. tuberculosis H37rv Δacr1Δacr2 were 
less heat resistant than WT M. tuberculosis H37rv or the acr2 mutant. Indeed 60 minutes at 
53ºC resulted in 3-4 log reduction in the M. tuberculosis H37rv or the acr2 mutant strains 
but a complete 7 log kill of the acr1 deficient strains (Figure 52)  
   
 171 
 
Figure 52. Heat resistance M. tuberculosis H37rv a-crystalline mutants 
The different strains were incubated for two hours in 53oC. A sample was taken at different time points 
for viability count by plating on 7H11 media and counting cfu after 21 days. Two technical replicate for 
each. Error bars show the standard error of the mean. The threshold of detection is 167 cfu/ml 
 
The acr1 gene is not inducible by heat and M. tuberculosis H37rv Δacr1 has previously been 
shown to have the same survival after 2hrs in 55oC as the wild type (Hu et al., 2006).  
However, the temperature Hu et al used in their experiment is 2oC higher than the 
temperature (53oC) used in this study and thus the present study may have detected a more 
subtle difference.  The α-crystallin 2 has been purported to protect M. tuberculosis H37rv 
from heat (Ohara et al., 1997) and is highly induced when M. tuberculosis H37rv is subjected 
to a heat shock of 45oC for 30minutes (Stewart et al., 2002b). Thus, it was surprising that 
the M. tuberculosis H37rv Δacr2 strain had wild-type resistance to heat. 
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5.4  H2O2 stress response of the acr1, acr2 and acr1acr2 mutant M. 
tuberculosis H37Rv 
 
The different strains were grown in 7H9 broth containing 10% ADC and 0.1% Tween80 to 
mid-log phase. The cultures were adjusted to OD 0.4 and washed once with sterile water to 
remove any residual growth media and were re-suspended in sterile water with the same 
starting OD. 100µl of the washed re-suspended cells were added to a set of 1ml tubes of 
Roisin’s medium containing 0mM, 10mM or 20mM freshly prepared H2O2 for each strain 
in triplicate. After incubation for 2hrs at 37oC without shaking, a sample was taken from 
each tube and serially diluted for viable count. 
 
As shown  in Figure 53, there is variability between the strains in the cfu number retrieved 
from incubation in medium alone (0mM), ranging from 1x105- 3x105 cfu/ml, which might 
be due to the fact that there is some difference in aggregation between the strains. Apart from 
the M. tuberculosis H37rv Δacr2 and its complement, 10mM H2O2 induced significant 
killing in all strains (p 0.0001). This is most clearly seen  in Figure 54 which shows 
percentage survival in the different H2O2 concentrations. Survival of wild type M. 
tuberculosis H37Rv, M. tuberculosis H37rv Δacr1 and M. tuberculosis H37rv Δacr1Δacr2, 
M. tuberculosis H37rv Δacr1 comp, M. tuberculosis H37rv Δacr1Δacr2 was reduced by 
80% but M. tuberculosis H37rv Δacr2 and its complemented strain were only reduced by 
70-80%.  
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Figure 53. H2O2 resistance of M. tuberculosis H37RV  a-crystallin mutants 
Wild type M. tuberculosis H37Rv, M. tuberculosis H37rv Δacr1, M. tuberculosis H37rv Δacr2 and M. 
tuberculosis H37rv Δacr1Δacr2 and their complemented strains were grown to mid log phase, washed and 
diluted to an OD of 0.4 The different strains were incubated for two hours in 0mM 10mM and 20mM H2O2. 
A sample was taken at different time points for viability counting on 7H11 media. Three biological replicates 
for each.  Error bars represent standard error of the mean of three independent replicates. Statistical significance 
was assessed by Tukey’s multiple comparisons test. 
 
This result disagrees however with Stewart et.al (2006) who previously reported that the loss 
of the acr2 gene rendered the knockout strain to be more susceptible to oxidative stress when 
subjected to 1mM and 10mM for 8hours. This difference may reflect the different parental 
strain used in these experiments or the different H2O2 concentrations and exposure times. 
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The elevated resistance of the M. tuberculosis H37rv Δacr2 and its compliment in the present 
experiment may indicate that a secondary mutation has been selected for during deletion of 
acr2 and that this overcompensates for any stress related functional deficiency in the 
oxidative stress response. This explanation is further supported by the observation that 
deletion of the acr2 gene in the acr1 mutant background does not increase resistance to H2O2. 
Further evidence to support the theory that the single acr2 mutant has acquired a secondary 
mutation would require genome sequencing of the parent strain and acr2 mutant, but this is 
beyond the scope of the present study. 
 
At the higher concentration of 20mM H2O2, there was a slightly higher percentage level of 
killing and no significant difference between strains except for the M. tuberculosis H37rv 
Δacr2 complement which survived at significantly higher levels than the wild-type ( Figure 
54) 
  
Deletion of the acr1 gene had no effect on resistance to H2O2.  M. tuberculosis H37rv Δacr1  
had the same resistance/survival rates as wild type M. tuberculosis  H37rv (Figure 54). This 
is in agreement with a previous study which reported that deletion of acr1, which is not 
induced by H2O2 (Hu et al., 2006), did not significantly increase the sensitivity to H2O2 in 
comparison to wild type M. tuberculosis H37rv (Yuan et al., 1998).    The most important 
question for this study was whether deletion of both a-crystallins had a cumulative or 
synergistic effect on resistance. The double mutant strain showed the same sensitivity to 
H2O2 as the wild-type M. tuberculosis H37rv (Figure 54) (Hu et al., 2006) 
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Figure 54. Percentage survival of M. tuberculosis H37RV a –crystallin mutants in 
H2O2  
Wild type M. tuberculosis H37Rv, M. tuberculosis H37rv Δacr1, M. tuberculosis H37rv Δacr2 and M. 
tuberculosis H37rv Δacr1Δacr2 and their complemented strains were grown to mid log phase, washed and 
diluted to an OD of 0.4 The different strains were incubated for two hours in 0mM 10mM and 20mM H2O2. A 
sample was taken at different time points for viability counting on 7H11 media. Survival is shown as percentage 
of survival for each strain in Roisin’s medium alone. Three biological replicate for each.  Error bars represent 
standard error of the mean of three independent replicates. Statistical significance was assessed by Tukey’s 
multiple comparisons test. 
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5.5  Resistance to low pH in acr1, acr2 and acr1acr2 mutant M. 
tuberculosis H37Rv 
The different strains were grown in 7H9 broth containing 10% ADC and 0.1% Tween80 to 
mid-log phase. The cultures were adjusted to OD600 0.4 and washed once with sterile water 
to remove any residual growth media and resuspended in sterile water with the same starting 
OD. 100µl of the washed resuspended cells were added to a set of 1ml aliquots of Roisin’s 
medium pH adjusted to 4.4 or 6.6 for each strain in triplicate. After static incubation for 7 
days at 37oC, a sample was taken from each tube and serially diluted for viable cell counting. 
The growth of different strains indicated by the increase in the cfu count after 7 days  (Figure 
55) of incubation from the input cfu count suggest the medium at pH6.6 is supportive for 
their growth.  
 
 Figure 56 shows the percentage survival of the α-crystallin mutants. Statistically there was 
no difference between the survival of the strains in pH4.4 after 7days of incubation. 
However, there appeared to be a trend towards the M. tuberculosis H37rv Δacr2 and M. 
tuberculosis H37rv Δacr1Δacr2 having a higher percentage of survival in comparison to the 
wild type M. tuberculosis H37Rv, M. tuberculosis H37rv Δacr1, and their respective 
complements.  There was no trend towards any change in acid resistance in the single acr1 
mutant, which is in agreement with previous studies (Hu et al., 2006). Thus, the deletion of 
acr2 again seems to induce compensatory changes which increase resistance. In this case, 
they are reversed by complementation which restored the wild type sensitivity to low pH 
stress. 
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 Figure 55. Acid pH resistance of M. tuberculosis H37rv a-crystalline mutants 
Growth/survival of wild type M. tuberculosis H37Rv, M. tuberculosis H37rv Δacr1, M. tuberculosis H37rv 
Δacr2 and M. tuberculosis H37rv Δacr1Δacr2 and their complemented strains in different pH. The different 
strains incubated in Roisin’s medium at pH 6.6 and 4.4 for 7days and cell viability assessed by plating on 7H11 
and counting cfus. Three biological replicates for each. Error bars represent standard error of the mean of three 
independent replicates. Statistical significance was assessed by Tukey’s multiple comparisons test. 
  
 
 Figure 55 shows that the acidic pH of 4.4 has an effect on the survival of M. tuberculosis 
H37rv reducing the viable count of all strains in comparison to their input counts and their 
viability at pH6.6.  
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Figure 56. Percent survival of M. tuberculosis H37rv a–crystallin mutants in acid 
stress 
Growth/survival of wild type M. tuberculosis H37Rv, M. tuberculosis H37rv Δacr1, M. tuberculosis H37rv 
Δacr2 and M. tuberculosis H37rv Δacr1Δacr2 and their complemented strains in different pH. The different 
strains incubated in Roisin’s medium at pH 6.6 and 4.4 for 7 days and cell viability assessed by plating on 
7H11 and counting cfus. Survival is shown as percentage of the input count for each strain. Three biological 
replicates for each. Error bars represent standard error of the mean of three independent replicates. Statistical 
significance was assessed by Tukey’s multiple comparisons test. 
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5.6  Intracellular phenotype of acr1, acr2 and acr1acr2 mutant M. 
tuberculosis H37rv in THP-1 macrophages. 
Macrophages play a significant role in the defence against M. tuberculosis H37rv infection 
and at the same time M. tuberculosis H37rv has adapted to overcome the killing mechanisms 
it faces within the macrophages.  The human acute monocytic  leukemia cells (THP-1) which 
are used in this study are one of many model cell lines used to study in vitro the host cell-M. 
tuberculosis H37rv interaction and they are considered to be a good model of a peripheral 
blood monocyte (Theus et al., 2004). The THP-1 cells were grown in RPMI 1640 medium 
supplemented with 10% FCS, 10mM L-glutamine and 10mM pyruvate in 5% CO2 at 37oC 
for 4 days.  A concentration of 106 ml-1 THP-1 cells was adjusted to the required volume of 
RPMI containing 100ng ml-1 PMA and added to 96 well plates to give about 2x105 cells per 
well. The cells then incubated for 3 days to differentiate and adhere to surface of the well to 
produce a monolayer.  The cells were then washed three times with warm RPMI and infected 
with the different M. tuberculosis H37rv strains diluted in warm RPMI (with10% FCS, 
10mM L-glutamine and 10mM pyruvate) medium at an MOI of 0.1 and incubated in 5% 
CO2 at 37oC for the required period of time. Different plates were set up for different time 
points of 2hrs, 24hrs, 48hrs and 7 days. At each time point the respective plate was taken out 
of the incubator, all the wells were washed with warm PBS then 3 wells were assessed for 
CFU counts. Additionally, three infected wells and 6 uninfected wells were fixed with 4% 
formaldehyde and stained with crystal violet to determine the number of macrophage cells 
present at each time point and to assess the level of bacterial induced cytotoxicity.  
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Figure 57: Intracellular survival of M. tuberculosis H37rv α-crystallin mutants in THP-
1 macrophages 
Viable bacterial counts from THP-1 macrophages infected at MOI of 0.1 with M. tuberculosis H37Rv, M. 
tuberculosis H37rv Δacr1, M. tuberculosis H37rv Δacr2 and M. tuberculosis H37rv Δacr1Δacr2 and their 
complemented strains. Three technical replicate for each.  Error bars represent standard error of the mean of 
three independent replicates. Statistical significance was assessed by Tukey’s multiple comparisons test. 
  
  
   
 181 
As indicated in  Figure 57 there was no statistically significant difference between the strains 
in CFU count after 2hrs of incubation, which represents the time allowed for phagocytosis. 
However, by eye it appears that the M. tuberculosis H37rv Δacr1 and M. tuberculosis H37rv 
Δacr1Δacr2 strains have been taken up in higher amounts compared to other strains.  This 
could represent a difference in the inocula or a difference in the efficiency of phagocytosis 
of these strains. The viable/CFU count of all the strains increased significantly after 24 hrs 
and remained almost the same at 48 hrs post-infection.  The M. tuberculosis H37rv Δacr1 
and M. tuberculosis H37rv Δacr1Δacr2 were present in significantly higher loads than the 
wild-type at both 24 and 48 hrs post-infection but at 84 hrs were significantly lower than the 
wild-type. There was no significant difference between the complemented mutant strains 
and the wild-type at any time point.  There was no significant difference between the M. 
tuberculosis H37rv Δacr2 and its complemented strain at any time point. Thus, mutants 
defective in the acr1 gene, either as a single mutant or as a double with acr2 deletion, had 
an enhanced intracellular survival over the first 48 hours which then crashed by 84 hours to 
levels below the WT M. tuberculosis H37Rv. These results are partially consistent with a 
previous study which showed that M. tuberculosis H37rv Δacr1 has been reported to have 
the same infectivity but substantial reduction in CFU count compared to the wild type after 
10 day of THP-1 infection (Yuan et al., 1998).  Also, in monocyte derived macrophages 
(MDM) M. tuberculosis H37rv Δacr2 the growth was the same as wild-type up to day 4 post-
infection (Wilkinson et al., 2005).  
 
To examine deeper into the dynamics of the intracellular growth of the α–crystallin mutants, 
we assessed the number of macrophages remaining in the monolayers throughout the 
experiment (Figure 58). There was no significant difference between the number of 
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macrophages in the different strain infections at 2, 24 0r 48 hrs post-infection. However, 
there was considerable cytotoxicity by 84 hrs. There was less cytotoxicity in macrophages 
infected with the acr2 mutant strain compared to those infected with wild-type M. 
tuberculosis. Wild-type cytotoxicity was not recovered in M. tuberculosis H37rv Δacr2 
infected cells by reintroduction of acr2 in the complemented strain. The complemented M. 
tuberculosis H37rv Δacr1Δacr2 strain also showed reduced cytotoxicity. This may indicate 
that α–crystallin 2 is required for M. tuberculosis to express full cytotoxicity. This phenotype 
is not simply reflective of an altered bacterial load because the M. tuberculosis H37rv Δacr2 
load was equivalent to WT M. tuberculosis H37rv throughout the infection. The inability of 
the complementing construct to restore this cytotoxic effect may be due to the only partial 
restoration of Acr2 expression in the complemented strains (Figure 49, lanes 4 and 6). 
Indeed, partial complementation using a similar integrating Acr2 expression construct has 
been observed before by Stewart et.al (2006). 
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Figure 58. Cytotoxicity of infection THP-1 macrophages infected with M. tuberculosis 
H37rv α-crystallin mutants. 
Number of THP-1 macrophages assessed by crystal violet staining in in vitro infections at MOI of 0.1 with M. 
tuberculosis H37Rv, M. tuberculosis H37rv Δacr1, M. tuberculosis H37rv Δacr2 and M. tuberculosis H37rv 
Δacr1Δacr2 and their complemented strains. Three technical replicate for each.  The error bars are the standard 
error of the mean of three independent replicates. 
  
   
 184 
5.7  Growth/survival of acr1, acr2 and acr1acr2 mutant M. tuberculosis 
H37rv in hypoxia/microaerophilic conditions 
The in vivo environment presents M. tuberculosis H37rv with a number of different stressful 
conditions, one of which is hypoxia which can occur inside the tubercle lesion or granuloma 
(Duque-Correa et al., 2014; Qualls and Murray, 2016). Hypoxic conditions are inimical to 
mycobacterial replication but M. tuberculosis H37rv has adapted to persist in this 
environment and become, so called, non-replicating persisters (NRP) (Fattorini et al., 2013). 
This adaptation involves the regulation of many genes including those involved in stress 
responses and metabolism and includes many prominent antigens. One of the many genes 
which is strongly induced by hypoxia is the acr1 gene encoding the heat shock (HspX) 
protein, which is regulated as part of the DosR regulon (Sherman et al., 2001; Tabira et al., 
1998; Voskuil et al., 2004; Yuan et al., 1998). Interestingly, acr2 which is not part of the 
DosR hypoxic response, is also upregulated during non-replicating persistence  (Stewart et 
al., 2005). Thus, it was chosen to study the functional role of α-crystallins in hypoxia by 
examining the survival of the acr deficient mutants under in vitro hypoxic conditions. 
 
Due to technical difficulty, it was not possible to employ the in vitro hypoxia model used by 
Wayne (Wayne and Hayes, 1996) in this study. Therefore, a modified method was used were 
sterile mineral oil was used to overlay static broth cultures to prevent oxygen dissolving in 
the culture during incubation and thus microaerophilic/hypoxic conditions would 
progressively develop. The different strains of M. tuberculosis H37rv were grown to mid-
log phase in 7H9 medium containing 10% ADC and 0.1% Tween80 at 37oC shaking. After 
adjusting all the cultures to the same OD, 1ml aliquots were distributed into 2ml O-ringed 
tubes in triplicates for each sampling time. To each tube 0.5ml of sterile mineral oil was 
layered on top of the 1ml of the culture and incubated at 37oC. Tubes were only sampled 
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once to avoid aeration of cultures. Methylene blue indicator at concentration of 1.5µgml-1 
was used as an indicator of oxygen depletion in one replicate of each strain culture and in a 
medium only control. The blue colour should disappear in the absence of oxygen.  Figure 59 
shows that the blue colour in the culture tubes was significantly less intense than in the 
medium alone tube, indicating that there was a level of oxygen depletion in the bacterial 
cultures but that it did not reach 100% oxygen depletion.  It may be that the static conditions 
of the culture did not encourage sufficient bacterial growth to deplete the oxygen levels fully. 
The Wayne model uses stirred cultures to overcome this issue but due to the technical 
difficulty it was not possible to perform this in this experiment. Thus the bacilli which were 
sedimented at the bottom of the tube were present in a microaerophilic environment at which 
the first sage NRP-1 may have occurred but, it was probably not sufficient to exert the stress 
that might trigger the bacilli to enter dormancy and NRP-2 stage. For the bacilli to enter the 
microaerophilic non replicating persisters  (NRP) stage 1 the oxygen content of the solution 
should drop below 1% (Wayne, 2001) and if the level of the dissolved oxygen drops below 
0.06% the NRP-2 stage occurs (Wayne and Hayes, 1996). As it was not technically possible 
to quantify the amount of the dissolved oxygen in this experiment, it is not possible to 
directly compare the results in this experiment with the NRP model reported by Wayne.  
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Figure 59: Methylene blue indication of oxygen depletion 
Tube (1) contains just sterile 7H9 media, tubes 2,3,4&5 contain 1ml of WT M. tuberculosis H37Rv, M. 
tuberculosis H37rv Δacr1, M. tuberculosis H37rv Δacr2 & M. tuberculosis H37rv Δacr1 Δacr2 cultures 
respectively at day 30. The difference in colour between tube 1 and the rest of the tubes indicate that most of 
the oxygen has been consumed by the living bacteria but, 100% oxygen depletion was not achieved. 
 
All the bacterial strains grew significantly during the first 10 days of culture in the oil-
overlayed broths. At this 10 day time point, all three acr mutant strains had a significantly 
lower number of bacteria, as measured by cfu/ml, compared to the wild type M. tuberculosis 
H37rv (p<0.001) (Figure 60). By 20 days only the acr1 mutant strain had a lower number of 
bacteria than the wild-type. Between 20 and 30 days, there was a significant reduction in the 
number of bacteria in all cultures (1.5-2 log) and there was no difference in survival between 
the strains at this time point. This experiment was repeated (Appendix 8.4) and the result 
was confirmed that there was no statistically significant difference in survival between the 
different strains after 30 days of incubation. Therefore, it can be concluded that neither acr1 
nor acr2 are essential for survival in non-replicating microaerophilic culture. 
1														2												3										4										5	 
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Figure 60: Growth/survival of M. tuberculosis H37rv α-crystallin mutants in 
microaerophilic culture 
The graph shows the result of microaerophilic/hypoxia stress on the different M. tuberculosis H37rv strains. 
The different M. tuberculosis H37rv strains were grown in 7H9 containing 10% ADC and 0.1% Tween80 until 
mid-log phase. The cultures were adjusted to the same OD. Replicate 1 ml volumes of the respective cultures 
were distributed into 2ml O-ringed screw capped tubes and layered with 0.5ml of sterile mineral oil.  The tubes 
were incubated still at 37oC for 30 days. Results show the mean of triplicate cultures at each time point. Error 
bars represent standard error of the mean of three independent replicates. Statistical significance was assessed 
by Tukey’s multiple comparisons test. 
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5.8 Discussion 
 
In this chapter, the acr2 gene was successfully deleted from WT M. tuberculosis to produce 
a M. tuberculosis H37rv Δacr2 single knockout mutant and from M. tuberculosis H37rv 
Δacr1 to produce the M. tuberculosis H37rv Δacr1Δacr2 double knockout mutant. The 
knockout of acr2 gene from the respective mutant was successfully confirmed by PCR, 
restriction enzyme digest of the PCR product and sequencing.  The deletion of acr1 was also 
verified by PCR. Further to this, Western blotting was used to confirm the absence of Acr1 
and Acr2 proteins from the respective mutant bacteria. The complementation of the 
respective genes in the knockout strains was also successfully confirmed by Western blotting 
although wild-type levels of expression were not achieved. 
 
M. tuberculosis H37rv Δacr2 had a similar growth curve to wild type in 7H9 broth when 
assessed by optical density. In contrast the M. tuberculosis H37rv Δacr1 and the double 
mutant M. tuberculosis H37rv Δacr1Δacr2 had an apparently slower than the wild-type 
growth, reaching a lower optical density.  However, this difference was not observed in the 
viable colony count growth curve in which all the strains showed similar growth kinetics.  
Our findings by optical density are in agreement with a previous study in which deletion of 
acr1 was reported to have slower growth than the wild type parent strain (Yuan et al., 1998).  
The similarity between growth of all the strains assessed by viability count may suggest that 
the loss of acr1 causes a change in the aggregation of the cells which results in the absence 
of correlation between cfu and optical density. Although this was not confirmed 
experimentally and also the growth curve for the complement strains was not done, it should 
be taken into consideration when interpreting the results of other in vitro stress conditions 
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experiments.  Most relevant to the aim of this chapter was the observation that there was no 
additive or synergistic effect of deleting both α–crystallins. Thus we can conclude that the 
chaperones do not have an essential but redundant function for normal growth.  
 
The M. tuberculosis H37rv Δacr1 and M. tuberculosis H37rv Δacr1Δacr2 strains were more 
sensitive to heat than WT M. tuberculosis H37rv or the single Δacr2 mutant. This is 
indicated by a 7 log reduction in cfu of single Δacr1 and the double Δacr1Δacr2 mutants 
compared to a 3-4 log reduction in cfu observed in wild type and single Δacr2 mutant at 53 ͦ 
C.  This is perhaps surprising given the published data that acr1 is not inducible by heat and  
a mutant was shown to have the same sensitivity to heat stress, albeit a higher temperature 
(Hu et al., 2006) whereas, acr2 is massively induced by heat (Stewart et al., 2005). One 
explanation for the enhanced sensitivity of the acr1 mutant is that it functions to control 
protein aggregation in the cytoplasm, as indicated by its localisation in the previous chapter, 
whereas Acr2 is only present in the cell wall. If in the short term, protein aggregation in the 
cytoplasm is more detrimental to cell viability than aggregation outside of the cell in the cell 
wall, then an absence of constitutive Acr1 may lead to a greater heat sensitivity than an 
absence of Acr2. Once again, the double mutant had no additive loss of fitness in this 
condition indicating that the chaperones do not perform essential but redundant roles during 
heat stress. 
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The M. tuberculosis H37rv response to oxidative stress is complex and it uses wide range of 
molecules to either detoxify ROI and RNI before they cause stress or by repairing the 
damage they cause (Sandgren et al., 2009). There are various proteins including AhpC, 
superoxide dismutase (SOD), KatG, Mel2, Rv2136c, Rv224c, PonA2, Acr1 and Acr2 that 
directly or indirectly are necessary for M. tuberculosis complex (MTBC) species to survive 
the oxidative and nitrosative stresses.  Rv2136c, Rv224c, PonA2 are thought to contribute 
to the cell wall integrity which may suggest that the mycobacterial lipid-rich cell envelope 
may act as an effective barrier against the entry of RNI and ROI (Forrellad et al., 2013). In 
this study, M. tuberculosis H37rv  Dacr2 and its complement showed significantly increased 
survival (p 0.0001) in H2O2 compared to the other tested strains.  This contrasts with previous 
reports that the loss of acr2  increased the susceptibility of M. tuberculosis H37rv  to 
oxidative stress (Stewart et al., 2006)  Again the experimental conditions, concentration of 
H2O2, the strains used and the length of exposure time may explain these different findings. 
Alternatively, this may suggest that M. tuberculosis H37rv Δacr2 in this study may have 
acquired some kind of compensatory mutation during the process of deleting acr2, which is 
also observed in the   response of its complement strain. Such a theory is partially supported 
by the fact that the double Δacr1Δacr2 mutant is not more resistant to oxidative than the 
single Δacr1. The confirmation of a secondary mutation will require genome sequencing of 
the parent strain and acr2 mutant (not performed in this study).  
 
M. tuberculosis H37rv can resist phagosomal pH  and it was reported to have survived pH 
4.5 in a simple buffer in vitro (Vandal et al., 2008). However, the interpretation of 
Mycobacteria resistance to acid in in vitro experiments is complicated. This is because the 
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survival of the bacteria in acid is dependent on culture conditions including bacterial density 
and composition of the media being used (Bodmer et al., 2000; Sung and Collins, 2003; 
Vandal et al., 2009). The optimal growth pH in liquid medium for M. tuberculosis H37Rv 
reported to between a bout 6.2- 7.3 (Chapman and Bernard, 1962) and its growth is inhibited 
below pH5.5 (Heifets and Iseman, 1985).  In this study, all the strains tested showed 
sensitivity to the acid pH4.4 which was indicated by reduction of the cfu in comparison to 
the input number. Although there is no statistical significant difference in the response to the 
acid pH, there is a trend of more resistance by M. tuberculosis H37rv Δacr2 and M. 
tuberculosis H37rv Δacr1Δacr2 mutants observed by naked eye. This trend was not 
observed in the respective complementary strains. This is surprising but consistent with the 
occurrence of compensatory physiological adaptations to the loss of Acr2. Once again, it is 
noteworthy that there are no synergistic or additive effects of deletion of both α–crystallins. 
 
Hypoxia is one of  the stresses that M. tuberculosis H37rv is facing within the  tubercle lesion 
or granuloma (Duque-Correa et al., 2014; Qualls and Murray, 2016). M. tuberculosis H37rv 
is able to evade such detrimental hypoxic condition by halting their replication and become 
non-replicating (NRP) persisters (Fattorini et al., 2013). HspX protein encoded by acr1 
which part of the DosR regulon and highly induced hypoxia  (Sherman et al., 2001; Tabira 
et al., 1998; Voskuil et al., 2004; Yuan et al., 1998). Although acr2 is not  part of the DosR 
hypoxic response, is also upregulated during non-replicating persistence  (Stewart et al., 
2005). It was thus of great interest to examine the phenotype of the α–crystalline mutants in 
hypoxic of microaerophilic non-replicating culture.  
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In this study the acr deficient mutants were grown in hypoxic conditions modified from the 
Wayne in vitro hypoxia model (Wayne and Hayes, 1996) due to technical constraints. The 
modification applied did not allow the 100% depletion of oxygen as indicated by presence 
of the methylene blue oxygen depletion indicator colour which should decolourise in the 
event of 100% absence of oxygen. However, there was a degree of hypoxia achieved and the 
replication of bacteria was inhibited in the cultures.  It seems likely that the bacilli 
sedimented at the bottom of the tube were present in microaerophilic conditions sufficient 
to cause the bacilli to enter the non-replicating persistence, NRP-1, stage. However, such a 
microaerophilic environment may not be sufficient to cause the bacilli to enter NRP-2 stage.  
For the bacilli to enter the microaerophilic non replicating persisters  (NRP) stage 1 the 
oxygen content of the solution should drop below 1% (Wayne, 2001) and if the level of the 
dissolved oxygen drops below 0.06% the NRP-2 stage occurs (Wayne and Hayes, 1996). As 
it was not technically possible to quantify the amount of the dissolved oxygen in this 
experiment, it is not possible to directly compare the results in this experiment with the NRP 
model reported by Wayne.  
 
All the bacterial strains grew significantly during the first 10 days of culture. Between 20 
and 30 days, there was a significant reduction in the number of bacteria in all cultures (1.5-
2 log) and there was no difference in survival between the strains at this time point. This 
experiment was repeated (Appendix 8.4) and result was confirmed that there was no 
statistically significant difference in survival between the different strains after 30 days of 
incubation. Therefore, it can be concluded that neither Acr1 nor Acr2 are essential for 
survival in non-replicating microaerophilic culture and that they do not confer redundant 
function in providing for survival in this condition. 
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In summary, except for Acr1 in heat shock, deficiency of neither α-crystallin was important 
for survival in any of the stress conditions tested and no redundancy in function was detected 
in which the presence of at least one α-crystallin could compensate for loss of the other and 
the loss of both engendered a weakened phenotype. In retrospect, the obvious omission from 
these experiments was the inclusion of a cell wall specific stress such as a detergent or 
surfactant. These are known to induce expression of Acr2 specifically via SigE and MprA/B 
and given the knowledge from chapter 4 that Acr2 is localised almost exclusively in the cell 
wall, it could be postulated that there would be a detectable phenotype in cells deficient in 
Acr2. Investigating if Acr1, with its lesser localisation in the cell wall, could compensate for 
any sensitivity to cell surface stress would be an important experiment. 
 
There have been contradictory reports about the importance of α-crystallins to M. 
tuberculosis during infection of host cells. In the present experiment, loss of acr1 in both the 
single mutant and in combination with deletion of acr2 led to an elevated bacterial load at 
24hr and 48hrs. However, consistent with previous studies (Yuan et al., 1998) the mutants 
lacking Acr1 survived less well than wild-type bacteria at the later stage of infection (84 
hours). This contrasted with the Δacr2 mutant which survived equally as well as wild-type 
throughout the experiment. Arguably the most interesting observation was that the Acr2 
deficient strain, despite an equal bacterial load, caused less host cell cytotoxicity than the 
WT M. tuberculosis H37Rv.  These results are consistent with a previous study which 
showed that in MDM M. tuberculosis H37rv Δacr2 growth was the same as wild-type up to 
day 4 post-infection (Wilkinson et al., 2005). Also, the reduced cytotoxicity is consistent 
with the altered pathology in murine infections with M. tuberculosis H37rv Δacr2 which 
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resulted in a reduction in disease symptoms despite similar bacterial load (Stewart et al., 
2005). 
  
Taken together, the experiments performed in Chapters 4 and 5 strongly indicate that the 
two α-crystallins of M. tuberculosis have different functions: they are localised in different 
parts of the cell and their individual deletion confers different phenotypes during 
macrophage infection. Importantly, in none of the phenotypic characterisation experiments 
was there observed a phenotype that was present in the double mutant but not in either single 
mutant. Thus there appears to be no or limited redundancy between the α–crystallins. Future 
experiments should include comparison of in vivo phenotypes of the single and double 
mutant strains during animal infection and also in other in vitro stress conditions such as 
surfactant cell surface stress. 
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Chapter 6 
General discussion & conclusion 
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6.0   General Discussion 
Tuberculosis remains a disease with high morbidity and mortality caused by  M. tuberculosis 
(WHO, 2015).  Humans get infected by inhaling microscopic aerosol droplets containing 
small numbers of bacilli (Kaufmann, 2001). In the terminal alveoli, the invading M. 
tuberculosis are engulfed by macrophages which migrate into the parenchyma of the lung 
and initiate formation of granulomatous lesions. The in vivo environment has the capacity to 
subject M. tuberculosis to many stresses, examples of which include nutrient limitation, 
hypoxia, oxidative stress, nitric oxide and low pH (Duque et al., 2014; Qualls and Murray, 
2016; Rohde et al., 2007; Schnappinger et al., 2003; Voskuil et al., 2003).  To survive this, 
the bacterium modulates the host immune response to limit exposure to the stresses (Ehrt 
and Schnappinger, 2009; Ehrt et al., 2001; Mahajan et al., 2012; McDonough et al., 1993) 
and also undergoes genome-wide changes in gene expression, which results in a changed 
physiological and metabolic state, such as dormancy (Fattorini et al., 2013; Gengenbacher 
and Kaufmann, 2012; Kelly and O'Neill, 2015; Mariotti et al., 2013; McKinney et al., 2000)  
These changes also result in the production of specific resistance mechanisms to the various 
stresses. A major requirement for the bacterial cell during stress is to up-regulate/activate 
systems that provide homeostasis for the protein component of the cell. This may include 
enzyme systems to degrade denatured, misfolded or truncated proteins generated under 
stress and also may include a group of so called heat shock proteins (Hsps). These Hsps are 
the molecular chaperones which function to bind denatured proteins to stop them 
aggregating and either encourage them to refold or traffic them to the aforementioned 
proteases. 
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Hsps are among the most up-regulated M. tuberculosis proteins following infection of the 
macrophage and some have been demonstrated to be essential for optimal growth in the in 
vivo environment (Monahan et al., 2001; Sherman et al., 2001; Stewart et al., 2005; Stewart 
et al., 2002a; Voskuil et al., 2004). This thesis considers the function of two molecular 
chaperones from a class of proteins known as the α-crystallins. Acr1 (HspX) is one of the 
many proteins which is regulated as part of the DosR regulon and is strongly induced by 
hypoxia (Sherman et al., 2001; Tabira et al., 1998; Voskuil et al., 2004; Yuan et al., 1998). 
Acr2 is also up-regulated during non-replicating persistence, including that induced under 
hypoxia, but it is not part of the DosR regulon. Instead it is regulated by a number of other 
systems that leads to its induction in response to many stresses  (Stewart et al., 2005) and it 
has been suggested to be associated with ribosomes during stress.  It is up-regulated more 
than any other gene during macrophage infection (Schnappinger et al., 2003). Thus, both α-
crystallins have been implicated as important during infection but there is a lack of detail 
regarding their specific functions and the degree of redundancy between them. Thus this 
thesis set out to test the below hypothesis: 
 
Hypothesis A 
There is some functional redundancy between the two α-crystallins and that one can 
compensate to some extent for the loss of the other. 
 
To begin to test Hypothesis A, this investigation compared the subcellular localisation of the 
α-crystallins in M. tuberculosis H37rv from stationary phase cultures.  The presence of Acr1 
and Acr2 was determined in different cellular fractions (culture supernatant, cell pellet, 
cytosolic and plasma membrane factions) by Western blot and the intracellular localisation 
of Acr1 and Acr2 was examined by immuno-electron microscopy.  
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The Acr1 immunogold electron microscopy showed localisation in all parts of the cell, with 
localisation biased to the cytoplasm of some cells and to the periphery in others.  This result 
largely agreed with the findings of Cunningham and Spreadbury (1998) and were consistent 
with Western blotting of the subcellular fractions of stationary phase BCG, in which Acr1 
was detected in all the fractions including the culture supernatant. In contrast, Acr2 was 
localized almost exclusively around the periphery of the cells and possibly associated with 
the presumed cell wall (that is seen as electron translucent zone) or on the cell membrane 
beneath it. Western blotting confirmed this localization with the immuno-reactivity only 
detected in the cell wall and plasma membrane fractions. Although, it has been reported that 
Acr2 is a ribosome associated protein and associated with the ribosomal 30S subunit (Ohara 
et al., 1997; Stewart et al., 2002a; Tabira et al., 2000), the findings in this study are not 
consistent with this and it is possible that the conclusions in the earlier studies (Ohara et al., 
1997; Tabira et al., 2000) resulted from the co-migration of Acr2-containg membrane/cell 
wall aggregates with ribosomes.  
 
Thus there were clearly differences in the subcellular distribution of the two M. 
tuberculosis/M. bovis (BCG str. Pasteur) α-crystallins. However, their overlapping 
subcellular localization on the cell wall/periphery of stationary phase bacteria may suggest 
some level of functional redundancy.  Unlike eukaryotic cells where damage is concentrated 
in the nuclei during heat shock, prokaryote heat shock is associated with the cytoplasmic 
membrane (Lindquist, 1986). Thus the identification that both Acr1 and Acr2 are associated 
with the cell wall puts them in the front line against heat shock and other surface stress. The 
α-crystallins belong to a class of heat shock proteins known as holdases which bind to their 
client proteins in an ATP-independent manner  (Basha et al., 2012). Therefore, their presence 
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in the cell wall/periphery of the cell is a logical assumption.  This ATP-independence also 
makes sense for these chaperones which are highly expressed in dormant bacilli with a very 
low metabolic activity. 
 
If there is functional redundancy for Acr1 and Acr2, it was anticipated that deletion of one 
chaperone would be partially compensated for by the remaining paralogue. To test this, we 
compared isogenic single mutants in acr1 and acr2 and a double mutant deleted of both acr1 
and acr2 in several in vitro stresses and during intracellular growth in macrophages. Except 
for Acr1 in heat shock, deficiency of neither of the two α-crystallins was important for 
survival in any of the stress conditions tested and no redundancy in function was detected. 
In retrospect, the obvious omission from these experiments was the inclusion of a cell wall 
specific stress such as a surfactant. These are known to induce expression of Acr2 
specifically via SigE and MprA/B and given the knowledge from the immune-electron 
microscopy and Western blots that Acr2 is localised almost exclusively in the cell wall, it 
would be reasonable to suggest that cells deficient in Acr2 may be sensitive to surface stress. 
Investigating if Acr1, with its lesser localisation in the cell wall, could compensate for any 
sensitivity to cell surface stress would be an important experiment to determine functional 
redundancy between the α-crystallins. 
 
In macrophages, loss of acr1 in both the single mutant and in combination with deletion of 
acr2 led to an elevated bacterial load at 24hr and 48hrs but a reduction in bacterial survival 
at 84 hrs. This is consistent with previous studies (Yuan et al., 1998) and contrasted with the 
Δacr2 mutant which survived equally as well as the wild-type throughout the experiment 
but induced less host cell cytotoxicity than the wild type M. tuberculosis H37Rv.    
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Taken together, the experiments in this thesis strongly indicate that the two α-crystallins of 
M. tuberculosis H37rv have different functions: they are localised in different parts of the 
cell and their individual deletion confers different phenotypes during macrophage infection. 
Importantly, in none of the phenotypic characterisation experiments was there observed a 
phenotype that was present in the double mutant but not in either single mutant. Thus we 
have no evidence to support Hypothesis A that “There is some functional redundancy 
between the two α-crystallins and that one can compensate to some extent for the loss of the 
other”. However, future experiments, including comparison of the in vivo phenotypes of the 
single and double mutant strains during animal infection and also in other in vitro stress 
conditions, such as surfactant cell surface stress, could yet reveal at least some overlap in 
function. 
 
The other aspect of this thesis is the transfer-messenger RNA (tmRNA) system of M. 
tuberculosis which has been shown in several bacteria to play an essential role in protein 
homeostasis in stress conditions (Keiler, 2008; Keiler and Shapiro, 2003; Komine et al., 
1994; Moore and Sauer, 2007; Oh and Apirion, 1991). It functions to rescue stalled 
ribosomes concurrently with tagging the truncated nascent protein to target it for degradation 
by the stress responsive Clp protease. Of particular interest tmRNA mediated trans-
translation may play a role in the expression of major Hsp/chaperones in the actinomycete 
Streptomyces coelicolor (Barends et al., 2010) and in M. tuberculosis is reported to play a 
role in its persistence (Shi et al., 2011). However, at the beginning of the present project 
there was little known about tmRNA in Mycobacteria because there was no description in 
the literature of the M. tuberculosis tmRNA target proteins and no study of the phenotype of 
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tmRNA null mutants. This information may be useful in the identification of new therapeutic 
targets against TB.  Therefore, this study was designed to test the following hypothesis: 
 
 
Hypothesis B 
Transfer messenger RNA (tmRNA) is involved in the translation of stress proteins during 
the stress response  
 
To test Hypothesis B that “Transfer messenger RNA (tmRNA) is involved in the translation 
of stress proteins during the stress response”, it was attempted to delete the ssrA gene which 
encodes tmRNA from M. tuberculosis H37Rv. In the present study, it was not possible to 
delete ssrA unless a second functional copy of ssrA was provided elsewhere on the genome. 
This suggested that tmRNA is an essential molecule for M. tuberculosis H37Rv. It was not 
possible to delete the ssrA when a second recombinant was provided with the protease tag 
coding sequence replaced with sequence encoding a run of histidines (ssrA9His). This 
suggested that tmRNA is essential in M. tuberculosis H37rv and moreover that the protease 
tagging function of tmRNA is an essential function. Since starting this project, a paper was 
published (Personne and Parish, 2014) that similarly describes experiments that indicate that 
tmRNA is essential although in this case the authors provided evidence that the protease 
tagging function was not an essential role. This discrepancy between conclusions is 
discussed further in Chapter 3, but the most important finding is the essentiality of tmRNA 
as this highlights this molecule as a potential target for anti-mycobacterial drugs. Indeed, it 
has been revealed that tmRNA is a target for pyrazinamide (Shi et al., 2011; Yang et al., 
2015)   
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To try to reveal the protein substrate targets for tmRNA and to determine if it is directly 
involved in translation of stress induced molecular chaperones as observed in the related 
actinomycete, Streptomyces (Barends et al., 2010)  we generated merodiploid strains of 
mycobacteria that expressed the ssrAHis genes in addition to the wild-type ssrA. The intention 
was to generate recombinant strains in which a proportion of the tmRNA protein substrates 
would be tagged with histidines instead of the Clp protease recognition tag. Subsequently, 
the His tagged proteins could be purified and identified as performed in Streptomyces 
(Barends et al., 2010). Despite an exhaustive array of experiments with different ssrAHis 
expression constructs and recombinant mycobacterial strains, the investigations failed to 
identify any His-labelled proteins. Experiments with some of the ssrAHis recombinant strains 
suggested that expression of the ssrAHis inhibited bacterial growth. Thus, the experiments 
described do not provide any evidence to support Hypothesis B that the mycobacterial 
tmRNA is directly involved in the translation of stress proteins as demonstrated in 
Streptomyces.  
 
Further work is clearly needed to elucidate the role of tmRNA.   Analysis of the accumulation 
of tagged proteins in ssrADD and ssrAHis expressing mycobacterial strains will help to 
understand the contrasting results reported in this and in the study of Personne et al 2014. In 
addition, research should incorporate analysis of the interaction of tmRNA with the 
translation machinery, possibly with an affinity tagged tmRNA to pull down interacting 
proteins and RNAs. Experiments examining the interactions between tmRNA, toxin-
antitoxin systems and ClpP may also help to understand the role of tmRNA in the growth 
regulation of mycobacteria. 
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6.1 Conclusion  
In conclusion although both acr1 and acr2 are important for Mycobacterium tuberculosis 
infection, in this study they were shown to be localised in different parts of the cell and 
individual deletion did confer a different phenotype in macrophage infection.  As the double 
mutant did not show a different phenotype from the individual deletion in the different 
characterisation experiments therefore, there is no evidence to support the hypothesis that 
“There is some functional redundancy between the two α-crystallins and that one can 
compensate to some extent for the loss of the other” 
 
As regards to the deletion of the ssrA, it was not possible to delete it unless a second 
functional copy was present elsewhere in the genome which agreed with what has since been 
described in literature. However, the findings of this study disagree with the literature as 
regards to the essentiality of the degradation tagging. Whilst Personne et al 2014 are of the 
opinion that tagging is not essential, the findings of this study has led us to believe that it is. 
However, there is insufficient evidence to support hypothesis B “Transfer messenger RNA 
(tmRNA) is involved in the translation of stress proteins during the stress response”. 
Therefore, further work is recommended for fully elucidate the role of tmRNA in trans-
translation of stress proteins. 
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Appendix 8.1. pH  repeat experiment graphs 
 
  
 
Growth/survival of wild type M. tuberculosis H37Rv, M. tuberculosis H37rv Δacr1, M. tuberculosis H37rv 
Δacr2 and M. tuberculosis H37rv Δacr1Δacr2 and their complemented strains except M. tuberculosis H37rv 
Δacr1 comp in different pH. The different strains incubated in Roisin’s medium at pH 6.6 and 4.4 for 7days 
and cell viability assessed by plating on 7H11 and counting cfus. Three biological replicates for each. Error 
bars represent standard error of the mean of three independent replicates. Statistical significance was assessed 
by Tukey’s multiple comparisons test. 
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Growth/survival of wild type M. tuberculosis H37Rv, M. tuberculosis H37rv Δacr1, M. tuberculosis H37rv 
Δacr2 and M. tuberculosis H37rv Δacr1Δacr2 and their complemented strains except M. tuberculosis H37rv 
Δacr1 comp in different pH. The different strains incubated in Roisin’s medium at pH 6.6 and 4.4 for 7 days 
and cell viability assessed by plating on 7H11 and counting cfus. Survival is shown as percentage of the input 
count for each strain. Three biological replicates for each. Error bars represent standard error of the mean of 
three independent replicates. Statistical significance was assessed by Tukey’s multiple comparisons test. 
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Appendix 8.2. H2O2 repeat experiment graphs 
 
 
Wild type M. tuberculosis H37Rv, M. tuberculosis H37rv Δacr1, M. tuberculosis H37rv Δacr2 and M. 
tuberculosis H37rv Δacr1Δacr2 and their complemented strains except M. tuberculosis H37rv Δacr1 comp 
were grown to mid log phase, washed and diluted to an OD of 0.4 The different strains were incubated for two 
hours in 0mM 10mM and 20mM H2O2. A sample was taken at different time points for viability counting on 
7H11 media. Three biological replicates for each.  Error bars represent standard error of the mean of three 
independent replicates. Statistical significance was assessed by Tukey’s multiple comparisons test. 
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Wild type M. tuberculosis H37Rv, M. tuberculosis H37rv Δacr1, M. tuberculosis H37rv Δacr2 and M. 
tuberculosis H37rv Δacr1Δacr2 and their complemented strains except M. tuberculosis H37rv Δacr1 comp 
were grown to mid log phase, washed and diluted to an OD of 0.4 The different strains were incubated for two 
hours in 0mM 10mM and 20mM H2O2. A sample was taken at different time points for viability counting on 
7H11 media. Survival is shown as percentage of survival for each strain in Roisin’s medium alone. Three 
biological replicate for each.  Error bars represent standard error of the mean of three independent replicates. 
Statistical significance was assessed by Tukey’s multiple comparisons test. 
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Appendix 8.3. THP-1 repeat  experiment graphs  
 
 
 
 Viable bacterial counts from THP-1 macrophages infected at MOI of 0.1 with M. tuberculosis H37Rv, M. 
tuberculosis H37rv Δacr1, M. tuberculosis H37rv Δacr2 and M. tuberculosis H37rv Δacr1Δacr2 and their 
complemented strains except M. tuberculosis H37rv Δacr1comp. Three technical replicates. Error bars 
represent standard error of the mean of three independent replicates. Statistical significance was assessed by 
Tukey’s multiple comparisons test. 
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Number of THP-1 macrophages assessed by crystal violet staining in in vitro infections at MOI of 0.1 with M. 
tuberculosis H37Rv, M. tuberculosis H37rv Δacr1, M. tuberculosis H37rv Δacr2 and M. tuberculosis H37rv 
Δacr1Δacr2 and their complemented strains except M. tuberculosis H37rv Δacr1 comp.  The error bars are the 
standard error of the mean. 
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Appendix 8.4. Hypoxia repeat experiment 
 
The graph shows the result of microaerophilic/hypoxia stress on the different M. tuberculosis H37rv strains. 
The different M. tuberculosis H37rv strains were grown in 7H9 containing 10% ADC and 0.1% Tween80 until 
mid-log phase. The cultures were adjusted to the same OD. Replicate 1 ml volumes of the respective cultures 
were distributed into 2ml O-ringed screw capped tubes and layered with 0.5ml of sterile mineral oil.  The tubes 
were incubated still at 37oC for 30 days. Results show the mean of triplicate cultures at each time point. Error 
bars represent standard error of the mean of three independent replicates. Statistical significance was assessed 
by Tukey’s multiple comparisons test. 
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Appendix 8.5. Heat shock repeat experiment 
 
 
 
 
The different strains were incubated for two hours in 53oC. A sample was taken at different time points 
for viability count by plating on 7H11 media and counting cfu after 21 days. Two technical replicate for 
each. Error bars show the standard error of the mean. The threshold of detection is 167 cfu/ml 
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Appendix 8.6. Checking M. smegmatis groEL1ΔC    
To check that the histidine at the C-terminal of the GroEL was actually removed from the 
strain received, the PCR primers were designed 65bp upstream (forward primer) and 196bp 
down stream (reverse primer) amplify inward across GroEL1 gene to give a product size of 
1842bp.  As it can be seen in the gel picture  (Figure 62) the right size fragment was 
amplified. 
 
Figure 61: GroEL1 down and up-stream schematic diagram 
Schematic diagram representing M. smegmatis groEL1ΔC genome showing the annealing sites 
of the two primers used to amplify inward across the GroEL1 gene for sequencing. The 
successful amplification should produce a PCR fragment of 1842bp  
 
	
Figure 62: M. smegmatis groEL1ΔC    PCR fragment 
Gel (1% agarose, TAE) picture shows the PCR products amplified by using primers xxx that 
were designed to anneal outside the flaking regions of M. smegmatis groEL1ΔC   genes inward 
across it. The expected 1824bp PCR products is shown. 
 
  
1671541	position	in	genome 
 
GroEL1 196	down	stream 65bp	upstream 
1673383	position	in	genome 
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The amplified PCR product was sent for sequencing and the obtained sequence confirmed 
the deletion of the histidine rich region of the M. smegmatis groEL1ΔC GroEL1 C-terminal 
 
WT Mycobacteria smegmatis GroEL1 sequence 
GCCTCGACGGTTCCGTCGTGGTGAACAAGGTCTCCGAACTTCCCAAGGGGCAG
GGCTTCAACGCCGCCACGCTGGAGTTCGGTGATCTGGTCTCCGCCGGCGTCGT
CGATCCGGCCAAGGTGACCCGCTCGGCTGTTCTCAACGCCGCCTCGGTGGCCC
GGATGATCCTGACGACGGAGACCGCCGTCGTCGACAAGCCGGCCGACGAGGA
CGAGCACGGCCACGGCCACCACCACGGCCACGCTCACTGA 
PADEDEHGHGHHHGHAHStop 
  
 M. smegmatis groEL1ΔC   obtained sequence 
CGGCTCCGCTCTACTGGATCGCCACCAACGCCGGCCTCGACGGTTCCGTCGTG
GTGAACAAGGTCTCCGAACTTCCCAAGGGGCAGGGCTTCAACGCCGCCACGCT
GGAGTTCGGTGATCTGGTCTCCGCCGGCGTCGTCGATCCGGCCAAGGTGACCC
GCTCGGCTGTTCTCAACGCCGCCTCGGTGGCCCGGATGATCCTGACGACGGAG
ACCGCCGTCGTCGACAAGCCGGCCGACGAGGACGAGTCTAGAACCGGTGTATC
CTAAAT 
PADEDESRTGVSStop 
 Figure 63   M. smegmatis groEL1ΔC sequence 
A segment of the C-terminal sequence of GroEL1 ΔC seen in red after being sequenced 
compared to the WT M. smegmatis GroEL1 sequence.  
The sequencing confirmed that the C-terminal histidine region was indeed deleted from the 
GroEL of the received strain. Although M. smegmatis groEL1ΔC   parent strain did not have 
histidine rich C-terminal, the western results suggested there is still some residual Histidine 
rich proteins that are in adequate concentration to give positive bands.    
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Appendix 8.7. acr2 deletion sequence confirmation  
 
Alignment output for M. tuberculosis Dacr2   vs. WT M. tuberculosis 
 
 
 
 
# bin/lalign36 -E 10.0 -f -12 -g -2 ./wwwtmp/lalign26729.1.seq 
./wwwtmp/lalign26729.2.seq -J -K 3 
LALIGN finds non-overlapping local alignments 
 version 36.3.5e Nov, 2012(preload8) 
Please cite: 
 X. Huang and W. Miller (1991) Adv. Appl. Math. 12:373-381 
 
Parameters not available for: +5/-4: -12/-2 
Query: ./wwwtmp/lalign26729.1.seq 
  1>>>KO 1116 bp - 1116 nt 
Library: ./wwwtmp/lalign26729.2.seq 
     1260 residues in     1 sequences 
 
Statistics: (shuffled [500]) MLE statistics: Lambda= 0.0418;  K=0.01246 
 statistics sampled from 1 (1) to 500 sequences 
Threshold: E() < 10 score: 178 
Algorithm: Smith-Waterman (SSE2, Michael Farrar 2006) (7.2 Nov 2010) 
Parameters: +5/-4 matrix (5:-4), open/ext: -12/-2 
 Scan time:  0.340 
 
>>WT M. tuberculosis 1260 bp                              (1260 nt) 
 Waterman-Eggert score: 1905;  121.3 bits; E(1) <  4.2e-31 
89.5% identity (89.5% similar) in 486 nt overlap (578-100:1-472) 
 
             570       560       550       540       530       520  
KO     TCCGCAGCGACCCGTCCGCGTCACGGGCACGCACCGCTTCGACCAGCCGATGGCCCACCA 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
WT     TCCGCAGCGACCCGTCCGCGTCACGGGCACGCACCGCTTCGACCAGCCGATGGCCCACCA 
               10        20        30        40        50        60 
 
             510       500       490       480       470       460  
KO     TGCCGTGGCCGACCACGACGATCTCGCGAGCCGCGGCAGGCGCGCGCGAACTCCCAGCCG 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
WT     TGCCGTGGCCGACCACGACGATCTCGCGAGCCGCGGCAGGCGCGCGCGAACTCCCAGCCG 
               70        80        90       100       110       120 
 
             450       440       430       420       410       400  
KO     TAGGCATGGTCTGAGGGTATGAGGGGCAAATTACCGAAAAATCGCCGAATGTGACGCACA 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
WT     TAGGCATGGTCTGAGGGTATGAGGGGCAAATTACCGAAAAATCGCCGAATGTGACGCACA 
              130       140       150       160       170       180 
 
             390       380       370       360       350       340  
KO     TATGACGCTGTGATCACACCTGGCGACCGGCTGTGTGACAGTGTTCGCTTCCGGTGAACG 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
WT     TATGACGCTGTGATCACACCTGGCGACCGGCTGTGTGACAGTGTTCGCTTCCGGTGAACG 
              190       200       210       220       230       240 
 
             330       320       310       300       290       280  
KO     CCGAGGTGGAACTTAAGCGTGGTCGACTCAGGTTCTTGGTATAGCGGGCCGGCAACGCGC 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
WT     CCGAGGTGGAACTTAAGCGTGGTCGACTCAGGTTCTTGGTATAGCGGGCCGGCAACGCGC 
              250       260       270       280       290       300 
 
             270       260       250       240       230       220  
KO     CGGACACAGCTAACTCACAACGAAGCATGAGGAGATAACCATGAACAATCTCGCATTGTG 
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       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
WT     CGGACACAGCTAACTCACAACGAAGCATGAGGAGATAACCATGAACAATCTCGCATTGTG 
              310       320       330       340       350       360 
 
             210       200          190       180       170         
KO     GTCGCGTCCGGTTCTAGTGGGCCCGT---CCCCGACGTGGCCGACCAGCCCGTCATCGTC 
       ::::::::::::    ::::: :  :   ::: :     :: : : : :  : : :: :: 
WT     GTCGCGTCCGGT----GTGGGACGTTGAGCCCTGGGACCGCTGGCTA-CGTGACTTCTTC 
              370           380       390       400        410      
 
      160       150        140       130       120          110     
KO     AACGCCTGATCCGCGGTG-CGGACAGGCCGTGTCGCGACCGGCCGTGCGGAA---TTAAG 
         : ::::  :::::  : ::::: ::     :  :: :::: ::  ::::    : : : 
WT     GGC-CCTG--CCGCGACGACGGACTGG-----TACCGCCCGGTCGC-CGGAGACTTCACG 
          420         430            440       450        460       
 
The bases in red are the last few bases upstream of the acr2 after which the hygromycin gene replaced the 
acr2 gene indicating the successful gene replacement. 
   
Mycobacterium tuberculosis H37Rv, complete genome 
Sequence ID: ref|NC_000962.3|Length: 4411532Number of Matches: 1 
  
Alignment statistics for match #1 
Score Expect Identities Gaps Strand 
134 bits(72) 5e-29 72/72(100%) 0/72(0%) Plus/Minus 
Features: 
heat shock protein 
Query  1       CGGACACAGCTAACTCACAACGAAGCATGAGGAGATAACCATGAACAATCTCGCATTGTG  60 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  302692  CGGACACAGCTAACTCACAACGAAGCATGAGGAGATAACCATGAACAATCTCGCATTGTG  
302633 
 
Query  61      GTCGCGTCCGGT  72 
               |||||||||||| 
Sbjct  302632  GTCGCGTCCGGT  302621 
 
These are the bases seen in red in the alignment above confirming the presence of the acr2 in the WT M. 
tuberculosis and its absence from  M. tuberculosis Dacr2   
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 Alignment  output for M. tuberculosis Dacr2    vs. WT M. tuberculosis 
 
  
 
 
 
# bin/lalign36 -E 10.0 -f -12 -g -2 ./wwwtmp/lalign4352.1.seq 
./wwwtmp/lalign4352.2.seq -J -K 3 
LALIGN finds non-overlapping local alignments 
 version 36.3.5e Nov, 2012(preload8) 
Please cite: 
 X. Huang and W. Miller (1991) Adv. Appl. Math. 12:373-381 
 
Parameters not available for: +5/-4: -12/-2 
Query: ./wwwtmp/lalign4352.1.seq 
  1>>>KO 1054 bp - 1054 nt 
Library: ./wwwtmp/lalign4352.2.seq 
     1260 residues in     1 sequences 
 
Statistics: (shuffled [500]) MLE statistics: Lambda= 0.0482;  K=0.008354 
 statistics sampled from 1 (1) to 500 sequences 
Threshold: E() < 10 score: 146 
Algorithm: Smith-Waterman (SSE2, Michael Farrar 2006) (7.2 Nov 2010) 
Parameters: +5/-4 matrix (5:-4), open/ext: -12/-2 
 Scan time:  0.370 
 
>>WT M. tuberculosis 1260 bp                              (1260 nt) 
 Waterman-Eggert score: 2357;  170.7 bits; E(1) <  5.4e-46 
88.2% identity (88.2% similar) in 618 nt overlap (3-613:652-1260) 
 
             10        20        30        40        50         60  
KO     GCCCGCGAACTGCTCGCCTTCACCTTCCTGCACGACTTCGAGGTGTTCGAGGA-GACCCC 
       ::  : :: : :::     :::  ::::  : :   :::  : ::  :: : : : : :: 
WT     GCGTGAGATCCGCTACGGATCA--TTCCGCCGCTCGTTCCGGCTGCCCGCGCACGTCACC 
             660       670         680       690       700          
 
              70         80        90       100       110           
KO     GCTGGATCTCTC-CGGCTTCACCGATCCGGAGGAACTGGCGCAGTTCCTCTGGGG-GCCG 
          :   :  :: :::::::  : ::   :: :     : :: :  : :: :::  :::: 
WT     AGCGAGGCCATCGCGGCTTC--CTAT---GACGCCGGTGTGCTGACCGTCCGGGTTGCCG 
     710       720         730          740       750       760     
 
     120         130         140       150       160       170      
KO     CCGG--ACACCGCCCCCGGCGC--CTGAAGATCTCAGCGCATCGCCATCACGAAGTAGTT 
        ::   :::  ::::: : ::   :: : :  : :::::::::::::::::::::::::: 
WT     GCGCCTACAAGGCCCCAGCCGAAACTCAGG--CGCAGCGCATCGCCATCACGAAGTAGTT 
          770       780       790         800       810       820   
 
         180       190       200       210       220       230      
KO     CGCGATACGGCATGATCCGGCCGGGCCGATGGGTCCGCCGGATCATGCCATTGGGCCGAG 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
WT     CGCGATACGGCATGATCCGGCCGGGCCGATGGGTCCGCCGGATCATGCCATTGGGCCGAG 
            830       840       850       860       870       880   
 
         240       250       260       270       280       290      
KO     TAGACCCAACGACTCCGTCCGTCGATAGCTAGTATCGGGAGCGTACTGTGATCTGTAACA 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
WT     TAGACCCAACGACTCCGTCCGTCGATAGCTAGTATCGGGAGCGTACTGTGATCTGTAACA 
            890       900       910       920       930       940   
 
         300       310       320       330       340       350      
KO     CCGCCAGCCCAGGGAGCACCCATTGTCCACGACTGCCGAACTCGCCGAACTGCACGACCT 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
WT     CCGCCAGCCCAGGGAGCACCCATTGTCCACGACTGCCGAACTCGCCGAACTGCACGACCT 
   
 240 
            950       960       970       980       990      1000   
 
         360       370       380       390       400       410      
KO     CGTCGGCGGACTGCGGCGGTGCGTGACCGCACTGAAGGCGCGATTCGGCGACAACCCGGC 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
WT     CGTCGGCGGACTGCGGCGGTGCGTGACCGCACTGAAGGCGCGATTCGGCGACAACCCGGC 
           1010      1020      1030      1040      1050      1060   
 
         420       430       440       450       460       470      
KO     AACGCGTCGCATCGTGATCGATGCCGACCGGATCCTCACCGACATCGAATTGCTCGACAC 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
WT     AACGCGTCGCATCGTGATCGATGCCGACCGGATCCTCACCGACATCGAATTGCTCGACAC 
           1070      1080      1090      1100      1110      1120   
 
         480       490       500       510       520       530      
KO     CGACGTCTCTGAATTAGACCTGGAACGGGCCGCCGTACCGCAACCCAGCGAGAAAATCGC 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
WT     CGACGTCTCTGAATTAGACCTGGAACGGGCCGCCGTACCGCAACCCAGCGAGAAAATCGC 
           1130      1140      1150      1160      1170      1180   
 
         540       550       560       570       580       590      
KO     CATCCCCGACACCGAGTACGATCGCGAATTTTGGCGCGATGTCGACGATGAGGGTGTCGG 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
WT     CATCCCCGACACCGAGTACGATCGCGAATTTTGGCGCGATGTCGACGATGAGGGTGTCGG 
           1190      1200      1210      1220      1230      1240   
 
The bases in red are the few bases down stream of acr2 after the sequence of hygromycin gene that replaced 
the acr2 gene indicating the successful gene replacement. 
 
Mycobacterium tuberculosis H37Rv, complete genome 
Sequence ID: ref|NC_000962.3|Length: 4411532Number of Matches: 4 
  Match 
Alignment statistics for match #1 
Score Expect Identities Gaps Strand 
56.0 bits(28) 3e-06 28/28(100%) 0/28(0%) Plus/Minus 
Features: 
heat shock protein 
Query  1       CGCAGCGCATCGCCATCACGAAGTAGTT  28 
               |||||||||||||||||||||||||||| 
Sbjct  302198  CGCAGCGCATCGCCATCACGAAGTAGTT  302171 
 
 
These are the bases seen in red in the alignment above confirming the presence of the acr2 in the WT M. 
tuberculosis and its absence from  M. tuberculosis Dacr2   
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Appendix 8.8. pK.smpB-Rv3099c-ssrA construct map 
 
 
 
pK-smpB-Rv3099c-ssrA construct map showing the smpB-Rv3099c-ssrA9His gene complex cloned at the SacI 
site.  This construct was used to produce smpB-Rv3099c-ssrA9His  which then was introduced into M. smegmatis 
groEL1DC parental strain and M. smegmatis groEL1DC Δlon to produce smpB-Rv3099c-ssrA9His merodiploid 
strains. 
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Appendix 8.9. pMV361-smpB-Rv3099c-ssrA9His construct map 
 
 
 
 
pmv361-smpB-Rv3099c-ssrA-9His construct map showing the smpB-Rv3099c-ssrA9His gene complex 
directionally cloned at HindIII and EcoRI sites. This construct was introduced into M. smegmatis groEL1DC 
parental strain and M. smegmatis groEL1DC Δlon to produce smpB-Rv3099c-ssrA9His merodiploid strains.    
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Appendix 8.10. ssrA6His sequence comparison with ssrA9His 
 
         TCAAGGGAAGCGTGCCGGTGCAGGCAAGAGACCACCGTAAGCGTCGTTGCGACCAAATAA 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
ssrA9H TCAAGGGAAGCGTGCCGGTGCAGGCAAGAGACCACCGTAAGCGTCGTTGCGACCAAATAA 
              550       560       570       580       590       600 
 
       190       180       170       160       150       140        
ssrA6H GCGCCGATTCACATCAGCGCCACCACCACCACCATCACTAATGGTCGTGTGGTGTGGCAG 
       :::::::::::::::: : ::::::::::::::::::::::::::::::::::::::::: 
ssrA9H GCGCCGATTCACATCACCACCACCACCACCACCATCACTAATGGTCGTGTGGTGTGGCAG 
              610       620       630       640       650       660 
 
       130       120       110       100        90        80        
ssrA6H ACCGGGAACGCCCTCGGCCCGGACCCTGGCATCAGCTAGAGGGATCCACCGATGAGTCCG 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
ssrA9H ACCGGGAACGCCCTCGGCCCGGACCCTGGCATCAGCTAGAGGGATCCACCGATGAGTCCG 
 
The sequence to confirm the successful mutagenesis to restore the arginine and glutamine and produce the 
ssrA6His variant. 
 
 
